#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Sample entropy reveals an age-related reduction in the complexity of dynamic brain
#Text=Dynamic reconfiguration of the human brain is characterized by the nature of complexity.
1-1	0-6	Sample	_	
1-2	7-14	entropy	_	
1-3	15-22	reveals	_	
1-4	23-25	an	_	
1-5	26-37	age-related	_	
1-6	38-47	reduction	_	
1-7	48-50	in	_	
1-8	51-54	the	_	
1-9	55-65	complexity	_	
1-10	66-68	of	_	
1-11	69-76	dynamic	_	
1-12	77-82	brain	_	
1-13	83-90	Dynamic	_	
1-14	91-106	reconfiguration	_	
1-15	107-109	of	_	
1-16	110-113	the	_	
1-17	114-119	human	_	
1-18	120-125	brain	_	
1-19	126-128	is	_	
1-20	129-142	characterized	_	
1-21	143-145	by	_	
1-22	146-149	the	_	
1-23	150-156	nature	_	
1-24	157-159	of	_	
1-25	160-170	complexity	_	
1-26	170-171	.	_	

#Text=The purpose of this study was to measure such complexity and also analyze its association with age.
2-1	172-175	The	_	
2-2	176-183	purpose	_	
2-3	184-186	of	_	
2-4	187-191	this	_	
2-5	192-197	study	_	
2-6	198-201	was	_	
2-7	202-204	to	_	
2-8	205-212	measure	_	
2-9	213-217	such	_	
2-10	218-228	complexity	_	
2-11	229-232	and	_	
2-12	233-237	also	_	
2-13	238-245	analyze	_	
2-14	246-249	its	_	
2-15	250-261	association	_	
2-16	262-266	with	_	
2-17	267-270	age	_	
2-18	270-271	.	_	

#Text=We modeled the dynamic reconfiguration process by dynamic functional connectivity, which was established by resting-state functional magnetic resonance imaging (fMRI) data, and we measured complexity within the dynamic functional connectivity by sample entropy (SampEn).
3-1	272-274	We	_	
3-2	275-282	modeled	_	
3-3	283-286	the	_	
3-4	287-294	dynamic	_	
3-5	295-310	reconfiguration	_	
3-6	311-318	process	_	
3-7	319-321	by	_	
3-8	322-329	dynamic	_	
3-9	330-340	functional	_	
3-10	341-353	connectivity	_	
3-11	353-354	,	_	
3-12	355-360	which	_	
3-13	361-364	was	_	
3-14	365-376	established	_	
3-15	377-379	by	_	
3-16	380-393	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
3-17	394-404	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
3-18	405-413	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
3-19	414-423	resonance	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
3-20	424-431	imaging	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
3-21	432-433	(	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
3-22	433-437	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
3-23	437-438	)	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
3-24	439-443	data	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
3-25	443-444	,	_	
3-26	445-448	and	_	
3-27	449-451	we	_	
3-28	452-460	measured	_	
3-29	461-471	complexity	_	
3-30	472-478	within	_	
3-31	479-482	the	_	
3-32	483-490	dynamic	_	
3-33	491-501	functional	_	
3-34	502-514	connectivity	_	
3-35	515-517	by	_	
3-36	518-524	sample	_	
3-37	525-532	entropy	_	
3-38	533-534	(	_	
3-39	534-540	SampEn	_	
3-40	540-541	)	_	
3-41	541-542	.	_	

#Text=A brainwide map of SampEn in healthy subjects shows larger values in the caudate, the olfactory gyrus, the amygdala, and the hippocampus, and lower values in primary sensorimotor and visual areas.
4-1	543-544	A	_	
4-2	545-554	brainwide	_	
4-3	555-558	map	_	
4-4	559-561	of	_	
4-5	562-568	SampEn	_	
4-6	569-571	in	_	
4-7	572-579	healthy	_	
4-8	580-588	subjects	_	
4-9	589-594	shows	_	
4-10	595-601	larger	_	
4-11	602-608	values	_	
4-12	609-611	in	_	
4-13	612-615	the	_	
4-14	616-623	caudate	_	
4-15	623-624	,	_	
4-16	625-628	the	_	
4-17	629-638	olfactory	_	
4-18	639-644	gyrus	_	
4-19	644-645	,	_	
4-20	646-649	the	_	
4-21	650-658	amygdala	_	
4-22	658-659	,	_	
4-23	660-663	and	_	
4-24	664-667	the	_	
4-25	668-679	hippocampus	_	
4-26	679-680	,	_	
4-27	681-684	and	_	
4-28	685-690	lower	_	
4-29	691-697	values	_	
4-30	698-700	in	_	
4-31	701-708	primary	_	
4-32	709-721	sensorimotor	_	
4-33	722-725	and	_	
4-34	726-732	visual	_	
4-35	733-738	areas	_	
4-36	738-739	.	_	

#Text=Association analysis in healthy subjects indicated that SampEn of the amygdala-cortical connectivity decreases with advancing age.
5-1	740-751	Association	_	
5-2	752-760	analysis	_	
5-3	761-763	in	_	
5-4	764-771	healthy	_	
5-5	772-780	subjects	_	
5-6	781-790	indicated	_	
5-7	791-795	that	_	
5-8	796-802	SampEn	_	
5-9	803-805	of	_	
5-10	806-809	the	_	
5-11	810-827	amygdala-cortical	_	
5-12	828-840	connectivity	_	
5-13	841-850	decreases	_	
5-14	851-855	with	_	
5-15	856-865	advancing	_	
5-16	866-869	age	_	
5-17	869-870	.	_	

#Text=Such age-related loss of SampEn, however, disappears in patients with schizophrenia.
6-1	871-875	Such	_	
6-2	876-887	age-related	_	
6-3	888-892	loss	_	
6-4	893-895	of	_	
6-5	896-902	SampEn	_	
6-6	902-903	,	_	
6-7	904-911	however	_	
6-8	911-912	,	_	
6-9	913-923	disappears	_	
6-10	924-926	in	_	
6-11	927-935	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[2]	
6-12	936-940	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[2]	
6-13	941-954	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[2]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[3]	
6-14	954-955	.	_	

#Text=These findings suggest that SampEn of the dynamic functional connectivity is a promising indicator of normal aging.
7-1	956-961	These	_	
7-2	962-970	findings	_	
7-3	971-978	suggest	_	
7-4	979-983	that	_	
7-5	984-990	SampEn	_	
7-6	991-993	of	_	
7-7	994-997	the	_	
7-8	998-1005	dynamic	_	
7-9	1006-1016	functional	_	
7-10	1017-1029	connectivity	_	
7-11	1030-1032	is	_	
7-12	1033-1034	a	_	
7-13	1035-1044	promising	_	
7-14	1045-1054	indicator	_	
7-15	1055-1057	of	_	
7-16	1058-1064	normal	_	
7-17	1065-1070	aging	_	
7-18	1070-1071	.	_	

#Text=Introduction
#Text=Complexity is one of the defining natures of the brain.
8-1	1072-1084	Introduction	_	
8-2	1085-1095	Complexity	_	
8-3	1096-1098	is	_	
8-4	1099-1102	one	_	
8-5	1103-1105	of	_	
8-6	1106-1109	the	_	
8-7	1110-1118	defining	_	
8-8	1119-1126	natures	_	
8-9	1127-1129	of	_	
8-10	1130-1133	the	_	
8-11	1134-1139	brain	_	
8-12	1139-1140	.	_	

#Text=Brain signals measured by neuroimaging techniques reflect the collective activities of populations of neurons with different rhythms.
9-1	1141-1146	Brain	_	
9-2	1147-1154	signals	_	
9-3	1155-1163	measured	_	
9-4	1164-1166	by	_	
9-5	1167-1179	neuroimaging	_	
9-6	1180-1190	techniques	_	
9-7	1191-1198	reflect	_	
9-8	1199-1202	the	_	
9-9	1203-1213	collective	_	
9-10	1214-1224	activities	_	
9-11	1225-1227	of	_	
9-12	1228-1239	populations	_	
9-13	1240-1242	of	_	
9-14	1243-1250	neurons	_	
9-15	1251-1255	with	_	
9-16	1256-1265	different	_	
9-17	1266-1273	rhythms	_	
9-18	1273-1274	.	_	

#Text=Because the rhythm of neurons can be periodic, chaotic, or random, brain signals would show different levels of complexity, which has been demonstrated by entropy analysis of blood oxygenation level–dependent (BOLD) signals.
10-1	1275-1282	Because	_	
10-2	1283-1286	the	_	
10-3	1287-1293	rhythm	_	
10-4	1294-1296	of	_	
10-5	1297-1304	neurons	_	
10-6	1305-1308	can	_	
10-7	1309-1311	be	_	
10-8	1312-1320	periodic	_	
10-9	1320-1321	,	_	
10-10	1322-1329	chaotic	_	
10-11	1329-1330	,	_	
10-12	1331-1333	or	_	
10-13	1334-1340	random	_	
10-14	1340-1341	,	_	
10-15	1342-1347	brain	_	
10-16	1348-1355	signals	_	
10-17	1356-1361	would	_	
10-18	1362-1366	show	_	
10-19	1367-1376	different	_	
10-20	1377-1383	levels	_	
10-21	1384-1386	of	_	
10-22	1387-1397	complexity	_	
10-23	1397-1398	,	_	
10-24	1399-1404	which	_	
10-25	1405-1408	has	_	
10-26	1409-1413	been	_	
10-27	1414-1426	demonstrated	_	
10-28	1427-1429	by	_	
10-29	1430-1437	entropy	_	
10-30	1438-1446	analysis	_	
10-31	1447-1449	of	_	
10-32	1450-1455	blood	_	
10-33	1456-1467	oxygenation	_	
10-34	1468-1483	level–dependent	_	
10-35	1484-1485	(	_	
10-36	1485-1489	BOLD	_	
10-37	1489-1490	)	_	
10-38	1491-1498	signals	_	
10-39	1498-1499	.	_	

#Text=Recently, neuroimaging studies have begun to reveal the dynamic reconfiguration of brain functional architecture using dynamic functional connectivity (i.e., time-varying correlations in BOLD signals between distinct brain regions across different time windows) and to demonstrate its relevance to cognitive functions and diseases.
11-1	1500-1508	Recently	_	
11-2	1508-1509	,	_	
11-3	1510-1522	neuroimaging	_	
11-4	1523-1530	studies	_	
11-5	1531-1535	have	_	
11-6	1536-1541	begun	_	
11-7	1542-1544	to	_	
11-8	1545-1551	reveal	_	
11-9	1552-1555	the	_	
11-10	1556-1563	dynamic	_	
11-11	1564-1579	reconfiguration	_	
11-12	1580-1582	of	_	
11-13	1583-1588	brain	_	
11-14	1589-1599	functional	_	
11-15	1600-1612	architecture	_	
11-16	1613-1618	using	_	
11-17	1619-1626	dynamic	_	
11-18	1627-1637	functional	_	
11-19	1638-1650	connectivity	_	
11-20	1651-1652	(	_	
11-21	1652-1655	i.e	_	
11-22	1655-1656	.	_	
11-23	1656-1657	,	_	
11-24	1658-1670	time-varying	_	
11-25	1671-1683	correlations	_	
11-26	1684-1686	in	_	
11-27	1687-1691	BOLD	_	
11-28	1692-1699	signals	_	
11-29	1700-1707	between	_	
11-30	1708-1716	distinct	_	
11-31	1717-1722	brain	_	
11-32	1723-1730	regions	_	
11-33	1731-1737	across	_	
11-34	1738-1747	different	_	
11-35	1748-1752	time	_	
11-36	1753-1760	windows	_	
11-37	1760-1761	)	_	
11-38	1762-1765	and	_	
11-39	1766-1768	to	_	
11-40	1769-1780	demonstrate	_	
11-41	1781-1784	its	_	
11-42	1785-1794	relevance	_	
11-43	1795-1797	to	_	
11-44	1798-1807	cognitive	_	
11-45	1808-1817	functions	_	
11-46	1818-1821	and	_	
11-47	1822-1830	diseases	_	
11-48	1830-1831	.	_	

#Text=As the complexity within the BOLD signal varies across different brain regions, we expect to see a distribution of the complexity within the dynamic functional connectivity of different brain regions.
12-1	1832-1834	As	_	
12-2	1835-1838	the	_	
12-3	1839-1849	complexity	_	
12-4	1850-1856	within	_	
12-5	1857-1860	the	_	
12-6	1861-1865	BOLD	_	
12-7	1866-1872	signal	_	
12-8	1873-1879	varies	_	
12-9	1880-1886	across	_	
12-10	1887-1896	different	_	
12-11	1897-1902	brain	_	
12-12	1903-1910	regions	_	
12-13	1910-1911	,	_	
12-14	1912-1914	we	_	
12-15	1915-1921	expect	_	
12-16	1922-1924	to	_	
12-17	1925-1928	see	_	
12-18	1929-1930	a	_	
12-19	1931-1943	distribution	_	
12-20	1944-1946	of	_	
12-21	1947-1950	the	_	
12-22	1951-1961	complexity	_	
12-23	1962-1968	within	_	
12-24	1969-1972	the	_	
12-25	1973-1980	dynamic	_	
12-26	1981-1991	functional	_	
12-27	1992-2004	connectivity	_	
12-28	2005-2007	of	_	
12-29	2008-2017	different	_	
12-30	2018-2023	brain	_	
12-31	2024-2031	regions	_	
12-32	2031-2032	.	_	

#Text=However, the complexity within the dynamic functional connectivity has yet to be quantitatively characterized.
13-1	2033-2040	However	_	
13-2	2040-2041	,	_	
13-3	2042-2045	the	_	
13-4	2046-2056	complexity	_	
13-5	2057-2063	within	_	
13-6	2064-2067	the	_	
13-7	2068-2075	dynamic	_	
13-8	2076-2086	functional	_	
13-9	2087-2099	connectivity	_	
13-10	2100-2103	has	_	
13-11	2104-2107	yet	_	
13-12	2108-2110	to	_	
13-13	2111-2113	be	_	
13-14	2114-2128	quantitatively	_	
13-15	2129-2142	characterized	_	
13-16	2142-2143	.	_	

#Text=Apart from complexity, several methods have been proposed to measure different aspects of dynamic functional connectivity.
14-1	2144-2149	Apart	_	
14-2	2150-2154	from	_	
14-3	2155-2165	complexity	_	
14-4	2165-2166	,	_	
14-5	2167-2174	several	_	
14-6	2175-2182	methods	_	
14-7	2183-2187	have	_	
14-8	2188-2192	been	_	
14-9	2193-2201	proposed	_	
14-10	2202-2204	to	_	
14-11	2205-2212	measure	_	
14-12	2213-2222	different	_	
14-13	2223-2230	aspects	_	
14-14	2231-2233	of	_	
14-15	2234-2241	dynamic	_	
14-16	2242-2252	functional	_	
14-17	2253-2265	connectivity	_	
14-18	2265-2266	.	_	

#Text=For example, patterns of the functional connectivity were clustered into distinct classes, and the functional reconfiguration among these classes was modeled as a Markov chain.
15-1	2267-2270	For	_	
15-2	2271-2278	example	_	
15-3	2278-2279	,	_	
15-4	2280-2288	patterns	_	
15-5	2289-2291	of	_	
15-6	2292-2295	the	_	
15-7	2296-2306	functional	_	
15-8	2307-2319	connectivity	_	
15-9	2320-2324	were	_	
15-10	2325-2334	clustered	_	
15-11	2335-2339	into	_	
15-12	2340-2348	distinct	_	
15-13	2349-2356	classes	_	
15-14	2356-2357	,	_	
15-15	2358-2361	and	_	
15-16	2362-2365	the	_	
15-17	2366-2376	functional	_	
15-18	2377-2392	reconfiguration	_	
15-19	2393-2398	among	_	
15-20	2399-2404	these	_	
15-21	2405-2412	classes	_	
15-22	2413-2416	was	_	
15-23	2417-2424	modeled	_	
15-24	2425-2427	as	_	
15-25	2428-2429	a	_	
15-26	2430-2436	Markov	_	
15-27	2437-2442	chain	_	
15-28	2442-2443	.	_	

#Text=To characterize the temporal variability of a brain region, resting-state BOLD signals were segmented into nonoverlapping windows and the functional connectivity patterns of this region were compared among these windows.
16-1	2444-2446	To	_	
16-2	2447-2459	characterize	_	
16-3	2460-2463	the	_	
16-4	2464-2472	temporal	_	
16-5	2473-2484	variability	_	
16-6	2485-2487	of	_	
16-7	2488-2489	a	_	
16-8	2490-2495	brain	_	
16-9	2496-2502	region	_	
16-10	2502-2503	,	_	
16-11	2504-2517	resting-state	_	
16-12	2518-2522	BOLD	_	
16-13	2523-2530	signals	_	
16-14	2531-2535	were	_	
16-15	2536-2545	segmented	_	
16-16	2546-2550	into	_	
16-17	2551-2565	nonoverlapping	_	
16-18	2566-2573	windows	_	
16-19	2574-2577	and	_	
16-20	2578-2581	the	_	
16-21	2582-2592	functional	_	
16-22	2593-2605	connectivity	_	
16-23	2606-2614	patterns	_	
16-24	2615-2617	of	_	
16-25	2618-2622	this	_	
16-26	2623-2629	region	_	
16-27	2630-2634	were	_	
16-28	2635-2643	compared	_	
16-29	2644-2649	among	_	
16-30	2650-2655	these	_	
16-31	2656-2663	windows	_	
16-32	2663-2664	.	_	

#Text=These methods, however, cannot estimate the complexity within the dynamic functional connectivity (see the supplementary information).
17-1	2665-2670	These	_	
17-2	2671-2678	methods	_	
17-3	2678-2679	,	_	
17-4	2680-2687	however	_	
17-5	2687-2688	,	_	
17-6	2689-2695	cannot	_	
17-7	2696-2704	estimate	_	
17-8	2705-2708	the	_	
17-9	2709-2719	complexity	_	
17-10	2720-2726	within	_	
17-11	2727-2730	the	_	
17-12	2731-2738	dynamic	_	
17-13	2739-2749	functional	_	
17-14	2750-2762	connectivity	_	
17-15	2763-2764	(	_	
17-16	2764-2767	see	_	
17-17	2768-2771	the	_	
17-18	2772-2785	supplementary	_	
17-19	2786-2797	information	_	
17-20	2797-2798	)	_	
17-21	2798-2799	.	_	

#Text=Entropy is a well-defined statistical concept used to measure the complexity within dynamic processes, with larger entropy corresponding to greater complexity.
18-1	2800-2807	Entropy	_	
18-2	2808-2810	is	_	
18-3	2811-2812	a	_	
18-4	2813-2825	well-defined	_	
18-5	2826-2837	statistical	_	
18-6	2838-2845	concept	_	
18-7	2846-2850	used	_	
18-8	2851-2853	to	_	
18-9	2854-2861	measure	_	
18-10	2862-2865	the	_	
18-11	2866-2876	complexity	_	
18-12	2877-2883	within	_	
18-13	2884-2891	dynamic	_	
18-14	2892-2901	processes	_	
18-15	2901-2902	,	_	
18-16	2903-2907	with	_	
18-17	2908-2914	larger	_	
18-18	2915-2922	entropy	_	
18-19	2923-2936	corresponding	_	
18-20	2937-2939	to	_	
18-21	2940-2947	greater	_	
18-22	2948-2958	complexity	_	
18-23	2958-2959	.	_	

#Text=Given the limited number of sampling points in an functional magnetic resonance imaging (fMRI) experiment, the classical estimations of the entropy are inaccurate.
19-1	2960-2965	Given	_	
19-2	2966-2969	the	_	
19-3	2970-2977	limited	_	
19-4	2978-2984	number	_	
19-5	2985-2987	of	_	
19-6	2988-2996	sampling	_	
19-7	2997-3003	points	_	
19-8	3004-3006	in	_	
19-9	3007-3009	an	_	
19-10	3010-3020	functional	_	
19-11	3021-3029	magnetic	_	
19-12	3030-3039	resonance	_	
19-13	3040-3047	imaging	_	
19-14	3048-3049	(	_	
19-15	3049-3053	fMRI	_	
19-16	3053-3054	)	_	
19-17	3055-3065	experiment	_	
19-18	3065-3066	,	_	
19-19	3067-3070	the	_	
19-20	3071-3080	classical	_	
19-21	3081-3092	estimations	_	
19-22	3093-3095	of	_	
19-23	3096-3099	the	_	
19-24	3100-3107	entropy	_	
19-25	3108-3111	are	_	
19-26	3112-3122	inaccurate	_	
19-27	3122-3123	.	_	

#Text=Sample entropy (SampEn) can overcome this drawback and has been used commonly in entropy analysis of fMRI data.
20-1	3124-3130	Sample	_	
20-2	3131-3138	entropy	_	
20-3	3139-3140	(	_	
20-4	3140-3146	SampEn	_	
20-5	3146-3147	)	_	
20-6	3148-3151	can	_	
20-7	3152-3160	overcome	_	
20-8	3161-3165	this	_	
20-9	3166-3174	drawback	_	
20-10	3175-3178	and	_	
20-11	3179-3182	has	_	
20-12	3183-3187	been	_	
20-13	3188-3192	used	_	
20-14	3193-3201	commonly	_	
20-15	3202-3204	in	_	
20-16	3205-3212	entropy	_	
20-17	3213-3221	analysis	_	
20-18	3222-3224	of	_	
20-19	3225-3229	fMRI	_	
20-20	3230-3234	data	_	
20-21	3234-3235	.	_	

#Text=As a universal and secular phenomenon, the aging process has been suggested to be a progressive loss of complexity within the dynamics of physiologic outputs.
21-1	3236-3238	As	_	
21-2	3239-3240	a	_	
21-3	3241-3250	universal	_	
21-4	3251-3254	and	_	
21-5	3255-3262	secular	_	
21-6	3263-3273	phenomenon	_	
21-7	3273-3274	,	_	
21-8	3275-3278	the	_	
21-9	3279-3284	aging	_	
21-10	3285-3292	process	_	
21-11	3293-3296	has	_	
21-12	3297-3301	been	_	
21-13	3302-3311	suggested	_	
21-14	3312-3314	to	_	
21-15	3315-3317	be	_	
21-16	3318-3319	a	_	
21-17	3320-3331	progressive	_	
21-18	3332-3336	loss	_	
21-19	3337-3339	of	_	
21-20	3340-3350	complexity	_	
21-21	3351-3357	within	_	
21-22	3358-3361	the	_	
21-23	3362-3370	dynamics	_	
21-24	3371-3373	of	_	
21-25	3374-3385	physiologic	_	
21-26	3386-3393	outputs	_	
21-27	3393-3394	.	_	

#Text=This age-related loss is believed to stem from the gradual deterioration of the underlying structural components of physiological systems and from alterations within the coupling between these systems.
22-1	3395-3399	This	_	
22-2	3400-3411	age-related	_	
22-3	3412-3416	loss	_	
22-4	3417-3419	is	_	
22-5	3420-3428	believed	_	
22-6	3429-3431	to	_	
22-7	3432-3436	stem	_	
22-8	3437-3441	from	_	
22-9	3442-3445	the	_	
22-10	3446-3453	gradual	_	
22-11	3454-3467	deterioration	_	
22-12	3468-3470	of	_	
22-13	3471-3474	the	_	
22-14	3475-3485	underlying	_	
22-15	3486-3496	structural	_	
22-16	3497-3507	components	_	
22-17	3508-3510	of	_	
22-18	3511-3524	physiological	_	
22-19	3525-3532	systems	_	
22-20	3533-3536	and	_	
22-21	3537-3541	from	_	
22-22	3542-3553	alterations	_	
22-23	3554-3560	within	_	
22-24	3561-3564	the	_	
22-25	3565-3573	coupling	_	
22-26	3574-3581	between	_	
22-27	3582-3587	these	_	
22-28	3588-3595	systems	_	
22-29	3595-3596	.	_	

#Text=Previous studies have shown that the complexity within the temporal dynamics of brain signals measured by electroencephalography (EEG), magnetoencephalography (MEG), and BOLD fMRI appears to decrease.
23-1	3597-3605	Previous	_	
23-2	3606-3613	studies	_	
23-3	3614-3618	have	_	
23-4	3619-3624	shown	_	
23-5	3625-3629	that	_	
23-6	3630-3633	the	_	
23-7	3634-3644	complexity	_	
23-8	3645-3651	within	_	
23-9	3652-3655	the	_	
23-10	3656-3664	temporal	_	
23-11	3665-3673	dynamics	_	
23-12	3674-3676	of	_	
23-13	3677-3682	brain	_	
23-14	3683-3690	signals	_	
23-15	3691-3699	measured	_	
23-16	3700-3702	by	_	
23-17	3703-3725	electroencephalography	_	
23-18	3726-3727	(	_	
23-19	3727-3730	EEG	_	
23-20	3730-3731	)	_	
23-21	3731-3732	,	_	
23-22	3733-3755	magnetoencephalography	_	
23-23	3756-3757	(	_	
23-24	3757-3760	MEG	_	
23-25	3760-3761	)	_	
23-26	3761-3762	,	_	
23-27	3763-3766	and	_	
23-28	3767-3771	BOLD	_	
23-29	3772-3776	fMRI	_	
23-30	3777-3784	appears	_	
23-31	3785-3787	to	_	
23-32	3788-3796	decrease	_	
23-33	3796-3797	.	_	

#Text=Because the dynamic functional connectivity also is a typical physiologic output of the brain, we expected that the complexity within the dynamic functional connectivity of some brain regions also would decrease with advancing age.
24-1	3798-3805	Because	_	
24-2	3806-3809	the	_	
24-3	3810-3817	dynamic	_	
24-4	3818-3828	functional	_	
24-5	3829-3841	connectivity	_	
24-6	3842-3846	also	_	
24-7	3847-3849	is	_	
24-8	3850-3851	a	_	
24-9	3852-3859	typical	_	
24-10	3860-3871	physiologic	_	
24-11	3872-3878	output	_	
24-12	3879-3881	of	_	
24-13	3882-3885	the	_	
24-14	3886-3891	brain	_	
24-15	3891-3892	,	_	
24-16	3893-3895	we	_	
24-17	3896-3904	expected	_	
24-18	3905-3909	that	_	
24-19	3910-3913	the	_	
24-20	3914-3924	complexity	_	
24-21	3925-3931	within	_	
24-22	3932-3935	the	_	
24-23	3936-3943	dynamic	_	
24-24	3944-3954	functional	_	
24-25	3955-3967	connectivity	_	
24-26	3968-3970	of	_	
24-27	3971-3975	some	_	
24-28	3976-3981	brain	_	
24-29	3982-3989	regions	_	
24-30	3990-3994	also	_	
24-31	3995-4000	would	_	
24-32	4001-4009	decrease	_	
24-33	4010-4014	with	_	
24-34	4015-4024	advancing	_	
24-35	4025-4028	age	_	
24-36	4028-4029	.	_	

#Text=In schizophrenia, nonlinearity has been assumed to be underlying the irregularity in psychotic symptoms.
25-1	4030-4032	In	_	
25-2	4033-4046	schizophrenia	_	
25-3	4046-4047	,	_	
25-4	4048-4060	nonlinearity	_	
25-5	4061-4064	has	_	
25-6	4065-4069	been	_	
25-7	4070-4077	assumed	_	
25-8	4078-4080	to	_	
25-9	4081-4083	be	_	
25-10	4084-4094	underlying	_	
25-11	4095-4098	the	_	
25-12	4099-4111	irregularity	_	
25-13	4112-4114	in	_	
25-14	4115-4124	psychotic	_	
25-15	4125-4133	symptoms	_	
25-16	4133-4134	.	_	

#Text=A large body of studies on electroencephalography (EEG) and magnetoencephalography (MEG) reported increased or reduced complexity in patients with schizophrenia compared with healthy controls.
26-1	4135-4136	A	_	
26-2	4137-4142	large	_	
26-3	4143-4147	body	_	
26-4	4148-4150	of	_	
26-5	4151-4158	studies	_	
26-6	4159-4161	on	_	
26-7	4162-4184	electroencephalography	_	
26-8	4185-4186	(	_	
26-9	4186-4189	EEG	_	
26-10	4189-4190	)	_	
26-11	4191-4194	and	_	
26-12	4195-4217	magnetoencephalography	_	
26-13	4218-4219	(	_	
26-14	4219-4222	MEG	_	
26-15	4222-4223	)	_	
26-16	4224-4232	reported	_	
26-17	4233-4242	increased	_	
26-18	4243-4245	or	_	
26-19	4246-4253	reduced	_	
26-20	4254-4264	complexity	_	
26-21	4265-4267	in	_	
26-22	4268-4276	patients	_	
26-23	4277-4281	with	_	
26-24	4282-4295	schizophrenia	_	
26-25	4296-4304	compared	_	
26-26	4305-4309	with	_	
26-27	4310-4317	healthy	_	
26-28	4318-4326	controls	_	
26-29	4326-4327	.	_	

#Text=Such divergence might be modulated by symptomatology, age effects, and so on (for a review, see Fernandez).
27-1	4328-4332	Such	_	
27-2	4333-4343	divergence	_	
27-3	4344-4349	might	_	
27-4	4350-4352	be	_	
27-5	4353-4362	modulated	_	
27-6	4363-4365	by	_	
27-7	4366-4380	symptomatology	_	
27-8	4380-4381	,	_	
27-9	4382-4385	age	_	
27-10	4386-4393	effects	_	
27-11	4393-4394	,	_	
27-12	4395-4398	and	_	
27-13	4399-4401	so	_	
27-14	4402-4404	on	_	
27-15	4405-4406	(	_	
27-16	4406-4409	for	_	
27-17	4410-4411	a	_	
27-18	4412-4418	review	_	
27-19	4418-4419	,	_	
27-20	4420-4423	see	_	
27-21	4424-4433	Fernandez	_	
27-22	4433-4434	)	_	
27-23	4434-4435	.	_	

#Text=More important, not only schizophrenia but also some other mental diseases, such as Alzheimer’s disease, major depression, and attention deficit-hyperactivity disorder, disrupt the normal evolution of complexity as a function of age.
28-1	4436-4440	More	_	
28-2	4441-4450	important	_	
28-3	4450-4451	,	_	
28-4	4452-4455	not	_	
28-5	4456-4460	only	_	
28-6	4461-4474	schizophrenia	_	
28-7	4475-4478	but	_	
28-8	4479-4483	also	_	
28-9	4484-4488	some	_	
28-10	4489-4494	other	_	
28-11	4495-4501	mental	_	
28-12	4502-4510	diseases	_	
28-13	4510-4511	,	_	
28-14	4512-4516	such	_	
28-15	4517-4519	as	_	
28-16	4520-4529	Alzheimer	_	
28-17	4529-4530	’	_	
28-18	4530-4531	s	_	
28-19	4532-4539	disease	_	
28-20	4539-4540	,	_	
28-21	4541-4546	major	_	
28-22	4547-4557	depression	_	
28-23	4557-4558	,	_	
28-24	4559-4562	and	_	
28-25	4563-4572	attention	_	
28-26	4573-4594	deficit-hyperactivity	_	
28-27	4595-4603	disorder	_	
28-28	4603-4604	,	_	
28-29	4605-4612	disrupt	_	
28-30	4613-4616	the	_	
28-31	4617-4623	normal	_	
28-32	4624-4633	evolution	_	
28-33	4634-4636	of	_	
28-34	4637-4647	complexity	_	
28-35	4648-4650	as	_	
28-36	4651-4652	a	_	
28-37	4653-4661	function	_	
28-38	4662-4664	of	_	
28-39	4665-4668	age	_	
28-40	4668-4669	.	_	

#Text=If complexity of dynamic functional connectivity is a promising indicator of normal aging, we would expect a disrupted association between complexity and age in patients with schizophrenia.
29-1	4670-4672	If	_	
29-2	4673-4683	complexity	_	
29-3	4684-4686	of	_	
29-4	4687-4694	dynamic	_	
29-5	4695-4705	functional	_	
29-6	4706-4718	connectivity	_	
29-7	4719-4721	is	_	
29-8	4722-4723	a	_	
29-9	4724-4733	promising	_	
29-10	4734-4743	indicator	_	
29-11	4744-4746	of	_	
29-12	4747-4753	normal	_	
29-13	4754-4759	aging	_	
29-14	4759-4760	,	_	
29-15	4761-4763	we	_	
29-16	4764-4769	would	_	
29-17	4770-4776	expect	_	
29-18	4777-4778	a	_	
29-19	4779-4788	disrupted	_	
29-20	4789-4800	association	_	
29-21	4801-4808	between	_	
29-22	4809-4819	complexity	_	
29-23	4820-4823	and	_	
29-24	4824-4827	age	_	
29-25	4828-4830	in	_	
29-26	4831-4839	patients	_	
29-27	4840-4844	with	_	
29-28	4845-4858	schizophrenia	_	
29-29	4858-4859	.	_	

#Text=In the present study, we used SampEn to (1) quantitatively characterize the complexity within the dynamic functional connectivity, (2) identify dynamic functional connectivity showing an age-related reduction in complexity during normal aging, and (3) test whether these age-related reductions are disrupted by schizophrenia.
30-1	4860-4862	In	_	
30-2	4863-4866	the	_	
30-3	4867-4874	present	_	
30-4	4875-4880	study	_	
30-5	4880-4881	,	_	
30-6	4882-4884	we	_	
30-7	4885-4889	used	_	
30-8	4890-4896	SampEn	_	
30-9	4897-4899	to	_	
30-10	4900-4901	(	_	
30-11	4901-4902	1	_	
30-12	4902-4903	)	_	
30-13	4904-4918	quantitatively	_	
30-14	4919-4931	characterize	_	
30-15	4932-4935	the	_	
30-16	4936-4946	complexity	_	
30-17	4947-4953	within	_	
30-18	4954-4957	the	_	
30-19	4958-4965	dynamic	_	
30-20	4966-4976	functional	_	
30-21	4977-4989	connectivity	_	
30-22	4989-4990	,	_	
30-23	4991-4992	(	_	
30-24	4992-4993	2	_	
30-25	4993-4994	)	_	
30-26	4995-5003	identify	_	
30-27	5004-5011	dynamic	_	
30-28	5012-5022	functional	_	
30-29	5023-5035	connectivity	_	
30-30	5036-5043	showing	_	
30-31	5044-5046	an	_	
30-32	5047-5058	age-related	_	
30-33	5059-5068	reduction	_	
30-34	5069-5071	in	_	
30-35	5072-5082	complexity	_	
30-36	5083-5089	during	_	
30-37	5090-5096	normal	_	
30-38	5097-5102	aging	_	
30-39	5102-5103	,	_	
30-40	5104-5107	and	_	
30-41	5108-5109	(	_	
30-42	5109-5110	3	_	
30-43	5110-5111	)	_	
30-44	5112-5116	test	_	
30-45	5117-5124	whether	_	
30-46	5125-5130	these	_	
30-47	5131-5142	age-related	_	
30-48	5143-5153	reductions	_	
30-49	5154-5157	are	_	
30-50	5158-5167	disrupted	_	
30-51	5168-5170	by	_	
30-52	5171-5184	schizophrenia	_	
30-53	5184-5185	.	_	

#Text=Materials and Methods
#Text=Participants
#Text=Demographic information for the participants.
31-1	5186-5195	Materials	http://www.case.edu/ProvCaRe/provcare#StudyMethod[4]	
31-2	5196-5199	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[4]	
31-3	5200-5207	Methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[4]	
31-4	5208-5220	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
31-5	5221-5232	Demographic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
31-6	5233-5244	information	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
31-7	5245-5248	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
31-8	5249-5252	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
31-9	5253-5265	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
31-10	5265-5266	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	

#Text=PANSS, Positive and Negative Syndrome Scale.
32-1	5267-5272	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[6]	
32-2	5272-5273	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[6]	
32-3	5274-5282	Positive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[6]	
32-4	5283-5286	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[6]	
32-5	5287-5295	Negative	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[6]	
32-6	5296-5304	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[6]	
32-7	5305-5310	Scale	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[6]	
32-8	5310-5311	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[6]	

#Text=Healthy subjects (n = 62)\tPatients with schizophrenia (n = 69)\tP value\t \tAge (year)\t29.87 ± 8.62\t31.95 ± 9.60\t0.2836\t \tEducation (year)\t15.29 ± 2.39\t14.19 ± 2.16\t0.0064\t \tSex (M/F)\t25/37\t35/34\t0.2328\t \tIllness duration (year)\t—\t7.17 ± 6.61\t—\t \tPANSS-positive scale\t—\t11.92 ± 4.71\t—\t \tPANSS-negative scale\t—\t13.61 ± 6.33\t—\t \tPANSS-general scale\t—\t27.28 ± 9.64\t—\t \t
#Text=The study included 62 healthy subjects (25 males and 37 females) and 69 patients with chronic schizophrenia (35 males and 34 females).
33-1	5313-5320	Healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]	
33-2	5321-5329	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]	
33-3	5330-5331	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-4	5331-5332	n	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-5	5333-5334	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-6	5335-5337	62	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-7	5337-5338	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-8	5339-5347	Patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[8]	
33-9	5348-5352	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[8]	
33-10	5353-5366	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[8]	
33-11	5367-5368	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-12	5368-5369	n	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-13	5370-5371	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-14	5372-5374	69	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-15	5374-5375	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-16	5376-5377	P	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-17	5378-5383	value	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-18	5386-5389	Age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-19	5390-5391	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-20	5391-5395	year	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-21	5395-5396	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-22	5397-5402	29.87	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-23	5403-5404	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-24	5405-5409	8.62	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-25	5410-5415	31.95	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-26	5416-5417	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-27	5418-5422	9.60	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-28	5423-5429	0.2836	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-29	5432-5441	Education	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-30	5442-5443	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-31	5443-5447	year	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-32	5447-5448	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-33	5449-5454	15.29	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-34	5455-5456	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-35	5457-5461	2.39	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-36	5462-5467	14.19	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-37	5468-5469	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-38	5470-5474	2.16	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-39	5475-5481	0.0064	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-40	5484-5487	Sex	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-41	5488-5489	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-42	5489-5490	M	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-43	5490-5491	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-44	5491-5492	F	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-45	5492-5493	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-46	5494-5496	25	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-47	5496-5497	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-48	5497-5499	37	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-49	5500-5502	35	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-50	5502-5503	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-51	5503-5505	34	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-52	5506-5512	0.2328	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-53	5515-5522	Illness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-54	5523-5531	duration	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-55	5532-5533	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-56	5533-5537	year	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-57	5537-5538	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-58	5539-5540	—	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-59	5541-5545	7.17	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-60	5546-5547	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-61	5548-5552	6.61	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-62	5553-5554	—	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-63	5557-5571	PANSS-positive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[9]	
33-64	5572-5577	scale	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-65	5578-5579	—	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-66	5580-5585	11.92	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-67	5586-5587	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-68	5588-5592	4.71	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-69	5593-5594	—	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-70	5597-5611	PANSS-negative	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[10]	
33-71	5612-5617	scale	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-72	5618-5619	—	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-73	5620-5625	13.61	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-74	5626-5627	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-75	5628-5632	6.33	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-76	5633-5634	—	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-77	5637-5650	PANSS-general	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[11]	
33-78	5651-5656	scale	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-79	5657-5658	—	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-80	5659-5664	27.28	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-81	5665-5666	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-82	5667-5671	9.64	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-83	5672-5673	—	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-84	5677-5680	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-85	5681-5686	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-86	5687-5695	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-87	5696-5698	62	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-88	5699-5706	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[12]	
33-89	5707-5715	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[12]	
33-90	5716-5717	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-91	5717-5719	25	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-92	5720-5725	males	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-93	5726-5729	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-94	5730-5732	37	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-95	5733-5740	females	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-96	5740-5741	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-97	5742-5745	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-98	5746-5748	69	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-99	5749-5757	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[13]	
33-100	5758-5762	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[13]	
33-101	5763-5770	chronic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[13]	
33-102	5771-5784	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[13]	
33-103	5785-5786	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-104	5786-5788	35	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-105	5789-5794	males	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-106	5795-5798	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-107	5799-5801	34	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-108	5802-5809	females	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-109	5809-5810	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
33-110	5810-5811	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	

#Text=Exclusion criteria included the presence of DSM-IV Axis I diagnoses of other disorders such as bipolar disorder, history of any substance dependence, or history of clinically significant head trauma.
34-1	5812-5821	Exclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-2	5822-5830	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-3	5831-5839	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-4	5840-5843	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-5	5844-5852	presence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-6	5853-5855	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-7	5856-5862	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-8	5863-5867	Axis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-9	5868-5869	I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-10	5870-5879	diagnoses	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-11	5880-5882	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-12	5883-5888	other	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-13	5889-5898	disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-14	5899-5903	such	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-15	5904-5906	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-16	5907-5914	bipolar	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-17	5915-5923	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-18	5923-5924	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-19	5925-5932	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-20	5933-5935	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-21	5936-5939	any	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-22	5940-5949	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-23	5950-5960	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-24	5960-5961	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-25	5962-5964	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-26	5965-5972	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-27	5973-5975	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-28	5976-5986	clinically	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-29	5987-5998	significant	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-30	5999-6003	head	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-31	6004-6010	trauma	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
34-32	6010-6011	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=Participants’ demographic characteristics are shown in Table 1.
35-1	6012-6024	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
35-2	6024-6025	’	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
35-3	6026-6037	demographic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
35-4	6038-6053	characteristics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
35-5	6054-6057	are	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
35-6	6058-6063	shown	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
35-7	6064-6066	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
35-8	6067-6072	Table	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
35-9	6072-6073	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
35-10	6073-6074	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
35-11	6074-6075	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=This dataset was selected from our previous resting-state fMRI study, which included multicenter datasets, and was suitable to investigate the aging process because the age of healthy subjects and the age of patients with schizophrenia were both uniformly distributed across a relatively wide range.
36-1	6076-6080	This	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-2	6081-6088	dataset	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-3	6089-6092	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-4	6093-6101	selected	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-5	6102-6106	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-6	6107-6110	our	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-7	6111-6119	previous	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-8	6120-6133	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[15]	
36-9	6134-6138	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[15]	
36-10	6139-6144	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[15]	
36-11	6144-6145	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-12	6146-6151	which	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-13	6152-6160	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-14	6161-6172	multicenter	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-15	6173-6181	datasets	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-16	6181-6182	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-17	6183-6186	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-18	6187-6190	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-19	6191-6199	suitable	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-20	6200-6202	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-21	6203-6214	investigate	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-22	6215-6218	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-23	6219-6224	aging	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-24	6225-6232	process	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-25	6233-6240	because	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-26	6241-6244	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-27	6245-6248	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-28	6249-6251	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-29	6252-6259	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-30	6260-6268	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-31	6269-6272	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-32	6273-6276	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-33	6277-6280	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-34	6281-6283	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-35	6284-6292	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[16]	
36-36	6293-6297	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[16]	
36-37	6298-6311	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[16]	
36-38	6312-6316	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-39	6317-6321	both	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-40	6322-6331	uniformly	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-41	6332-6343	distributed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-42	6344-6350	across	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-43	6351-6352	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-44	6353-6363	relatively	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-45	6364-6368	wide	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-46	6369-6374	range	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
36-47	6374-6375	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=The age of healthy subjects was from 19 to 51 years (mean ± SD, 29.87 ± 8.62 years) and the degree of education was from 6 to 21 years (mean ± SD, 15.29 ± 2.39 years).
37-1	6376-6379	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-2	6380-6383	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-3	6384-6386	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-4	6387-6394	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[17]	
37-5	6395-6403	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[17]	
37-6	6404-6407	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-7	6408-6412	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-8	6413-6415	19	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-9	6416-6418	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-10	6419-6421	51	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-11	6422-6427	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-12	6428-6429	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-13	6429-6433	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-14	6434-6435	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-15	6436-6438	SD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-16	6438-6439	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-17	6440-6445	29.87	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-18	6446-6447	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-19	6448-6452	8.62	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-20	6453-6458	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-21	6458-6459	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-22	6460-6463	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-23	6464-6467	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-24	6468-6474	degree	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Education[18]	
37-25	6475-6477	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Education[18]	
37-26	6478-6487	education	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Education[18]	
37-27	6488-6491	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-28	6492-6496	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-29	6497-6498	6	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-30	6499-6501	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-31	6502-6504	21	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-32	6505-6510	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-33	6511-6512	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-34	6512-6516	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-35	6517-6518	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-36	6519-6521	SD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-37	6521-6522	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-38	6523-6528	15.29	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-39	6529-6530	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-40	6531-6535	2.39	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-41	6536-6541	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-42	6541-6542	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
37-43	6542-6543	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=One of the healthy subjects was left-handed, and the others were right-handed.
38-1	6544-6547	One	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
38-2	6548-6550	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
38-3	6551-6554	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
38-4	6555-6562	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]	
38-5	6563-6571	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]	
38-6	6572-6575	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
38-7	6576-6587	left-handed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
38-8	6587-6588	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
38-9	6589-6592	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
38-10	6593-6596	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
38-11	6597-6603	others	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
38-12	6604-6608	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
38-13	6609-6621	right-handed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
38-14	6621-6622	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=The healthy subjects were assessed in accordance with DSM-IV criteria as being free of schizophrenia.
39-1	6623-6626	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
39-2	6627-6634	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[20]	
39-3	6635-6643	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[20]	
39-4	6644-6648	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
39-5	6649-6657	assessed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
39-6	6658-6660	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
39-7	6661-6671	accordance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
39-8	6672-6676	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
39-9	6677-6683	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
39-10	6684-6692	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
39-11	6693-6695	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
39-12	6696-6701	being	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
39-13	6702-6706	free	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
39-14	6707-6709	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
39-15	6710-6723	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
39-16	6723-6724	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=The age of patients with schizophrenia was from 17 to 55 years (mean ± SD, 31.95 ± 9.60 years) and the degree of education was from 9 to 18 years (mean ± SD, 14.19 ± 2.16 years).
40-1	6725-6728	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-2	6729-6732	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-3	6733-6735	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-4	6736-6744	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[21]	
40-5	6745-6749	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[21]	
40-6	6750-6763	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[21]	
40-7	6764-6767	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-8	6768-6772	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-9	6773-6775	17	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-10	6776-6778	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-11	6779-6781	55	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-12	6782-6787	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-13	6788-6789	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-14	6789-6793	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-15	6794-6795	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-16	6796-6798	SD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-17	6798-6799	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-18	6800-6805	31.95	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-19	6806-6807	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-20	6808-6812	9.60	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-21	6813-6818	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-22	6818-6819	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-23	6820-6823	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-24	6824-6827	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-25	6828-6834	degree	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Education[22]	
40-26	6835-6837	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Education[22]	
40-27	6838-6847	education	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#Education[22]	
40-28	6848-6851	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-29	6852-6856	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-30	6857-6858	9	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-31	6859-6861	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-32	6862-6864	18	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-33	6865-6870	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-34	6871-6872	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-35	6872-6876	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-36	6877-6878	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-37	6879-6881	SD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-38	6881-6882	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-39	6883-6888	14.19	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-40	6889-6890	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-41	6891-6895	2.16	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-42	6896-6901	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-43	6901-6902	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
40-44	6902-6903	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=Two of the patients were left-handed, and the others were right-handed.
41-1	6904-6907	Two	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
41-2	6908-6910	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
41-3	6911-6914	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
41-4	6915-6923	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
41-5	6924-6928	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
41-6	6929-6940	left-handed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
41-7	6940-6941	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
41-8	6942-6945	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
41-9	6946-6949	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
41-10	6950-6956	others	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
41-11	6957-6961	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
41-12	6962-6974	right-handed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
41-13	6974-6975	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=Illness durations of the patients ranged from a few months to 30 years (mean ± SD, 7.17 ± 6.61 years).
42-1	6976-6983	Illness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-2	6984-6993	durations	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-3	6994-6996	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-4	6997-7000	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-5	7001-7009	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-6	7010-7016	ranged	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-7	7017-7021	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-8	7022-7023	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-9	7024-7027	few	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-10	7028-7034	months	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-11	7035-7037	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-12	7038-7040	30	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-13	7041-7046	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-14	7047-7048	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-15	7048-7052	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-16	7053-7054	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-17	7055-7057	SD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-18	7057-7058	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-19	7059-7063	7.17	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-20	7064-7065	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-21	7066-7070	6.61	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-22	7071-7076	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-23	7076-7077	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
42-24	7077-7078	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=Symptom severity was measured using the Positive and Negative Syndrome Scale (PANSS) assessment, which was given to all patients either one week before or one week after the MRI scan.
43-1	7079-7086	Symptom	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-2	7087-7095	severity	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-3	7096-7099	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-4	7100-7108	measured	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-5	7109-7114	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-6	7115-7118	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-7	7119-7127	Positive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[23]	
43-8	7128-7131	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[23]	
43-9	7132-7140	Negative	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[23]	
43-10	7141-7149	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[23]	
43-11	7150-7155	Scale	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[23]	
43-12	7156-7157	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[23]	
43-13	7157-7162	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[23]	
43-14	7162-7163	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[23]	
43-15	7164-7174	assessment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-16	7174-7175	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-17	7176-7181	which	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-18	7182-7185	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-19	7186-7191	given	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-20	7192-7194	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-21	7195-7198	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-22	7199-7207	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-23	7208-7214	either	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-24	7215-7218	one	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-25	7219-7223	week	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-26	7224-7230	before	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-27	7231-7233	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-28	7234-7237	one	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-29	7238-7242	week	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-30	7243-7248	after	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-31	7249-7252	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
43-32	7253-7256	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[24]	
43-33	7257-7261	scan	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[24]	
43-34	7261-7262	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=Five patients, however, were not able to complete their PANSS assessment because of their poor health condition.
44-1	7263-7267	Five	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-2	7268-7276	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-3	7276-7277	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-4	7278-7285	however	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-5	7285-7286	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-6	7287-7291	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-7	7292-7295	not	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-8	7296-7300	able	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-9	7301-7303	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-10	7304-7312	complete	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-11	7313-7318	their	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-12	7319-7324	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]|http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[25]	
44-13	7325-7335	assessment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-14	7336-7343	because	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-15	7344-7346	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-16	7347-7352	their	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-17	7353-7357	poor	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-18	7358-7364	health	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-19	7365-7374	condition	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
44-20	7374-7375	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=The healthy and patient groups were well matched by gender (χ 2 = 1.4234, P = 0.2328) and age (t-test, P = 0.2836), although the healthy subjects had a slightly longer education degree (t-test, P = 0.0064).
45-1	7376-7379	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-2	7380-7387	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-3	7388-7391	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-4	7392-7399	patient	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-5	7400-7406	groups	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-6	7407-7411	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-7	7412-7416	well	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-8	7417-7424	matched	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-9	7425-7427	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-10	7428-7434	gender	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-11	7435-7436	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-12	7436-7437	χ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-13	7438-7439	2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-14	7440-7441	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-15	7442-7448	1.4234	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-16	7448-7449	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-17	7450-7451	P	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-18	7452-7453	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-19	7454-7460	0.2328	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-20	7460-7461	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-21	7462-7465	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-22	7466-7469	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-23	7470-7471	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-24	7471-7477	t-test	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-25	7477-7478	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-26	7479-7480	P	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-27	7481-7482	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-28	7483-7489	0.2836	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-29	7489-7490	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-30	7490-7491	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-31	7492-7500	although	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-32	7501-7504	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-33	7505-7512	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-34	7513-7521	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-35	7522-7525	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-36	7526-7527	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-37	7528-7536	slightly	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-38	7537-7543	longer	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-39	7544-7553	education	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-40	7554-7560	degree	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-41	7561-7562	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-42	7562-7568	t-test	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-43	7568-7569	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-44	7570-7571	P	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-45	7572-7573	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-46	7574-7580	0.0064	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-47	7580-7581	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
45-48	7581-7582	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=All of the research procedures and ethical guidelines were in accordance with the Institutional Review Board (IRB) of the National Taiwan University Hospital.
46-1	7583-7586	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-2	7587-7589	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-3	7590-7593	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-4	7594-7602	research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-5	7603-7613	procedures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-6	7614-7617	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-7	7618-7625	ethical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-8	7626-7636	guidelines	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-9	7637-7641	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-10	7642-7644	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-11	7645-7655	accordance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-12	7656-7660	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-13	7661-7664	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-14	7665-7678	Institutional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-15	7679-7685	Review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-16	7686-7691	Board	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-17	7692-7693	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-18	7693-7696	IRB	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-19	7696-7697	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-20	7698-7700	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-21	7701-7704	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-22	7705-7713	National	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-23	7714-7720	Taiwan	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-24	7721-7731	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-25	7732-7740	Hospital	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
46-26	7740-7741	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=We obtained written informed consent from all individual participants, and IRB of the National Taiwan University Hospital approved this study.
47-1	7742-7744	We	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-2	7745-7753	obtained	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-3	7754-7761	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-4	7762-7770	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-5	7771-7778	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-6	7779-7783	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-7	7784-7787	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-8	7788-7798	individual	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-9	7799-7811	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-10	7811-7812	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-11	7813-7816	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-12	7817-7820	IRB	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-13	7821-7823	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-14	7824-7827	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-15	7828-7836	National	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-16	7837-7843	Taiwan	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-17	7844-7854	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-18	7855-7863	Hospital	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-19	7864-7872	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-20	7873-7877	this	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-21	7878-7883	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-22	7883-7884	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=Image acquisition
#Text=Scanning was performed on a 3 T Siemens Trio Tim MRI scanner.
48-1	7886-7891	Image	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[26]	
48-2	7892-7903	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[26]	
48-3	7904-7912	Scanning	_	
48-4	7913-7916	was	_	
48-5	7917-7926	performed	_	
48-6	7927-7929	on	_	
48-7	7930-7931	a	_	
48-8	7932-7933	3	_	
48-9	7934-7935	T	_	
48-10	7936-7943	Siemens	_	
48-11	7944-7948	Trio	_	
48-12	7949-7952	Tim	_	
48-13	7953-7956	MRI	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[27]	
48-14	7957-7964	scanner	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[27]	
48-15	7964-7965	.	_	

#Text=FMRI images were acquired using a gradient-echo echo planar imaging (GE-EPI) sequence.
49-1	7966-7970	FMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[28]	
49-2	7971-7977	images	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[28]	
49-3	7978-7982	were	_	
49-4	7983-7991	acquired	_	
49-5	7992-7997	using	_	
49-6	7998-7999	a	_	
49-7	8000-8013	gradient-echo	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol[29]	
49-8	8014-8018	echo	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol[29]	
49-9	8019-8025	planar	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol[29]	
49-10	8026-8033	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol[29]	
49-11	8034-8035	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol[29]	
49-12	8035-8041	GE-EPI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol[29]	
49-13	8041-8042	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol[29]	
49-14	8043-8051	sequence	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol[29]	
49-15	8051-8052	.	_	

#Text=The following parameters were used: repetition time (TR), 2000 ms; echo time (TE), 24 ms; field of view (FOV), 256 × 256 mm2; matrix, 64 × 64; slice thickness, 3 mm; flip angle (FA), 90°.
50-1	8053-8056	The	_	
50-2	8057-8066	following	_	
50-3	8067-8077	parameters	_	
50-4	8078-8082	were	_	
50-5	8083-8087	used	_	
50-6	8087-8088	:	_	
50-7	8089-8099	repetition	_	
50-8	8100-8104	time	_	
50-9	8105-8106	(	_	
50-10	8106-8108	TR	_	
50-11	8108-8109	)	_	
50-12	8109-8110	,	_	
50-13	8111-8115	2000	_	
50-14	8116-8118	ms	_	
50-15	8118-8119	;	_	
50-16	8120-8124	echo	_	
50-17	8125-8129	time	_	
50-18	8130-8131	(	_	
50-19	8131-8133	TE	_	
50-20	8133-8134	)	_	
50-21	8134-8135	,	_	
50-22	8136-8138	24	_	
50-23	8139-8141	ms	_	
50-24	8141-8142	;	_	
50-25	8143-8148	field	_	
50-26	8149-8151	of	_	
50-27	8152-8156	view	_	
50-28	8157-8158	(	_	
50-29	8158-8161	FOV	_	
50-30	8161-8162	)	_	
50-31	8162-8163	,	_	
50-32	8164-8167	256	_	
50-33	8168-8169	×	_	
50-34	8170-8173	256	_	
50-35	8174-8177	mm2	_	
50-36	8177-8178	;	_	
50-37	8179-8185	matrix	_	
50-38	8185-8186	,	_	
50-39	8187-8189	64	_	
50-40	8190-8191	×	_	
50-41	8192-8194	64	_	
50-42	8194-8195	;	_	
50-43	8196-8201	slice	_	
50-44	8202-8211	thickness	_	
50-45	8211-8212	,	_	
50-46	8213-8214	3	_	
50-47	8215-8217	mm	_	
50-48	8217-8218	;	_	
50-49	8219-8223	flip	_	
50-50	8224-8229	angle	_	
50-51	8230-8231	(	_	
50-52	8231-8233	FA	_	
50-53	8233-8234	)	_	
50-54	8234-8235	,	_	
50-55	8236-8238	90	_	
50-56	8238-8239	°	_	
50-57	8239-8240	.	_	

#Text=For each subject, 34 transaxial slices with no gap were acquired to cover the whole brain volume.
51-1	8241-8244	For	_	
51-2	8245-8249	each	_	
51-3	8250-8257	subject	_	
51-4	8257-8258	,	_	
51-5	8259-8261	34	_	
51-6	8262-8272	transaxial	_	
51-7	8273-8279	slices	_	
51-8	8280-8284	with	_	
51-9	8285-8287	no	_	
51-10	8288-8291	gap	_	
51-11	8292-8296	were	_	
51-12	8297-8305	acquired	_	
51-13	8306-8308	to	_	
51-14	8309-8314	cover	_	
51-15	8315-8318	the	_	
51-16	8319-8324	whole	_	
51-17	8325-8330	brain	_	
51-18	8331-8337	volume	_	
51-19	8337-8338	.	_	

#Text=Each scan contained 180 volumes.
52-1	8339-8343	Each	_	
52-2	8344-8348	scan	_	
52-3	8349-8358	contained	_	
52-4	8359-8362	180	_	
52-5	8363-8370	volumes	_	
52-6	8370-8371	.	_	

#Text=During the scan, participants were instructed to relax, remain calm, keep their eyes closed, and refrain from thinking about anything in particular.
53-1	8372-8378	During	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-2	8379-8382	the	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-3	8383-8387	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-4	8387-8388	,	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-5	8389-8401	participants	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-6	8402-8406	were	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-7	8407-8417	instructed	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-8	8418-8420	to	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-9	8421-8426	relax	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-10	8426-8427	,	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-11	8428-8434	remain	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-12	8435-8439	calm	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-13	8439-8440	,	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-14	8441-8445	keep	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-15	8446-8451	their	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-16	8452-8456	eyes	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-17	8457-8463	closed	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-18	8463-8464	,	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-19	8465-8468	and	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-20	8469-8476	refrain	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-21	8477-8481	from	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-22	8482-8490	thinking	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-23	8491-8496	about	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-24	8497-8505	anything	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-25	8506-8508	in	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-26	8509-8519	particular	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]	
53-27	8519-8520	.	_	

#Text=Data preprocessing
#Text=The fMRI data were preprocessed using Statistical Parametric Mapping (SPM8; http://www.fil.ion.ucl.ac.uk/spm) and Data Preprocessing Assistant for Resting-state fMRI (DPARSF).
54-1	8521-8525	Data	_	
54-2	8526-8539	preprocessing	_	
54-3	8540-8543	The	_	
54-4	8544-8548	fMRI	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[31]	
54-5	8549-8553	data	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[31]	
54-6	8554-8558	were	_	
54-7	8559-8571	preprocessed	_	
54-8	8572-8577	using	_	
54-9	8578-8589	Statistical	_	
54-10	8590-8600	Parametric	_	
54-11	8601-8608	Mapping	_	
54-12	8609-8610	(	_	
54-13	8610-8614	SPM8	_	
54-14	8614-8615	;	_	
54-15	8616-8620	http	_	
54-16	8620-8621	:	_	
54-17	8621-8622	/	_	
54-18	8622-8623	/	_	
54-19	8623-8644	www.fil.ion.ucl.ac.uk	_	
54-20	8644-8645	/	_	
54-21	8645-8648	spm	_	
54-22	8648-8649	)	_	
54-23	8650-8653	and	_	
54-24	8654-8658	Data	_	
54-25	8659-8672	Preprocessing	_	
54-26	8673-8682	Assistant	_	
54-27	8683-8686	for	_	
54-28	8687-8700	Resting-state	_	
54-29	8701-8705	fMRI	_	
54-30	8706-8707	(	_	
54-31	8707-8713	DPARSF	_	
54-32	8713-8714	)	_	
54-33	8714-8715	.	_	

#Text=The first 10 volumes were discarded to allow for scanner stabilization and subject adaption to the scanning environment.
55-1	8716-8719	The	_	
55-2	8720-8725	first	_	
55-3	8726-8728	10	_	
55-4	8729-8736	volumes	_	
55-5	8737-8741	were	_	
55-6	8742-8751	discarded	_	
55-7	8752-8754	to	_	
55-8	8755-8760	allow	_	
55-9	8761-8764	for	_	
55-10	8765-8772	scanner	_	
55-11	8773-8786	stabilization	_	
55-12	8787-8790	and	_	
55-13	8791-8798	subject	_	
55-14	8799-8807	adaption	_	
55-15	8808-8810	to	_	
55-16	8811-8814	the	_	
55-17	8815-8823	scanning	_	
55-18	8824-8835	environment	_	
55-19	8835-8836	.	_	

#Text=The remaining functional scans were corrected for delay in slice acquisition and interscan head movement.
56-1	8837-8840	The	_	
56-2	8841-8850	remaining	_	
56-3	8851-8861	functional	_	
56-4	8862-8867	scans	_	
56-5	8868-8872	were	_	
56-6	8873-8882	corrected	_	
56-7	8883-8886	for	_	
56-8	8887-8892	delay	_	
56-9	8893-8895	in	_	
56-10	8896-8901	slice	_	
56-11	8902-8913	acquisition	_	
56-12	8914-8917	and	_	
56-13	8918-8927	interscan	_	
56-14	8928-8932	head	_	
56-15	8933-8941	movement	_	
56-16	8941-8942	.	_	

#Text=Subsequently, the functional scans were spatially normalized to the stereotactic space (Montreal Neurological Institute) and resampled to 3 mm isotropic voxels.
57-1	8943-8955	Subsequently	_	
57-2	8955-8956	,	_	
57-3	8957-8960	the	_	
57-4	8961-8971	functional	_	
57-5	8972-8977	scans	_	
57-6	8978-8982	were	_	
57-7	8983-8992	spatially	_	
57-8	8993-9003	normalized	_	
57-9	9004-9006	to	_	
57-10	9007-9010	the	_	
57-11	9011-9023	stereotactic	_	
57-12	9024-9029	space	_	
57-13	9030-9031	(	_	
57-14	9031-9039	Montreal	_	
57-15	9040-9052	Neurological	_	
57-16	9053-9062	Institute	_	
57-17	9062-9063	)	_	
57-18	9064-9067	and	_	
57-19	9068-9077	resampled	_	
57-20	9078-9080	to	_	
57-21	9081-9082	3	_	
57-22	9083-9085	mm	_	
57-23	9086-9095	isotropic	_	
57-24	9096-9102	voxels	_	
57-25	9102-9103	.	_	

#Text=All normalized images were then smoothed with an 8 mm Gaussian kernel.
58-1	9104-9107	All	_	
58-2	9108-9118	normalized	_	
58-3	9119-9125	images	_	
58-4	9126-9130	were	_	
58-5	9131-9135	then	_	
58-6	9136-9144	smoothed	_	
58-7	9145-9149	with	_	
58-8	9150-9152	an	_	
58-9	9153-9154	8	_	
58-10	9155-9157	mm	_	
58-11	9158-9166	Gaussian	_	
58-12	9167-9173	kernel	_	
58-13	9173-9174	.	_	

#Text=The BOLD signal of each voxel was then linearly detrended and passed through a band-pass filter (0.01–0.08 Hz).
59-1	9175-9178	The	_	
59-2	9179-9183	BOLD	_	
59-3	9184-9190	signal	_	
59-4	9191-9193	of	_	
59-5	9194-9198	each	_	
59-6	9199-9204	voxel	_	
59-7	9205-9208	was	_	
59-8	9209-9213	then	_	
59-9	9214-9222	linearly	_	
59-10	9223-9232	detrended	_	
59-11	9233-9236	and	_	
59-12	9237-9243	passed	_	
59-13	9244-9251	through	_	
59-14	9252-9253	a	_	
59-15	9254-9263	band-pass	_	
59-16	9264-9270	filter	_	
59-17	9271-9272	(	_	
59-18	9272-9276	0.01	_	
59-19	9276-9277	–	_	
59-20	9277-9281	0.08	_	
59-21	9282-9284	Hz	_	
59-22	9284-9285	)	_	
59-23	9285-9286	.	_	

#Text=Nuisance covariates were regressed out using multiple linear regression, including six head-motion parameters, white matter signals, cerebrospinal signals, and global mean signals.
60-1	9287-9295	Nuisance	_	
60-2	9296-9306	covariates	_	
60-3	9307-9311	were	_	
60-4	9312-9321	regressed	_	
60-5	9322-9325	out	_	
60-6	9326-9331	using	_	
60-7	9332-9340	multiple	_	
60-8	9341-9347	linear	_	
60-9	9348-9358	regression	_	
60-10	9358-9359	,	_	
60-11	9360-9369	including	_	
60-12	9370-9373	six	_	
60-13	9374-9385	head-motion	_	
60-14	9386-9396	parameters	_	
60-15	9396-9397	,	_	
60-16	9398-9403	white	_	
60-17	9404-9410	matter	_	
60-18	9411-9418	signals	_	
60-19	9418-9419	,	_	
60-20	9420-9433	cerebrospinal	_	
60-21	9434-9441	signals	_	
60-22	9441-9442	,	_	
60-23	9443-9446	and	_	
60-24	9447-9453	global	_	
60-25	9454-9458	mean	_	
60-26	9459-9466	signals	_	
60-27	9466-9467	.	_	

#Text=We chose global signal removal as it has been shown to reduce physiological noise and the variance because of movement-related effects.
61-1	9468-9470	We	_	
61-2	9471-9476	chose	_	
61-3	9477-9483	global	_	
61-4	9484-9490	signal	_	
61-5	9491-9498	removal	_	
61-6	9499-9501	as	_	
61-7	9502-9504	it	_	
61-8	9505-9508	has	_	
61-9	9509-9513	been	_	
61-10	9514-9519	shown	_	
61-11	9520-9522	to	_	
61-12	9523-9529	reduce	_	
61-13	9530-9543	physiological	_	
61-14	9544-9549	noise	_	
61-15	9550-9553	and	_	
61-16	9554-9557	the	_	
61-17	9558-9566	variance	_	
61-18	9567-9574	because	_	
61-19	9575-9577	of	_	
61-20	9578-9594	movement-related	_	
61-21	9595-9602	effects	_	
61-22	9602-9603	.	_	

#Text=To reduce the effect of head motion, we further conducted careful volume censoring (“scrubbing”) movement correction.
62-1	9604-9606	To	_	
62-2	9607-9613	reduce	_	
62-3	9614-9617	the	_	
62-4	9618-9624	effect	_	
62-5	9625-9627	of	_	
62-6	9628-9632	head	_	
62-7	9633-9639	motion	_	
62-8	9639-9640	,	_	
62-9	9641-9643	we	_	
62-10	9644-9651	further	_	
62-11	9652-9661	conducted	_	
62-12	9662-9669	careful	_	
62-13	9670-9676	volume	_	
62-14	9677-9686	censoring	_	
62-15	9687-9688	(	_	
62-16	9688-9689	“	_	
62-17	9689-9698	scrubbing	_	
62-18	9698-9699	”	_	
62-19	9699-9700	)	_	
62-20	9701-9709	movement	_	
62-21	9710-9720	correction	_	
62-22	9720-9721	.	_	

#Text=The mean framewise displacement (FD) was calculated with an FD threshold of 0.5 mm for exclusion.
63-1	9722-9725	The	_	
63-2	9726-9730	mean	_	
63-3	9731-9740	framewise	_	
63-4	9741-9753	displacement	_	
63-5	9754-9755	(	_	
63-6	9755-9757	FD	_	
63-7	9757-9758	)	_	
63-8	9759-9762	was	_	
63-9	9763-9773	calculated	_	
63-10	9774-9778	with	_	
63-11	9779-9781	an	_	
63-12	9782-9784	FD	_	
63-13	9785-9794	threshold	_	
63-14	9795-9797	of	_	
63-15	9798-9801	0.5	_	
63-16	9802-9804	mm	_	
63-17	9805-9808	for	_	
63-18	9809-9818	exclusion	_	
63-19	9818-9819	.	_	

#Text=Except for the frame corresponding to the displaced time point, we also removed one preceding and two succeeding time points to reduce the spillover influence of head motion.
64-1	9820-9826	Except	_	
64-2	9827-9830	for	_	
64-3	9831-9834	the	_	
64-4	9835-9840	frame	_	
64-5	9841-9854	corresponding	_	
64-6	9855-9857	to	_	
64-7	9858-9861	the	_	
64-8	9862-9871	displaced	_	
64-9	9872-9876	time	_	
64-10	9877-9882	point	_	
64-11	9882-9883	,	_	
64-12	9884-9886	we	_	
64-13	9887-9891	also	_	
64-14	9892-9899	removed	_	
64-15	9900-9903	one	_	
64-16	9904-9913	preceding	_	
64-17	9914-9917	and	_	
64-18	9918-9921	two	_	
64-19	9922-9932	succeeding	_	
64-20	9933-9937	time	_	
64-21	9938-9944	points	_	
64-22	9945-9947	to	_	
64-23	9948-9954	reduce	_	
64-24	9955-9958	the	_	
64-25	9959-9968	spillover	_	
64-26	9969-9978	influence	_	
64-27	9979-9981	of	_	
64-28	9982-9986	head	_	
64-29	9987-9993	motion	_	
64-30	9993-9994	.	_	

#Text=All participants with >10% displaced frames or who exhibited more than 3° of maximal rotation or 3 mm of maximal translation were completely excluded from the following analysis.
65-1	9995-9998	All	_	
65-2	9999-10011	participants	_	
65-3	10012-10016	with	_	
65-4	10017-10018	>	_	
65-5	10018-10021	10%	_	
65-6	10022-10031	displaced	_	
65-7	10032-10038	frames	_	
65-8	10039-10041	or	_	
65-9	10042-10045	who	_	
65-10	10046-10055	exhibited	_	
65-11	10056-10060	more	_	
65-12	10061-10065	than	_	
65-13	10066-10067	3	_	
65-14	10067-10068	°	_	
65-15	10069-10071	of	_	
65-16	10072-10079	maximal	_	
65-17	10080-10088	rotation	_	
65-18	10089-10091	or	_	
65-19	10092-10093	3	_	
65-20	10094-10096	mm	_	
65-21	10097-10099	of	_	
65-22	10100-10107	maximal	_	
65-23	10108-10119	translation	_	
65-24	10120-10124	were	_	
65-25	10125-10135	completely	_	
65-26	10136-10144	excluded	_	
65-27	10145-10149	from	_	
65-28	10150-10153	the	_	
65-29	10154-10163	following	_	
65-30	10164-10172	analysis	_	
65-31	10172-10173	.	_	

#Text=Dynamic functional connectivity analysis
#Text=SampEn analysis of dynamic functional connectivity.
66-1	10174-10181	Dynamic	_	
66-2	10182-10192	functional	_	
66-3	10193-10205	connectivity	_	
66-4	10206-10214	analysis	_	
66-5	10215-10221	SampEn	_	
66-6	10222-10230	analysis	_	
66-7	10231-10233	of	_	
66-8	10234-10241	dynamic	_	
66-9	10242-10252	functional	_	
66-10	10253-10265	connectivity	_	
66-11	10265-10266	.	_	

#Text=Dynamic functional connectivity matrices at different time windows for one subject (a).
67-1	10267-10274	Dynamic	_	
67-2	10275-10285	functional	_	
67-3	10286-10298	connectivity	_	
67-4	10299-10307	matrices	_	
67-5	10308-10310	at	_	
67-6	10311-10320	different	_	
67-7	10321-10325	time	_	
67-8	10326-10333	windows	_	
67-9	10334-10337	for	_	
67-10	10338-10341	one	_	
67-11	10342-10349	subject	_	
67-12	10350-10351	(	_	
67-13	10351-10352	a	_	
67-14	10352-10353	)	_	
67-15	10353-10354	.	_	

#Text=We extracted the functional connectivity time series between each pair of ROIs from these dynamic functional connectivity matrices, and evaluated SampEn of each functional connectivity time series (b).
68-1	10355-10357	We	_	
68-2	10358-10367	extracted	_	
68-3	10368-10371	the	_	
68-4	10372-10382	functional	_	
68-5	10383-10395	connectivity	_	
68-6	10396-10400	time	_	
68-7	10401-10407	series	_	
68-8	10408-10415	between	_	
68-9	10416-10420	each	_	
68-10	10421-10425	pair	_	
68-11	10426-10428	of	_	
68-12	10429-10433	ROIs	_	
68-13	10434-10438	from	_	
68-14	10439-10444	these	_	
68-15	10445-10452	dynamic	_	
68-16	10453-10463	functional	_	
68-17	10464-10476	connectivity	_	
68-18	10477-10485	matrices	_	
68-19	10485-10486	,	_	
68-20	10487-10490	and	_	
68-21	10491-10500	evaluated	_	
68-22	10501-10507	SampEn	_	
68-23	10508-10510	of	_	
68-24	10511-10515	each	_	
68-25	10516-10526	functional	_	
68-26	10527-10539	connectivity	_	
68-27	10540-10544	time	_	
68-28	10545-10551	series	_	
68-29	10552-10553	(	_	
68-30	10553-10554	b	_	
68-31	10554-10555	)	_	
68-32	10555-10556	.	_	

#Text=FC, functional connectivity.
69-1	10557-10559	FC	_	
69-2	10559-10560	,	_	
69-3	10561-10571	functional	_	
69-4	10572-10584	connectivity	_	
69-5	10584-10585	.	_	

#Text=We used the automated anatomical labeling atlas to divide the human brain into 90 relatively large regions of interests (ROIs).
70-1	10586-10588	We	_	
70-2	10589-10593	used	_	
70-3	10594-10597	the	_	
70-4	10598-10607	automated	_	
70-5	10608-10618	anatomical	_	
70-6	10619-10627	labeling	_	
70-7	10628-10633	atlas	_	
70-8	10634-10636	to	_	
70-9	10637-10643	divide	_	
70-10	10644-10647	the	_	
70-11	10648-10653	human	_	
70-12	10654-10659	brain	_	
70-13	10660-10664	into	_	
70-14	10665-10667	90	_	
70-15	10668-10678	relatively	_	
70-16	10679-10684	large	_	
70-17	10685-10692	regions	_	
70-18	10693-10695	of	_	
70-19	10696-10705	interests	_	
70-20	10706-10707	(	_	
70-21	10707-10711	ROIs	_	
70-22	10711-10712	)	_	
70-23	10712-10713	.	_	

#Text=The time series was extracted in each ROI by averaging the BOLD signals of all voxels within that ROI.
71-1	10714-10717	The	_	
71-2	10718-10722	time	_	
71-3	10723-10729	series	_	
71-4	10730-10733	was	_	
71-5	10734-10743	extracted	_	
71-6	10744-10746	in	_	
71-7	10747-10751	each	_	
71-8	10752-10755	ROI	_	
71-9	10756-10758	by	_	
71-10	10759-10768	averaging	_	
71-11	10769-10772	the	_	
71-12	10773-10777	BOLD	_	
71-13	10778-10785	signals	_	
71-14	10786-10788	of	_	
71-15	10789-10792	all	_	
71-16	10793-10799	voxels	_	
71-17	10800-10806	within	_	
71-18	10807-10811	that	_	
71-19	10812-10815	ROI	_	
71-20	10815-10816	.	_	

#Text=This approach reduces noise contained in these BOLD signals and commonly has been used in resting-state fMRI studies.
72-1	10817-10821	This	_	
72-2	10822-10830	approach	_	
72-3	10831-10838	reduces	_	
72-4	10839-10844	noise	_	
72-5	10845-10854	contained	_	
72-6	10855-10857	in	_	
72-7	10858-10863	these	_	
72-8	10864-10868	BOLD	_	
72-9	10869-10876	signals	_	
72-10	10877-10880	and	_	
72-11	10881-10889	commonly	_	
72-12	10890-10893	has	_	
72-13	10894-10898	been	_	
72-14	10899-10903	used	_	
72-15	10904-10906	in	_	
72-16	10907-10920	resting-state	_	
72-17	10921-10925	fMRI	_	
72-18	10926-10933	studies	_	
72-19	10933-10934	.	_	

#Text=The names and abbreviations of the ROIs are listed in Supplementary Table S1.
73-1	10935-10938	The	_	
73-2	10939-10944	names	_	
73-3	10945-10948	and	_	
73-4	10949-10962	abbreviations	_	
73-5	10963-10965	of	_	
73-6	10966-10969	the	_	
73-7	10970-10974	ROIs	_	
73-8	10975-10978	are	_	
73-9	10979-10985	listed	_	
73-10	10986-10988	in	_	
73-11	10989-11002	Supplementary	_	
73-12	11003-11008	Table	_	
73-13	11008-11009	 	_	
73-14	11009-11011	S1	_	
73-15	11011-11012	.	_	

#Text=For each subject, we performed dynamic functional connectivity analysis using the sliding window approach.
74-1	11013-11016	For	_	
74-2	11017-11021	each	_	
74-3	11022-11029	subject	_	
74-4	11029-11030	,	_	
74-5	11031-11033	we	_	
74-6	11034-11043	performed	_	
74-7	11044-11051	dynamic	_	
74-8	11052-11062	functional	_	
74-9	11063-11075	connectivity	_	
74-10	11076-11084	analysis	_	
74-11	11085-11090	using	_	
74-12	11091-11094	the	_	
74-13	11095-11102	sliding	_	
74-14	11103-11109	window	_	
74-15	11110-11118	approach	_	
74-16	11118-11119	.	_	

#Text=The time window with a length of 20 TRs (40 s) slid in steps of 1 TR, resulting in 150 windows.
75-1	11120-11123	The	_	
75-2	11124-11128	time	_	
75-3	11129-11135	window	_	
75-4	11136-11140	with	_	
75-5	11141-11142	a	_	
75-6	11143-11149	length	_	
75-7	11150-11152	of	_	
75-8	11153-11155	20	_	
75-9	11156-11159	TRs	_	
75-10	11160-11161	(	_	
75-11	11161-11163	40	_	
75-12	11164-11165	s	_	
75-13	11165-11166	)	_	
75-14	11167-11171	slid	_	
75-15	11172-11174	in	_	
75-16	11175-11180	steps	_	
75-17	11181-11183	of	_	
75-18	11184-11185	1	_	
75-19	11186-11188	TR	_	
75-20	11188-11189	,	_	
75-21	11190-11199	resulting	_	
75-22	11200-11202	in	_	
75-23	11203-11206	150	_	
75-24	11207-11214	windows	_	
75-25	11214-11215	.	_	

#Text=Given a time window, we evaluated the functional connectivity between each pair of ROIs using Pearson correlation.
76-1	11216-11221	Given	_	
76-2	11222-11223	a	_	
76-3	11224-11228	time	_	
76-4	11229-11235	window	_	
76-5	11235-11236	,	_	
76-6	11237-11239	we	_	
76-7	11240-11249	evaluated	_	
76-8	11250-11253	the	_	
76-9	11254-11264	functional	_	
76-10	11265-11277	connectivity	_	
76-11	11278-11285	between	_	
76-12	11286-11290	each	_	
76-13	11291-11295	pair	_	
76-14	11296-11298	of	_	
76-15	11299-11303	ROIs	_	
76-16	11304-11309	using	_	
76-17	11310-11317	Pearson	_	
76-18	11318-11329	correlation	_	
76-19	11329-11330	.	_	

#Text=Thus, we obtained dynamic functional connectivity matrices for each subject (Fig. 1a).
77-1	11331-11335	Thus	_	
77-2	11335-11336	,	_	
77-3	11337-11339	we	_	
77-4	11340-11348	obtained	_	
77-5	11349-11356	dynamic	_	
77-6	11357-11367	functional	_	
77-7	11368-11380	connectivity	_	
77-8	11381-11389	matrices	_	
77-9	11390-11393	for	_	
77-10	11394-11398	each	_	
77-11	11399-11406	subject	_	
77-12	11407-11408	(	_	
77-13	11408-11411	Fig	_	
77-14	11411-11412	.	_	
77-15	11412-11413	 	_	
77-16	11413-11415	1a	_	
77-17	11415-11416	)	_	
77-18	11416-11417	.	_	

#Text=The functional connectivity time series between each pair of ROIs then was extracted from these matrices (Fig. 1b).
78-1	11418-11421	The	_	
78-2	11422-11432	functional	_	
78-3	11433-11445	connectivity	_	
78-4	11446-11450	time	_	
78-5	11451-11457	series	_	
78-6	11458-11465	between	_	
78-7	11466-11470	each	_	
78-8	11471-11475	pair	_	
78-9	11476-11478	of	_	
78-10	11479-11483	ROIs	_	
78-11	11484-11488	then	_	
78-12	11489-11492	was	_	
78-13	11493-11502	extracted	_	
78-14	11503-11507	from	_	
78-15	11508-11513	these	_	
78-16	11514-11522	matrices	_	
78-17	11523-11524	(	_	
78-18	11524-11527	Fig	_	
78-19	11527-11528	.	_	
78-20	11528-11529	 	_	
78-21	11529-11531	1b	_	
78-22	11531-11532	)	_	
78-23	11532-11533	.	_	

#Text=We selected the window length on the basis of the observations that window sizes in the range of 30–60 s produce robust results in cognitive states, and variations of functional connectivity are not sensitive to the specific window size in the range of 20–40 s.
79-1	11534-11536	We	_	
79-2	11537-11545	selected	_	
79-3	11546-11549	the	_	
79-4	11550-11556	window	_	
79-5	11557-11563	length	_	
79-6	11564-11566	on	_	
79-7	11567-11570	the	_	
79-8	11571-11576	basis	_	
79-9	11577-11579	of	_	
79-10	11580-11583	the	_	
79-11	11584-11596	observations	_	
79-12	11597-11601	that	_	
79-13	11602-11608	window	_	
79-14	11609-11614	sizes	_	
79-15	11615-11617	in	_	
79-16	11618-11621	the	_	
79-17	11622-11627	range	_	
79-18	11628-11630	of	_	
79-19	11631-11633	30	_	
79-20	11633-11634	–	_	
79-21	11634-11636	60	_	
79-22	11637-11638	s	_	
79-23	11639-11646	produce	_	
79-24	11647-11653	robust	_	
79-25	11654-11661	results	_	
79-26	11662-11664	in	_	
79-27	11665-11674	cognitive	_	
79-28	11675-11681	states	_	
79-29	11681-11682	,	_	
79-30	11683-11686	and	_	
79-31	11687-11697	variations	_	
79-32	11698-11700	of	_	
79-33	11701-11711	functional	_	
79-34	11712-11724	connectivity	_	
79-35	11725-11728	are	_	
79-36	11729-11732	not	_	
79-37	11733-11742	sensitive	_	
79-38	11743-11745	to	_	
79-39	11746-11749	the	_	
79-40	11750-11758	specific	_	
79-41	11759-11765	window	_	
79-42	11766-11770	size	_	
79-43	11771-11773	in	_	
79-44	11774-11777	the	_	
79-45	11778-11783	range	_	
79-46	11784-11786	of	_	
79-47	11787-11789	20	_	
79-48	11789-11790	–	_	
79-49	11790-11792	40	_	
79-50	11793-11794	s	_	
79-51	11794-11795	.	_	

#Text=Pearson correlation only captures linear associations between time series and often results in negative correlations.
80-1	11797-11804	Pearson	_	
80-2	11805-11816	correlation	_	
80-3	11817-11821	only	_	
80-4	11822-11830	captures	_	
80-5	11831-11837	linear	_	
80-6	11838-11850	associations	_	
80-7	11851-11858	between	_	
80-8	11859-11863	time	_	
80-9	11864-11870	series	_	
80-10	11871-11874	and	_	
80-11	11875-11880	often	_	
80-12	11881-11888	results	_	
80-13	11889-11891	in	_	
80-14	11892-11900	negative	_	
80-15	11901-11913	correlations	_	
80-16	11913-11914	.	_	

#Text=Indeed, we found that the mean proportion of negative correlations across all dynamic functional connectivity matrices of all participants was 0.4998 ± 0.0134 (mean ± SD).
81-1	11915-11921	Indeed	_	
81-2	11921-11922	,	_	
81-3	11923-11925	we	_	
81-4	11926-11931	found	_	
81-5	11932-11936	that	_	
81-6	11937-11940	the	_	
81-7	11941-11945	mean	_	
81-8	11946-11956	proportion	_	
81-9	11957-11959	of	_	
81-10	11960-11968	negative	_	
81-11	11969-11981	correlations	_	
81-12	11982-11988	across	_	
81-13	11989-11992	all	_	
81-14	11993-12000	dynamic	_	
81-15	12001-12011	functional	_	
81-16	12012-12024	connectivity	_	
81-17	12025-12033	matrices	_	
81-18	12034-12036	of	_	
81-19	12037-12040	all	_	
81-20	12041-12053	participants	_	
81-21	12054-12057	was	_	
81-22	12058-12064	0.4998	_	
81-23	12065-12066	±	_	
81-24	12067-12073	0.0134	_	
81-25	12074-12075	(	_	
81-26	12075-12079	mean	_	
81-27	12080-12081	±	_	
81-28	12082-12084	SD	_	
81-29	12084-12085	)	_	
81-30	12085-12086	.	_	

#Text=Because we were mainly interested in the dynamic property of the functional connectivity, we did not deal with these negative correlations and directly calculated SampEn of each functional connectivity time series (Fig. 1b).
82-1	12087-12094	Because	_	
82-2	12095-12097	we	_	
82-3	12098-12102	were	_	
82-4	12103-12109	mainly	_	
82-5	12110-12120	interested	_	
82-6	12121-12123	in	_	
82-7	12124-12127	the	_	
82-8	12128-12135	dynamic	_	
82-9	12136-12144	property	_	
82-10	12145-12147	of	_	
82-11	12148-12151	the	_	
82-12	12152-12162	functional	_	
82-13	12163-12175	connectivity	_	
82-14	12175-12176	,	_	
82-15	12177-12179	we	_	
82-16	12180-12183	did	_	
82-17	12184-12187	not	_	
82-18	12188-12192	deal	_	
82-19	12193-12197	with	_	
82-20	12198-12203	these	_	
82-21	12204-12212	negative	_	
82-22	12213-12225	correlations	_	
82-23	12226-12229	and	_	
82-24	12230-12238	directly	_	
82-25	12239-12249	calculated	_	
82-26	12250-12256	SampEn	_	
82-27	12257-12259	of	_	
82-28	12260-12264	each	_	
82-29	12265-12275	functional	_	
82-30	12276-12288	connectivity	_	
82-31	12289-12293	time	_	
82-32	12294-12300	series	_	
82-33	12301-12302	(	_	
82-34	12302-12305	Fig	_	
82-35	12305-12306	.	_	
82-36	12306-12307	 	_	
82-37	12307-12309	1b	_	
82-38	12309-12310	)	_	
82-39	12310-12311	.	_	

#Text=SampEn analysis of dynamic functional connectivity
#Text=We denote a time series of length N by x = [x 1, x 2, …, x N].
83-1	12312-12318	SampEn	_	
83-2	12319-12327	analysis	_	
83-3	12328-12330	of	_	
83-4	12331-12338	dynamic	_	
83-5	12339-12349	functional	_	
83-6	12350-12362	connectivity	_	
83-7	12363-12365	We	_	
83-8	12366-12372	denote	_	
83-9	12373-12374	a	_	
83-10	12375-12379	time	_	
83-11	12380-12386	series	_	
83-12	12387-12389	of	_	
83-13	12390-12396	length	_	
83-14	12397-12398	N	_	
83-15	12399-12401	by	_	
83-16	12402-12403	x	_	
83-17	12404-12405	=	_	
83-18	12406-12407	[	_	
83-19	12407-12408	x	_	
83-20	12409-12410	1	_	
83-21	12410-12411	,	_	
83-22	12412-12413	x	_	
83-23	12414-12415	2	_	
83-24	12415-12416	,	_	
83-25	12417-12418	…	_	
83-26	12418-12419	,	_	
83-27	12420-12421	x	_	
83-28	12422-12423	N	_	
83-29	12423-12424	]	_	
83-30	12424-12425	.	_	

#Text=SampEn of the time series can be calculated as follows.
84-1	12426-12432	SampEn	_	
84-2	12433-12435	of	_	
84-3	12436-12439	the	_	
84-4	12440-12444	time	_	
84-5	12445-12451	series	_	
84-6	12452-12455	can	_	
84-7	12456-12458	be	_	
84-8	12459-12469	calculated	_	
84-9	12470-12472	as	_	
84-10	12473-12480	follows	_	
84-11	12480-12481	.	_	

#Text=First, construct an embedding vector with m consecutive data points extracted from x: v i = [x i, x i+1, …, x i+m−1], where m is the embedding dimension.
85-1	12482-12487	First	_	
85-2	12487-12488	,	_	
85-3	12489-12498	construct	_	
85-4	12499-12501	an	_	
85-5	12502-12511	embedding	_	
85-6	12512-12518	vector	_	
85-7	12519-12523	with	_	
85-8	12524-12525	m	_	
85-9	12526-12537	consecutive	_	
85-10	12538-12542	data	_	
85-11	12543-12549	points	_	
85-12	12550-12559	extracted	_	
85-13	12560-12564	from	_	
85-14	12565-12566	x	_	
85-15	12566-12567	:	_	
85-16	12568-12569	v	_	
85-17	12570-12571	i	_	
85-18	12572-12573	=	_	
85-19	12574-12575	[	_	
85-20	12575-12576	x	_	
85-21	12577-12578	i	_	
85-22	12578-12579	,	_	
85-23	12580-12581	x	_	
85-24	12582-12583	i	_	
85-25	12583-12584	+	_	
85-26	12584-12585	1	_	
85-27	12585-12586	,	_	
85-28	12587-12588	…	_	
85-29	12588-12589	,	_	
85-30	12590-12591	x	_	
85-31	12592-12593	i	_	
85-32	12593-12594	+	_	
85-33	12594-12595	m	_	
85-34	12595-12596	−	_	
85-35	12596-12597	1	_	
85-36	12597-12598	]	_	
85-37	12598-12599	,	_	
85-38	12600-12605	where	_	
85-39	12606-12607	m	_	
85-40	12608-12610	is	_	
85-41	12611-12614	the	_	
85-42	12615-12624	embedding	_	
85-43	12625-12634	dimension	_	
85-44	12634-12635	.	_	

#Text=Second, define for each i (1 ≤ i ≤ N − m)Here, r specifies a tolerance value and r = εσ x, where ε is a scaling parameter and σ x is the standard deviation of x.
86-1	12636-12642	Second	_	
86-2	12642-12643	,	_	
86-3	12644-12650	define	_	
86-4	12651-12654	for	_	
86-5	12655-12659	each	_	
86-6	12660-12661	i	_	
86-7	12662-12663	(	_	
86-8	12663-12664	1	_	
86-9	12665-12666	≤	_	
86-10	12667-12668	i	_	
86-11	12669-12670	≤	_	
86-12	12671-12672	N	_	
86-13	12673-12674	−	_	
86-14	12675-12676	m	_	
86-15	12676-12677	)	_	
86-16	12677-12681	Here	_	
86-17	12681-12682	,	_	
86-18	12683-12684	r	_	
86-19	12685-12694	specifies	_	
86-20	12695-12696	a	_	
86-21	12697-12706	tolerance	_	
86-22	12707-12712	value	_	
86-23	12713-12716	and	_	
86-24	12717-12718	r	_	
86-25	12719-12720	=	_	
86-26	12721-12723	εσ	_	
86-27	12724-12725	x	_	
86-28	12725-12726	,	_	
86-29	12727-12732	where	_	
86-30	12733-12734	ε	_	
86-31	12735-12737	is	_	
86-32	12738-12739	a	_	
86-33	12740-12747	scaling	_	
86-34	12748-12757	parameter	_	
86-35	12758-12761	and	_	
86-36	12762-12763	σ	_	
86-37	12764-12765	x	_	
86-38	12766-12768	is	_	
86-39	12769-12772	the	_	
86-40	12773-12781	standard	_	
86-41	12782-12791	deviation	_	
86-42	12792-12794	of	_	
86-43	12795-12796	x	_	
86-44	12796-12797	.	_	

#Text=is the Heaviside function:and  represents Chebyshev distance, that is, 
#Text=That is,  represents the proportion of v j (j ≠ i) whose distances to v i are less than r.
87-1	12799-12801	is	_	
87-2	12802-12805	the	_	
87-3	12806-12815	Heaviside	_	
87-4	12816-12824	function	_	
87-5	12824-12825	:	_	
87-6	12825-12828	and	_	
87-7	12830-12840	represents	_	
87-8	12841-12850	Chebyshev	_	
87-9	12851-12859	distance	_	
87-10	12859-12860	,	_	
87-11	12861-12865	that	_	
87-12	12866-12868	is	_	
87-13	12868-12869	,	_	
87-14	12871-12875	That	_	
87-15	12876-12878	is	_	
87-16	12878-12879	,	_	
87-17	12881-12891	represents	_	
87-18	12892-12895	the	_	
87-19	12896-12906	proportion	_	
87-20	12907-12909	of	_	
87-21	12910-12911	v	_	
87-22	12912-12913	j	_	
87-23	12914-12915	(	_	
87-24	12915-12916	j	_	
87-25	12917-12918	≠	_	
87-26	12919-12920	i	_	
87-27	12920-12921	)	_	
87-28	12922-12927	whose	_	
87-29	12928-12937	distances	_	
87-30	12938-12940	to	_	
87-31	12941-12942	v	_	
87-32	12943-12944	i	_	
87-33	12945-12948	are	_	
87-34	12949-12953	less	_	
87-35	12954-12958	than	_	
87-36	12959-12960	r	_	
87-37	12960-12961	.	_	

#Text=Similarly, for each i (1 ≤ i ≤ N − m), we also definewhere  represents the proportion corresponding to the dimension of m + 1;  and  have the same form, but embedding vectors in the two cases are defined in different phase spaces.
88-1	12962-12971	Similarly	_	
88-2	12971-12972	,	_	
88-3	12973-12976	for	_	
88-4	12977-12981	each	_	
88-5	12982-12983	i	_	
88-6	12984-12985	(	_	
88-7	12985-12986	1	_	
88-8	12987-12988	≤	_	
88-9	12989-12990	i	_	
88-10	12991-12992	≤	_	
88-11	12993-12994	N	_	
88-12	12995-12996	−	_	
88-13	12997-12998	m	_	
88-14	12998-12999	)	_	
88-15	12999-13000	,	_	
88-16	13001-13003	we	_	
88-17	13004-13008	also	_	
88-18	13009-13020	definewhere	_	
88-19	13022-13032	represents	_	
88-20	13033-13036	the	_	
88-21	13037-13047	proportion	_	
88-22	13048-13061	corresponding	_	
88-23	13062-13064	to	_	
88-24	13065-13068	the	_	
88-25	13069-13078	dimension	_	
88-26	13079-13081	of	_	
88-27	13082-13083	m	_	
88-28	13084-13085	+	_	
88-29	13086-13087	1	_	
88-30	13087-13088	;	_	
88-31	13090-13093	and	_	
88-32	13095-13099	have	_	
88-33	13100-13103	the	_	
88-34	13104-13108	same	_	
88-35	13109-13113	form	_	
88-36	13113-13114	,	_	
88-37	13115-13118	but	_	
88-38	13119-13128	embedding	_	
88-39	13129-13136	vectors	_	
88-40	13137-13139	in	_	
88-41	13140-13143	the	_	
88-42	13144-13147	two	_	
88-43	13148-13153	cases	_	
88-44	13154-13157	are	_	
88-45	13158-13165	defined	_	
88-46	13166-13168	in	_	
88-47	13169-13178	different	_	
88-48	13179-13184	phase	_	
88-49	13185-13191	spaces	_	
88-50	13191-13192	.	_	

#Text=Third, by averaging across all embedding vectors, we getand 
#Text=Fourth, SampEn of x is calculated as 
#Text=Following these four steps, we obtained SampEn of each functional connectivity time series for each subject (Fig. 1b).
89-1	13193-13198	Third	_	
89-2	13198-13199	,	_	
89-3	13200-13202	by	_	
89-4	13203-13212	averaging	_	
89-5	13213-13219	across	_	
89-6	13220-13223	all	_	
89-7	13224-13233	embedding	_	
89-8	13234-13241	vectors	_	
89-9	13241-13242	,	_	
89-10	13243-13245	we	_	
89-11	13246-13252	getand	_	
89-12	13254-13260	Fourth	_	
89-13	13260-13261	,	_	
89-14	13262-13268	SampEn	_	
89-15	13269-13271	of	_	
89-16	13272-13273	x	_	
89-17	13274-13276	is	_	
89-18	13277-13287	calculated	_	
89-19	13288-13290	as	_	
89-20	13292-13301	Following	_	
89-21	13302-13307	these	_	
89-22	13308-13312	four	_	
89-23	13313-13318	steps	_	
89-24	13318-13319	,	_	
89-25	13320-13322	we	_	
89-26	13323-13331	obtained	_	
89-27	13332-13338	SampEn	_	
89-28	13339-13341	of	_	
89-29	13342-13346	each	_	
89-30	13347-13357	functional	_	
89-31	13358-13370	connectivity	_	
89-32	13371-13375	time	_	
89-33	13376-13382	series	_	
89-34	13383-13386	for	_	
89-35	13387-13391	each	_	
89-36	13392-13399	subject	_	
89-37	13400-13401	(	_	
89-38	13401-13404	Fig	_	
89-39	13404-13405	.	_	
89-40	13405-13406	 	_	
89-41	13406-13408	1b	_	
89-42	13408-13409	)	_	
89-43	13409-13410	.	_	

#Text=SampEn assigned a nonnegative number to each functional connectivity time series, with larger values corresponding to more complexity or irregularity in the time series.
90-1	13411-13417	SampEn	_	
90-2	13418-13426	assigned	_	
90-3	13427-13428	a	_	
90-4	13429-13440	nonnegative	_	
90-5	13441-13447	number	_	
90-6	13448-13450	to	_	
90-7	13451-13455	each	_	
90-8	13456-13466	functional	_	
90-9	13467-13479	connectivity	_	
90-10	13480-13484	time	_	
90-11	13485-13491	series	_	
90-12	13491-13492	,	_	
90-13	13493-13497	with	_	
90-14	13498-13504	larger	_	
90-15	13505-13511	values	_	
90-16	13512-13525	corresponding	_	
90-17	13526-13528	to	_	
90-18	13529-13533	more	_	
90-19	13534-13544	complexity	_	
90-20	13545-13547	or	_	
90-21	13548-13560	irregularity	_	
90-22	13561-13563	in	_	
90-23	13564-13567	the	_	
90-24	13568-13572	time	_	
90-25	13573-13579	series	_	
90-26	13579-13580	.	_	

#Text=It was suggested that, for m = 1 or 2 and ε in the range of 0.1–0.25, SampEn shows good statistical properties.
91-1	13581-13583	It	_	
91-2	13584-13587	was	_	
91-3	13588-13597	suggested	_	
91-4	13598-13602	that	_	
91-5	13602-13603	,	_	
91-6	13604-13607	for	_	
91-7	13608-13609	m	_	
91-8	13610-13611	=	_	
91-9	13612-13613	1	_	
91-10	13614-13616	or	_	
91-11	13617-13618	2	_	
91-12	13619-13622	and	_	
91-13	13623-13624	ε	_	
91-14	13625-13627	in	_	
91-15	13628-13631	the	_	
91-16	13632-13637	range	_	
91-17	13638-13640	of	_	
91-18	13641-13644	0.1	_	
91-19	13644-13645	–	_	
91-20	13645-13649	0.25	_	
91-21	13649-13650	,	_	
91-22	13651-13657	SampEn	_	
91-23	13658-13663	shows	_	
91-24	13664-13668	good	_	
91-25	13669-13680	statistical	_	
91-26	13681-13691	properties	_	
91-27	13691-13692	.	_	

#Text=Throughout this study, m was fixed at 2 as it was shown that m = 2 enables more detailed reconstruction of the joint probabilistic dynamics of the time series.
92-1	13693-13703	Throughout	_	
92-2	13704-13708	this	_	
92-3	13709-13714	study	_	
92-4	13714-13715	,	_	
92-5	13716-13717	m	_	
92-6	13718-13721	was	_	
92-7	13722-13727	fixed	_	
92-8	13728-13730	at	_	
92-9	13731-13732	2	_	
92-10	13733-13735	as	_	
92-11	13736-13738	it	_	
92-12	13739-13742	was	_	
92-13	13743-13748	shown	_	
92-14	13749-13753	that	_	
92-15	13754-13755	m	_	
92-16	13756-13757	=	_	
92-17	13758-13759	2	_	
92-18	13760-13767	enables	_	
92-19	13768-13772	more	_	
92-20	13773-13781	detailed	_	
92-21	13782-13796	reconstruction	_	
92-22	13797-13799	of	_	
92-23	13800-13803	the	_	
92-24	13804-13809	joint	_	
92-25	13810-13823	probabilistic	_	
92-26	13824-13832	dynamics	_	
92-27	13833-13835	of	_	
92-28	13836-13839	the	_	
92-29	13840-13844	time	_	
92-30	13845-13851	series	_	
92-31	13851-13852	.	_	

#Text=In the main analysis, ε was fixed at 0.2.
93-1	13853-13855	In	_	
93-2	13856-13859	the	_	
93-3	13860-13864	main	_	
93-4	13865-13873	analysis	_	
93-5	13873-13874	,	_	
93-6	13875-13876	ε	_	
93-7	13877-13880	was	_	
93-8	13881-13886	fixed	_	
93-9	13887-13889	at	_	
93-10	13890-13893	0.2	_	
93-11	13893-13894	.	_	

#Text=For each subject, after SampEn of each functional connectivity time series was obtained, we further calculated SampEn of ROIs.
94-1	13895-13898	For	_	
94-2	13899-13903	each	_	
94-3	13904-13911	subject	_	
94-4	13911-13912	,	_	
94-5	13913-13918	after	_	
94-6	13919-13925	SampEn	_	
94-7	13926-13928	of	_	
94-8	13929-13933	each	_	
94-9	13934-13944	functional	_	
94-10	13945-13957	connectivity	_	
94-11	13958-13962	time	_	
94-12	13963-13969	series	_	
94-13	13970-13973	was	_	
94-14	13974-13982	obtained	_	
94-15	13982-13983	,	_	
94-16	13984-13986	we	_	
94-17	13987-13994	further	_	
94-18	13995-14005	calculated	_	
94-19	14006-14012	SampEn	_	
94-20	14013-14015	of	_	
94-21	14016-14020	ROIs	_	
94-22	14020-14021	.	_	

#Text=We obtained SampEn of a given ROI by averaging SampEn of 89 functional connectivity time series corresponding to it.
95-1	14022-14024	We	_	
95-2	14025-14033	obtained	_	
95-3	14034-14040	SampEn	_	
95-4	14041-14043	of	_	
95-5	14044-14045	a	_	
95-6	14046-14051	given	_	
95-7	14052-14055	ROI	_	
95-8	14056-14058	by	_	
95-9	14059-14068	averaging	_	
95-10	14069-14075	SampEn	_	
95-11	14076-14078	of	_	
95-12	14079-14081	89	_	
95-13	14082-14092	functional	_	
95-14	14093-14105	connectivity	_	
95-15	14106-14110	time	_	
95-16	14111-14117	series	_	
95-17	14118-14131	corresponding	_	
95-18	14132-14134	to	_	
95-19	14135-14137	it	_	
95-20	14137-14138	.	_	

#Text=We also calculated SampEn of resting state networks (RSNs).
96-1	14139-14141	We	_	
96-2	14142-14146	also	_	
96-3	14147-14157	calculated	_	
96-4	14158-14164	SampEn	_	
96-5	14165-14167	of	_	
96-6	14168-14175	resting	_	
96-7	14176-14181	state	_	
96-8	14182-14190	networks	_	
96-9	14191-14192	(	_	
96-10	14192-14196	RSNs	_	
96-11	14196-14197	)	_	
96-12	14197-14198	.	_	

#Text=Previous studies showed that the whole brain can be divided into six RSNs, which can be classified as follows: a default mode network (RSN 1), an attention network (RSN 2), a visual recognition network (RSN 3), an auditory network (RSN 4), a sensorimotor network (RSN 5), and a subcortical network (RSN 6).
97-1	14199-14207	Previous	_	
97-2	14208-14215	studies	_	
97-3	14216-14222	showed	_	
97-4	14223-14227	that	_	
97-5	14228-14231	the	_	
97-6	14232-14237	whole	_	
97-7	14238-14243	brain	_	
97-8	14244-14247	can	_	
97-9	14248-14250	be	_	
97-10	14251-14258	divided	_	
97-11	14259-14263	into	_	
97-12	14264-14267	six	_	
97-13	14268-14272	RSNs	_	
97-14	14272-14273	,	_	
97-15	14274-14279	which	_	
97-16	14280-14283	can	_	
97-17	14284-14286	be	_	
97-18	14287-14297	classified	_	
97-19	14298-14300	as	_	
97-20	14301-14308	follows	_	
97-21	14308-14309	:	_	
97-22	14310-14311	a	_	
97-23	14312-14319	default	_	
97-24	14320-14324	mode	_	
97-25	14325-14332	network	_	
97-26	14333-14334	(	_	
97-27	14334-14337	RSN	_	
97-28	14338-14339	1	_	
97-29	14339-14340	)	_	
97-30	14340-14341	,	_	
97-31	14342-14344	an	_	
97-32	14345-14354	attention	_	
97-33	14355-14362	network	_	
97-34	14363-14364	(	_	
97-35	14364-14367	RSN	_	
97-36	14368-14369	2	_	
97-37	14369-14370	)	_	
97-38	14370-14371	,	_	
97-39	14372-14373	a	_	
97-40	14374-14380	visual	_	
97-41	14381-14392	recognition	_	
97-42	14393-14400	network	_	
97-43	14401-14402	(	_	
97-44	14402-14405	RSN	_	
97-45	14406-14407	3	_	
97-46	14407-14408	)	_	
97-47	14408-14409	,	_	
97-48	14410-14412	an	_	
97-49	14413-14421	auditory	_	
97-50	14422-14429	network	_	
97-51	14430-14431	(	_	
97-52	14431-14434	RSN	_	
97-53	14435-14436	4	_	
97-54	14436-14437	)	_	
97-55	14437-14438	,	_	
97-56	14439-14440	a	_	
97-57	14441-14453	sensorimotor	_	
97-58	14454-14461	network	_	
97-59	14462-14463	(	_	
97-60	14463-14466	RSN	_	
97-61	14467-14468	5	_	
97-62	14468-14469	)	_	
97-63	14469-14470	,	_	
97-64	14471-14474	and	_	
97-65	14475-14476	a	_	
97-66	14477-14488	subcortical	_	
97-67	14489-14496	network	_	
97-68	14497-14498	(	_	
97-69	14498-14501	RSN	_	
97-70	14502-14503	6	_	
97-71	14503-14504	)	_	
97-72	14504-14505	.	_	

#Text=Supplementary Table S2 lists the ROIs in each RSN.
98-1	14506-14519	Supplementary	_	
98-2	14520-14525	Table	_	
98-3	14525-14526	 	_	
98-4	14526-14528	S2	_	
98-5	14529-14534	lists	_	
98-6	14535-14538	the	_	
98-7	14539-14543	ROIs	_	
98-8	14544-14546	in	_	
98-9	14547-14551	each	_	
98-10	14552-14555	RSN	_	
98-11	14555-14556	.	_	

#Text=We obtained SampEn of a given RSN by averaging SampEn of all ROIs contained in it.
99-1	14557-14559	We	_	
99-2	14560-14568	obtained	_	
99-3	14569-14575	SampEn	_	
99-4	14576-14578	of	_	
99-5	14579-14580	a	_	
99-6	14581-14586	given	_	
99-7	14587-14590	RSN	_	
99-8	14591-14593	by	_	
99-9	14594-14603	averaging	_	
99-10	14604-14610	SampEn	_	
99-11	14611-14613	of	_	
99-12	14614-14617	all	_	
99-13	14618-14622	ROIs	_	
99-14	14623-14632	contained	_	
99-15	14633-14635	in	_	
99-16	14636-14638	it	_	
99-17	14638-14639	.	_	

#Text=Association analysis between SampEn and age in healthy subjects
#Text=We used partial correlation coefficients to investigate associations between SampEn and age, conditioning on gender, education, and head motion.
100-1	14640-14651	Association	_	
100-2	14652-14660	analysis	_	
100-3	14661-14668	between	_	
100-4	14669-14675	SampEn	_	
100-5	14676-14679	and	_	
100-6	14680-14683	age	_	
100-7	14684-14686	in	_	
100-8	14687-14694	healthy	_	
100-9	14695-14703	subjects	_	
100-10	14704-14706	We	_	
100-11	14707-14711	used	_	
100-12	14712-14719	partial	_	
100-13	14720-14731	correlation	_	
100-14	14732-14744	coefficients	_	
100-15	14745-14747	to	_	
100-16	14748-14759	investigate	_	
100-17	14760-14772	associations	_	
100-18	14773-14780	between	_	
100-19	14781-14787	SampEn	_	
100-20	14788-14791	and	_	
100-21	14792-14795	age	_	
100-22	14795-14796	,	_	
100-23	14797-14809	conditioning	_	
100-24	14810-14812	on	_	
100-25	14813-14819	gender	_	
100-26	14819-14820	,	_	
100-27	14821-14830	education	_	
100-28	14830-14831	,	_	
100-29	14832-14835	and	_	
100-30	14836-14840	head	_	
100-31	14841-14847	motion	_	
100-32	14847-14848	.	_	

#Text=We performed the partial correlation analyses sequentially at three different levels of the brain.
101-1	14849-14851	We	_	
101-2	14852-14861	performed	_	
101-3	14862-14865	the	_	
101-4	14866-14873	partial	_	
101-5	14874-14885	correlation	_	
101-6	14886-14894	analyses	_	
101-7	14895-14907	sequentially	_	
101-8	14908-14910	at	_	
101-9	14911-14916	three	_	
101-10	14917-14926	different	_	
101-11	14927-14933	levels	_	
101-12	14934-14936	of	_	
101-13	14937-14940	the	_	
101-14	14941-14946	brain	_	
101-15	14946-14947	.	_	

#Text=First, we obtained partial correlation coefficients of all RSNs.
102-1	14948-14953	First	_	
102-2	14953-14954	,	_	
102-3	14955-14957	we	_	
102-4	14958-14966	obtained	_	
102-5	14967-14974	partial	_	
102-6	14975-14986	correlation	_	
102-7	14987-14999	coefficients	_	
102-8	15000-15002	of	_	
102-9	15003-15006	all	_	
102-10	15007-15011	RSNs	_	
102-11	15011-15012	.	_	

#Text=Second, for each RSN significantly identified in the first step, we calculated partial correlation coefficients of all ROIs contained in this RSN.
103-1	15013-15019	Second	_	
103-2	15019-15020	,	_	
103-3	15021-15024	for	_	
103-4	15025-15029	each	_	
103-5	15030-15033	RSN	_	
103-6	15034-15047	significantly	_	
103-7	15048-15058	identified	_	
103-8	15059-15061	in	_	
103-9	15062-15065	the	_	
103-10	15066-15071	first	_	
103-11	15072-15076	step	_	
103-12	15076-15077	,	_	
103-13	15078-15080	we	_	
103-14	15081-15091	calculated	_	
103-15	15092-15099	partial	_	
103-16	15100-15111	correlation	_	
103-17	15112-15124	coefficients	_	
103-18	15125-15127	of	_	
103-19	15128-15131	all	_	
103-20	15132-15136	ROIs	_	
103-21	15137-15146	contained	_	
103-22	15147-15149	in	_	
103-23	15150-15154	this	_	
103-24	15155-15158	RSN	_	
103-25	15158-15159	.	_	

#Text=Third, for each ROI that showed a significant effect in the second step, we obtained partial correlation coefficients of all functional connections corresponding to this ROI.
104-1	15160-15165	Third	_	
104-2	15165-15166	,	_	
104-3	15167-15170	for	_	
104-4	15171-15175	each	_	
104-5	15176-15179	ROI	_	
104-6	15180-15184	that	_	
104-7	15185-15191	showed	_	
104-8	15192-15193	a	_	
104-9	15194-15205	significant	_	
104-10	15206-15212	effect	_	
104-11	15213-15215	in	_	
104-12	15216-15219	the	_	
104-13	15220-15226	second	_	
104-14	15227-15231	step	_	
104-15	15231-15232	,	_	
104-16	15233-15235	we	_	
104-17	15236-15244	obtained	_	
104-18	15245-15252	partial	_	
104-19	15253-15264	correlation	_	
104-20	15265-15277	coefficients	_	
104-21	15278-15280	of	_	
104-22	15281-15284	all	_	
104-23	15285-15295	functional	_	
104-24	15296-15307	connections	_	
104-25	15308-15321	corresponding	_	
104-26	15322-15324	to	_	
104-27	15325-15329	this	_	
104-28	15330-15333	ROI	_	
104-29	15333-15334	.	_	

#Text=We applied false-positive discovery rate (FDR) controls to correct for multiple comparisons in each of the three steps.
105-1	15335-15337	We	_	
105-2	15338-15345	applied	_	
105-3	15346-15360	false-positive	_	
105-4	15361-15370	discovery	_	
105-5	15371-15375	rate	_	
105-6	15376-15377	(	_	
105-7	15377-15380	FDR	_	
105-8	15380-15381	)	_	
105-9	15382-15390	controls	_	
105-10	15391-15393	to	_	
105-11	15394-15401	correct	_	
105-12	15402-15405	for	_	
105-13	15406-15414	multiple	_	
105-14	15415-15426	comparisons	_	
105-15	15427-15429	in	_	
105-16	15430-15434	each	_	
105-17	15435-15437	of	_	
105-18	15438-15441	the	_	
105-19	15442-15447	three	_	
105-20	15448-15453	steps	_	
105-21	15453-15454	.	_	

#Text=The dimensions of the correction in the first step and the third step were the number of RSNs (=6) and the number of functional connections corresponding to an ROI (=89), respectively.
106-1	15455-15458	The	_	
106-2	15459-15469	dimensions	_	
106-3	15470-15472	of	_	
106-4	15473-15476	the	_	
106-5	15477-15487	correction	_	
106-6	15488-15490	in	_	
106-7	15491-15494	the	_	
106-8	15495-15500	first	_	
106-9	15501-15505	step	_	
106-10	15506-15509	and	_	
106-11	15510-15513	the	_	
106-12	15514-15519	third	_	
106-13	15520-15524	step	_	
106-14	15525-15529	were	_	
106-15	15530-15533	the	_	
106-16	15534-15540	number	_	
106-17	15541-15543	of	_	
106-18	15544-15548	RSNs	_	
106-19	15549-15550	(	_	
106-20	15550-15551	=	_	
106-21	15551-15552	6	_	
106-22	15552-15553	)	_	
106-23	15554-15557	and	_	
106-24	15558-15561	the	_	
106-25	15562-15568	number	_	
106-26	15569-15571	of	_	
106-27	15572-15582	functional	_	
106-28	15583-15594	connections	_	
106-29	15595-15608	corresponding	_	
106-30	15609-15611	to	_	
106-31	15612-15614	an	_	
106-32	15615-15618	ROI	_	
106-33	15619-15620	(	_	
106-34	15620-15621	=	_	
106-35	15621-15623	89	_	
106-36	15623-15624	)	_	
106-37	15624-15625	,	_	
106-38	15626-15638	respectively	_	
106-39	15638-15639	.	_	

#Text=Because the number of ROIs in different RSNs is different, the dimension of the correction in the second step was not a fixed constant.
107-1	15640-15647	Because	_	
107-2	15648-15651	the	_	
107-3	15652-15658	number	_	
107-4	15659-15661	of	_	
107-5	15662-15666	ROIs	_	
107-6	15667-15669	in	_	
107-7	15670-15679	different	_	
107-8	15680-15684	RSNs	_	
107-9	15685-15687	is	_	
107-10	15688-15697	different	_	
107-11	15697-15698	,	_	
107-12	15699-15702	the	_	
107-13	15703-15712	dimension	_	
107-14	15713-15715	of	_	
107-15	15716-15719	the	_	
107-16	15720-15730	correction	_	
107-17	15731-15733	in	_	
107-18	15734-15737	the	_	
107-19	15738-15744	second	_	
107-20	15745-15749	step	_	
107-21	15750-15753	was	_	
107-22	15754-15757	not	_	
107-23	15758-15759	a	_	
107-24	15760-15765	fixed	_	
107-25	15766-15774	constant	_	
107-26	15774-15775	.	_	

#Text=Association analysis between SampEn and age in patients with schizophrenia
#Text=To test whether the schizophrenic disorder alters the associations between SampEn and age, in patients with schizophrenia, we also performed association analyses of the functional connections that were identified as significant in the association analysis between SampEn and age in healthy subjects.
108-1	15776-15787	Association	_	
108-2	15788-15796	analysis	_	
108-3	15797-15804	between	_	
108-4	15805-15811	SampEn	_	
108-5	15812-15815	and	_	
108-6	15816-15819	age	_	
108-7	15820-15822	in	_	
108-8	15823-15831	patients	_	
108-9	15832-15836	with	_	
108-10	15837-15850	schizophrenia	_	
108-11	15851-15853	To	_	
108-12	15854-15858	test	_	
108-13	15859-15866	whether	_	
108-14	15867-15870	the	_	
108-15	15871-15884	schizophrenic	_	
108-16	15885-15893	disorder	_	
108-17	15894-15900	alters	_	
108-18	15901-15904	the	_	
108-19	15905-15917	associations	_	
108-20	15918-15925	between	_	
108-21	15926-15932	SampEn	_	
108-22	15933-15936	and	_	
108-23	15937-15940	age	_	
108-24	15940-15941	,	_	
108-25	15942-15944	in	_	
108-26	15945-15953	patients	_	
108-27	15954-15958	with	_	
108-28	15959-15972	schizophrenia	_	
108-29	15972-15973	,	_	
108-30	15974-15976	we	_	
108-31	15977-15981	also	_	
108-32	15982-15991	performed	_	
108-33	15992-16003	association	_	
108-34	16004-16012	analyses	_	
108-35	16013-16015	of	_	
108-36	16016-16019	the	_	
108-37	16020-16030	functional	_	
108-38	16031-16042	connections	_	
108-39	16043-16047	that	_	
108-40	16048-16052	were	_	
108-41	16053-16063	identified	_	
108-42	16064-16066	as	_	
108-43	16067-16078	significant	_	
108-44	16079-16081	in	_	
108-45	16082-16085	the	_	
108-46	16086-16097	association	_	
108-47	16098-16106	analysis	_	
108-48	16107-16114	between	_	
108-49	16115-16121	SampEn	_	
108-50	16122-16125	and	_	
108-51	16126-16129	age	_	
108-52	16130-16132	in	_	
108-53	16133-16140	healthy	_	
108-54	16141-16149	subjects	_	
108-55	16149-16150	.	_	

#Text=We also used partial correlation coefficients to investigate these associations between SampEn and age, conditioning on gender, education, and head motion.
109-1	16151-16153	We	_	
109-2	16154-16158	also	_	
109-3	16159-16163	used	_	
109-4	16164-16171	partial	_	
109-5	16172-16183	correlation	_	
109-6	16184-16196	coefficients	_	
109-7	16197-16199	to	_	
109-8	16200-16211	investigate	_	
109-9	16212-16217	these	_	
109-10	16218-16230	associations	_	
109-11	16231-16238	between	_	
109-12	16239-16245	SampEn	_	
109-13	16246-16249	and	_	
109-14	16250-16253	age	_	
109-15	16253-16254	,	_	
109-16	16255-16267	conditioning	_	
109-17	16268-16270	on	_	
109-18	16271-16277	gender	_	
109-19	16277-16278	,	_	
109-20	16279-16288	education	_	
109-21	16288-16289	,	_	
109-22	16290-16293	and	_	
109-23	16294-16298	head	_	
109-24	16299-16305	motion	_	
109-25	16305-16306	.	_	

#Text=For each functional connection, using the webpage http://vassarstats.net/rdiff.html, we calculated a value of Z that could be applied to assess the significance of the difference between the partial correlation coefficient of the healthy group and that of the patient group.
110-1	16307-16310	For	_	
110-2	16311-16315	each	_	
110-3	16316-16326	functional	_	
110-4	16327-16337	connection	_	
110-5	16337-16338	,	_	
110-6	16339-16344	using	_	
110-7	16345-16348	the	_	
110-8	16349-16356	webpage	_	
110-9	16357-16361	http	_	
110-10	16361-16362	:	_	
110-11	16362-16363	/	_	
110-12	16363-16364	/	_	
110-13	16364-16379	vassarstats.net	_	
110-14	16379-16380	/	_	
110-15	16380-16390	rdiff.html	_	
110-16	16390-16391	,	_	
110-17	16392-16394	we	_	
110-18	16395-16405	calculated	_	
110-19	16406-16407	a	_	
110-20	16408-16413	value	_	
110-21	16414-16416	of	_	
110-22	16417-16418	Z	_	
110-23	16419-16423	that	_	
110-24	16424-16429	could	_	
110-25	16430-16432	be	_	
110-26	16433-16440	applied	_	
110-27	16441-16443	to	_	
110-28	16444-16450	assess	_	
110-29	16451-16454	the	_	
110-30	16455-16467	significance	_	
110-31	16468-16470	of	_	
110-32	16471-16474	the	_	
110-33	16475-16485	difference	_	
110-34	16486-16493	between	_	
110-35	16494-16497	the	_	
110-36	16498-16505	partial	_	
110-37	16506-16517	correlation	_	
110-38	16518-16529	coefficient	_	
110-39	16530-16532	of	_	
110-40	16533-16536	the	_	
110-41	16537-16544	healthy	_	
110-42	16545-16550	group	_	
110-43	16551-16554	and	_	
110-44	16555-16559	that	_	
110-45	16560-16562	of	_	
110-46	16563-16566	the	_	
110-47	16567-16574	patient	_	
110-48	16575-16580	group	_	
110-49	16580-16581	.	_	

#Text=To correct for multiple comparisons, we applied the FDR control.
111-1	16582-16584	To	_	
111-2	16585-16592	correct	_	
111-3	16593-16596	for	_	
111-4	16597-16605	multiple	_	
111-5	16606-16617	comparisons	_	
111-6	16617-16618	,	_	
111-7	16619-16621	we	_	
111-8	16622-16629	applied	_	
111-9	16630-16633	the	_	
111-10	16634-16637	FDR	_	
111-11	16638-16645	control	_	
111-12	16645-16646	.	_	

#Text=The dimension of the correction was the number of functional connections identified as significant in the association analysis between SampEn and age in healthy subjects.
112-1	16647-16650	The	_	
112-2	16651-16660	dimension	_	
112-3	16661-16663	of	_	
112-4	16664-16667	the	_	
112-5	16668-16678	correction	_	
112-6	16679-16682	was	_	
112-7	16683-16686	the	_	
112-8	16687-16693	number	_	
112-9	16694-16696	of	_	
112-10	16697-16707	functional	_	
112-11	16708-16719	connections	_	
112-12	16720-16730	identified	_	
112-13	16731-16733	as	_	
112-14	16734-16745	significant	_	
112-15	16746-16748	in	_	
112-16	16749-16752	the	_	
112-17	16753-16764	association	_	
112-18	16765-16773	analysis	_	
112-19	16774-16781	between	_	
112-20	16782-16788	SampEn	_	
112-21	16789-16792	and	_	
112-22	16793-16796	age	_	
112-23	16797-16799	in	_	
112-24	16800-16807	healthy	_	
112-25	16808-16816	subjects	_	
112-26	16816-16817	.	_	

#Text=To study whether the recognized deviations from the normal aging are related to schizophrenia, we studied associations between SampEn of the functional connections, which show significant group differences in partial correlation coefficients, and clinical variables including symptom severity scores (i.e., PANSS) and illness duration.
113-1	16818-16820	To	_	
113-2	16821-16826	study	_	
113-3	16827-16834	whether	_	
113-4	16835-16838	the	_	
113-5	16839-16849	recognized	_	
113-6	16850-16860	deviations	_	
113-7	16861-16865	from	_	
113-8	16866-16869	the	_	
113-9	16870-16876	normal	_	
113-10	16877-16882	aging	_	
113-11	16883-16886	are	_	
113-12	16887-16894	related	_	
113-13	16895-16897	to	_	
113-14	16898-16911	schizophrenia	_	
113-15	16911-16912	,	_	
113-16	16913-16915	we	_	
113-17	16916-16923	studied	_	
113-18	16924-16936	associations	_	
113-19	16937-16944	between	_	
113-20	16945-16951	SampEn	_	
113-21	16952-16954	of	_	
113-22	16955-16958	the	_	
113-23	16959-16969	functional	_	
113-24	16970-16981	connections	_	
113-25	16981-16982	,	_	
113-26	16983-16988	which	_	
113-27	16989-16993	show	_	
113-28	16994-17005	significant	_	
113-29	17006-17011	group	_	
113-30	17012-17023	differences	_	
113-31	17024-17026	in	_	
113-32	17027-17034	partial	_	
113-33	17035-17046	correlation	_	
113-34	17047-17059	coefficients	_	
113-35	17059-17060	,	_	
113-36	17061-17064	and	_	
113-37	17065-17073	clinical	_	
113-38	17074-17083	variables	_	
113-39	17084-17093	including	_	
113-40	17094-17101	symptom	_	
113-41	17102-17110	severity	_	
113-42	17111-17117	scores	_	
113-43	17118-17119	(	_	
113-44	17119-17122	i.e	_	
113-45	17122-17123	.	_	
113-46	17123-17124	,	_	
113-47	17125-17130	PANSS	_	
113-48	17130-17131	)	_	
113-49	17132-17135	and	_	
113-50	17136-17143	illness	_	
113-51	17144-17152	duration	_	
113-52	17152-17153	.	_	

#Text=Partial correlation coefficients were used to investigate these associations, conditioning on age, gender, education, and head motion.
114-1	17154-17161	Partial	_	
114-2	17162-17173	correlation	_	
114-3	17174-17186	coefficients	_	
114-4	17187-17191	were	_	
114-5	17192-17196	used	_	
114-6	17197-17199	to	_	
114-7	17200-17211	investigate	_	
114-8	17212-17217	these	_	
114-9	17218-17230	associations	_	
114-10	17230-17231	,	_	
114-11	17232-17244	conditioning	_	
114-12	17245-17247	on	_	
114-13	17248-17251	age	_	
114-14	17251-17252	,	_	
114-15	17253-17259	gender	_	
114-16	17259-17260	,	_	
114-17	17261-17270	education	_	
114-18	17270-17271	,	_	
114-19	17272-17275	and	_	
114-20	17276-17280	head	_	
114-21	17281-17287	motion	_	
114-22	17287-17288	.	_	

#Text=Data Availability
#Text=The datasets generated during the current study are available from the corresponding author on reasonable request.
115-1	17289-17293	Data	_	
115-2	17294-17306	Availability	_	
115-3	17307-17310	The	_	
115-4	17311-17319	datasets	_	
115-5	17320-17329	generated	_	
115-6	17330-17336	during	_	
115-7	17337-17340	the	_	
115-8	17341-17348	current	_	
115-9	17349-17354	study	_	
115-10	17355-17358	are	_	
115-11	17359-17368	available	_	
115-12	17369-17373	from	_	
115-13	17374-17377	the	_	
115-14	17378-17391	corresponding	_	
115-15	17392-17398	author	_	
115-16	17399-17401	on	_	
115-17	17402-17412	reasonable	_	
115-18	17413-17420	request	_	
115-19	17420-17421	.	_	

#Text=Results
#Text=SampEn varies throughout the brain
#Text=Connectogram of functional connections with the largest and the lowest 0.5% SampEn.
116-1	17422-17429	Results	_	
116-2	17430-17436	SampEn	_	
116-3	17437-17443	varies	_	
116-4	17444-17454	throughout	_	
116-5	17455-17458	the	_	
116-6	17459-17464	brain	_	
116-7	17465-17477	Connectogram	_	
116-8	17478-17480	of	_	
116-9	17481-17491	functional	_	
116-10	17492-17503	connections	_	
116-11	17504-17508	with	_	
116-12	17509-17512	the	_	
116-13	17513-17520	largest	_	
116-14	17521-17524	and	_	
116-15	17525-17528	the	_	
116-16	17529-17535	lowest	_	
116-17	17536-17540	0.5%	_	
116-18	17541-17547	SampEn	_	
116-19	17547-17548	.	_	

#Text=Functional connections with the largest SampEn (a).
117-1	17549-17559	Functional	_	
117-2	17560-17571	connections	_	
117-3	17572-17576	with	_	
117-4	17577-17580	the	_	
117-5	17581-17588	largest	_	
117-6	17589-17595	SampEn	_	
117-7	17596-17597	(	_	
117-8	17597-17598	a	_	
117-9	17598-17599	)	_	
117-10	17599-17600	.	_	

#Text=Functional connections with the lowest SampEn (b).
118-1	17601-17611	Functional	_	
118-2	17612-17623	connections	_	
118-3	17624-17628	with	_	
118-4	17629-17632	the	_	
118-5	17633-17639	lowest	_	
118-6	17640-17646	SampEn	_	
118-7	17647-17648	(	_	
118-8	17648-17649	b	_	
118-9	17649-17650	)	_	
118-10	17650-17651	.	_	

#Text=The left part and the right part of the connectogram represent the left hemisphere and the right hemisphere of the brain, respectively.
119-1	17652-17655	The	_	
119-2	17656-17660	left	_	
119-3	17661-17665	part	_	
119-4	17666-17669	and	_	
119-5	17670-17673	the	_	
119-6	17674-17679	right	_	
119-7	17680-17684	part	_	
119-8	17685-17687	of	_	
119-9	17688-17691	the	_	
119-10	17692-17704	connectogram	_	
119-11	17705-17714	represent	_	
119-12	17715-17718	the	_	
119-13	17719-17723	left	_	
119-14	17724-17734	hemisphere	_	
119-15	17735-17738	and	_	
119-16	17739-17742	the	_	
119-17	17743-17748	right	_	
119-18	17749-17759	hemisphere	_	
119-19	17760-17762	of	_	
119-20	17763-17766	the	_	
119-21	17767-17772	brain	_	
119-22	17772-17773	,	_	
119-23	17774-17786	respectively	_	
119-24	17786-17787	.	_	

#Text=Supplementary Table S1 lists the full name of each ROI.
120-1	17788-17801	Supplementary	_	
120-2	17802-17807	Table	_	
120-3	17807-17808	 	_	
120-4	17808-17810	S1	_	
120-5	17811-17816	lists	_	
120-6	17817-17820	the	_	
120-7	17821-17825	full	_	
120-8	17826-17830	name	_	
120-9	17831-17833	of	_	
120-10	17834-17838	each	_	
120-11	17839-17842	ROI	_	
120-12	17842-17843	.	_	

#Text=We quantified SampEn of each functional connection by the mean SampEn averaged across all healthy subjects.
121-1	17844-17846	We	_	
121-2	17847-17857	quantified	_	
121-3	17858-17864	SampEn	_	
121-4	17865-17867	of	_	
121-5	17868-17872	each	_	
121-6	17873-17883	functional	_	
121-7	17884-17894	connection	_	
121-8	17895-17897	by	_	
121-9	17898-17901	the	_	
121-10	17902-17906	mean	_	
121-11	17907-17913	SampEn	_	
121-12	17914-17922	averaged	_	
121-13	17923-17929	across	_	
121-14	17930-17933	all	_	
121-15	17934-17941	healthy	_	
121-16	17942-17950	subjects	_	
121-17	17950-17951	.	_	

#Text=Figure 2 shows the functional connections among 90 ROIs with the largest and the lowest 0.5% SampEn.
122-1	17952-17958	Figure	_	
122-2	17958-17959	 	_	
122-3	17959-17960	2	_	
122-4	17961-17966	shows	_	
122-5	17967-17970	the	_	
122-6	17971-17981	functional	_	
122-7	17982-17993	connections	_	
122-8	17994-17999	among	_	
122-9	18000-18002	90	_	
122-10	18003-18007	ROIs	_	
122-11	18008-18012	with	_	
122-12	18013-18016	the	_	
122-13	18017-18024	largest	_	
122-14	18025-18028	and	_	
122-15	18029-18032	the	_	
122-16	18033-18039	lowest	_	
122-17	18040-18044	0.5%	_	
122-18	18045-18051	SampEn	_	
122-19	18051-18052	.	_	

#Text=Supplementary Dataset 1 also lists the mean SampEn of each functional connection in descending order.
123-1	18053-18066	Supplementary	_	
123-2	18067-18074	Dataset	_	
123-3	18075-18076	1	_	
123-4	18077-18081	also	_	
123-5	18082-18087	lists	_	
123-6	18088-18091	the	_	
123-7	18092-18096	mean	_	
123-8	18097-18103	SampEn	_	
123-9	18104-18106	of	_	
123-10	18107-18111	each	_	
123-11	18112-18122	functional	_	
123-12	18123-18133	connection	_	
123-13	18134-18136	in	_	
123-14	18137-18147	descending	_	
123-15	18148-18153	order	_	
123-16	18153-18154	.	_	

#Text=We found that functional connections implicated in higher cognitive functions (e.g., memory, emotion, and reward) show larger SampEn, including the fronto-limbic system (e.g., the fronto-hippocampal and the fronto-amygdala connectivity) and the fronto-striatal system (e.g., the rectus-caudate connectivity).
124-1	18155-18157	We	_	
124-2	18158-18163	found	_	
124-3	18164-18168	that	_	
124-4	18169-18179	functional	_	
124-5	18180-18191	connections	_	
124-6	18192-18202	implicated	_	
124-7	18203-18205	in	_	
124-8	18206-18212	higher	_	
124-9	18213-18222	cognitive	_	
124-10	18223-18232	functions	_	
124-11	18233-18234	(	_	
124-12	18234-18237	e.g	_	
124-13	18237-18238	.	_	
124-14	18238-18239	,	_	
124-15	18240-18246	memory	_	
124-16	18246-18247	,	_	
124-17	18248-18255	emotion	_	
124-18	18255-18256	,	_	
124-19	18257-18260	and	_	
124-20	18261-18267	reward	_	
124-21	18267-18268	)	_	
124-22	18269-18273	show	_	
124-23	18274-18280	larger	_	
124-24	18281-18287	SampEn	_	
124-25	18287-18288	,	_	
124-26	18289-18298	including	_	
124-27	18299-18302	the	_	
124-28	18303-18316	fronto-limbic	_	
124-29	18317-18323	system	_	
124-30	18324-18325	(	_	
124-31	18325-18328	e.g	_	
124-32	18328-18329	.	_	
124-33	18329-18330	,	_	
124-34	18331-18334	the	_	
124-35	18335-18353	fronto-hippocampal	_	
124-36	18354-18357	and	_	
124-37	18358-18361	the	_	
124-38	18362-18377	fronto-amygdala	_	
124-39	18378-18390	connectivity	_	
124-40	18390-18391	)	_	
124-41	18392-18395	and	_	
124-42	18396-18399	the	_	
124-43	18400-18415	fronto-striatal	_	
124-44	18416-18422	system	_	
124-45	18423-18424	(	_	
124-46	18424-18427	e.g	_	
124-47	18427-18428	.	_	
124-48	18428-18429	,	_	
124-49	18430-18433	the	_	
124-50	18434-18448	rectus-caudate	_	
124-51	18449-18461	connectivity	_	
124-52	18461-18462	)	_	
124-53	18462-18463	.	_	

#Text=In contrast, functional connections in sensorimotor cortices (e.g., the lingual gyrus, the calcarine gyrus, the precentral gyrus, and the postcentral gyrus) show lower SampEn.
125-1	18464-18466	In	_	
125-2	18467-18475	contrast	_	
125-3	18475-18476	,	_	
125-4	18477-18487	functional	_	
125-5	18488-18499	connections	_	
125-6	18500-18502	in	_	
125-7	18503-18515	sensorimotor	_	
125-8	18516-18524	cortices	_	
125-9	18525-18526	(	_	
125-10	18526-18529	e.g	_	
125-11	18529-18530	.	_	
125-12	18530-18531	,	_	
125-13	18532-18535	the	_	
125-14	18536-18543	lingual	_	
125-15	18544-18549	gyrus	_	
125-16	18549-18550	,	_	
125-17	18551-18554	the	_	
125-18	18555-18564	calcarine	_	
125-19	18565-18570	gyrus	_	
125-20	18570-18571	,	_	
125-21	18572-18575	the	_	
125-22	18576-18586	precentral	_	
125-23	18587-18592	gyrus	_	
125-24	18592-18593	,	_	
125-25	18594-18597	and	_	
125-26	18598-18601	the	_	
125-27	18602-18613	postcentral	_	
125-28	18614-18619	gyrus	_	
125-29	18619-18620	)	_	
125-30	18621-18625	show	_	
125-31	18626-18631	lower	_	
125-32	18632-18638	SampEn	_	
125-33	18638-18639	.	_	

#Text=We also found that the homotopic interhemispheric connections show lower SampEn such as functional connections of the postcentral gyrus, the thalamus, the calcarine gyrus, and the lingual gyrus.
126-1	18640-18642	We	_	
126-2	18643-18647	also	_	
126-3	18648-18653	found	_	
126-4	18654-18658	that	_	
126-5	18659-18662	the	_	
126-6	18663-18672	homotopic	_	
126-7	18673-18689	interhemispheric	_	
126-8	18690-18701	connections	_	
126-9	18702-18706	show	_	
126-10	18707-18712	lower	_	
126-11	18713-18719	SampEn	_	
126-12	18720-18724	such	_	
126-13	18725-18727	as	_	
126-14	18728-18738	functional	_	
126-15	18739-18750	connections	_	
126-16	18751-18753	of	_	
126-17	18754-18757	the	_	
126-18	18758-18769	postcentral	_	
126-19	18770-18775	gyrus	_	
126-20	18775-18776	,	_	
126-21	18777-18780	the	_	
126-22	18781-18789	thalamus	_	
126-23	18789-18790	,	_	
126-24	18791-18794	the	_	
126-25	18795-18804	calcarine	_	
126-26	18805-18810	gyrus	_	
126-27	18810-18811	,	_	
126-28	18812-18815	and	_	
126-29	18816-18819	the	_	
126-30	18820-18827	lingual	_	
126-31	18828-18833	gyrus	_	
126-32	18833-18834	.	_	

#Text=The mean SampEn of each ROI and each RSN across all healthy subjects.
127-1	18836-18839	The	_	
127-2	18840-18844	mean	_	
127-3	18845-18851	SampEn	_	
127-4	18852-18854	of	_	
127-5	18855-18859	each	_	
127-6	18860-18863	ROI	_	
127-7	18864-18867	and	_	
127-8	18868-18872	each	_	
127-9	18873-18876	RSN	_	
127-10	18877-18883	across	_	
127-11	18884-18887	all	_	
127-12	18888-18895	healthy	_	
127-13	18896-18904	subjects	_	
127-14	18904-18905	.	_	

#Text=The mean SampEn of each ROI across all healthy subjects (a).
128-1	18906-18909	The	_	
128-2	18910-18914	mean	_	
128-3	18915-18921	SampEn	_	
128-4	18922-18924	of	_	
128-5	18925-18929	each	_	
128-6	18930-18933	ROI	_	
128-7	18934-18940	across	_	
128-8	18941-18944	all	_	
128-9	18945-18952	healthy	_	
128-10	18953-18961	subjects	_	
128-11	18962-18963	(	_	
128-12	18963-18964	a	_	
128-13	18964-18965	)	_	
128-14	18965-18966	.	_	

#Text=The color bar indicates the values of SampEn.
129-1	18967-18970	The	_	
129-2	18971-18976	color	_	
129-3	18977-18980	bar	_	
129-4	18981-18990	indicates	_	
129-5	18991-18994	the	_	
129-6	18995-19001	values	_	
129-7	19002-19004	of	_	
129-8	19005-19011	SampEn	_	
129-9	19011-19012	.	_	

#Text=The mean SampEn of each RSN across all healthy subjects is depicted in descending order (b).
130-1	19013-19016	The	_	
130-2	19017-19021	mean	_	
130-3	19022-19028	SampEn	_	
130-4	19029-19031	of	_	
130-5	19032-19036	each	_	
130-6	19037-19040	RSN	_	
130-7	19041-19047	across	_	
130-8	19048-19051	all	_	
130-9	19052-19059	healthy	_	
130-10	19060-19068	subjects	_	
130-11	19069-19071	is	_	
130-12	19072-19080	depicted	_	
130-13	19081-19083	in	_	
130-14	19084-19094	descending	_	
130-15	19095-19100	order	_	
130-16	19101-19102	(	_	
130-17	19102-19103	b	_	
130-18	19103-19104	)	_	
130-19	19104-19105	.	_	

#Text=The error bars represent SD.
131-1	19106-19109	The	_	
131-2	19110-19115	error	_	
131-3	19116-19120	bars	_	
131-4	19121-19130	represent	_	
131-5	19131-19133	SD	_	
131-6	19133-19134	.	_	

#Text=RSN1, the default mode network; RSN 2, the attention network; RSN 3, the visual recognition network; RSN 4, the auditory network; RSN 5, the sensorimotor network; RSN6, the subcortical network.
132-1	19135-19139	RSN1	_	
132-2	19139-19140	,	_	
132-3	19141-19144	the	_	
132-4	19145-19152	default	_	
132-5	19153-19157	mode	_	
132-6	19158-19165	network	_	
132-7	19165-19166	;	_	
132-8	19167-19170	RSN	_	
132-9	19171-19172	2	_	
132-10	19172-19173	,	_	
132-11	19174-19177	the	_	
132-12	19178-19187	attention	_	
132-13	19188-19195	network	_	
132-14	19195-19196	;	_	
132-15	19197-19200	RSN	_	
132-16	19201-19202	3	_	
132-17	19202-19203	,	_	
132-18	19204-19207	the	_	
132-19	19208-19214	visual	_	
132-20	19215-19226	recognition	_	
132-21	19227-19234	network	_	
132-22	19234-19235	;	_	
132-23	19236-19239	RSN	_	
132-24	19240-19241	4	_	
132-25	19241-19242	,	_	
132-26	19243-19246	the	_	
132-27	19247-19255	auditory	_	
132-28	19256-19263	network	_	
132-29	19263-19264	;	_	
132-30	19265-19268	RSN	_	
132-31	19269-19270	5	_	
132-32	19270-19271	,	_	
132-33	19272-19275	the	_	
132-34	19276-19288	sensorimotor	_	
132-35	19289-19296	network	_	
132-36	19296-19297	;	_	
132-37	19298-19302	RSN6	_	
132-38	19302-19303	,	_	
132-39	19304-19307	the	_	
132-40	19308-19319	subcortical	_	
132-41	19320-19327	network	_	
132-42	19327-19328	.	_	

#Text=The mean SampEn of each ROI across all healthy subjects is shown in Fig. 3a and also is listed in descending order in Supplementary Dataset 2.
133-1	19329-19332	The	_	
133-2	19333-19337	mean	_	
133-3	19338-19344	SampEn	_	
133-4	19345-19347	of	_	
133-5	19348-19352	each	_	
133-6	19353-19356	ROI	_	
133-7	19357-19363	across	_	
133-8	19364-19367	all	_	
133-9	19368-19375	healthy	_	
133-10	19376-19384	subjects	_	
133-11	19385-19387	is	_	
133-12	19388-19393	shown	_	
133-13	19394-19396	in	_	
133-14	19397-19400	Fig	_	
133-15	19400-19401	.	_	
133-16	19401-19402	 	_	
133-17	19402-19404	3a	_	
133-18	19405-19408	and	_	
133-19	19409-19413	also	_	
133-20	19414-19416	is	_	
133-21	19417-19423	listed	_	
133-22	19424-19426	in	_	
133-23	19427-19437	descending	_	
133-24	19438-19443	order	_	
133-25	19444-19446	in	_	
133-26	19447-19460	Supplementary	_	
133-27	19461-19468	Dataset	_	
133-28	19469-19470	2	_	
133-29	19470-19471	.	_	

#Text=We found that the limbic system and its adjacent areas show higher SampEn (e.g., the caudate, the olfactory gyrus, the amygdala, the parahippocampus, and the hippocampus), whereas sensorimotor cortices (e.g., the lingual gyrus, the calcarine gyrus, and the postcentral gyrus) demonstrate lower SampEn.
134-1	19472-19474	We	_	
134-2	19475-19480	found	_	
134-3	19481-19485	that	_	
134-4	19486-19489	the	_	
134-5	19490-19496	limbic	_	
134-6	19497-19503	system	_	
134-7	19504-19507	and	_	
134-8	19508-19511	its	_	
134-9	19512-19520	adjacent	_	
134-10	19521-19526	areas	_	
134-11	19527-19531	show	_	
134-12	19532-19538	higher	_	
134-13	19539-19545	SampEn	_	
134-14	19546-19547	(	_	
134-15	19547-19550	e.g	_	
134-16	19550-19551	.	_	
134-17	19551-19552	,	_	
134-18	19553-19556	the	_	
134-19	19557-19564	caudate	_	
134-20	19564-19565	,	_	
134-21	19566-19569	the	_	
134-22	19570-19579	olfactory	_	
134-23	19580-19585	gyrus	_	
134-24	19585-19586	,	_	
134-25	19587-19590	the	_	
134-26	19591-19599	amygdala	_	
134-27	19599-19600	,	_	
134-28	19601-19604	the	_	
134-29	19605-19620	parahippocampus	_	
134-30	19620-19621	,	_	
134-31	19622-19625	and	_	
134-32	19626-19629	the	_	
134-33	19630-19641	hippocampus	_	
134-34	19641-19642	)	_	
134-35	19642-19643	,	_	
134-36	19644-19651	whereas	_	
134-37	19652-19664	sensorimotor	_	
134-38	19665-19673	cortices	_	
134-39	19674-19675	(	_	
134-40	19675-19678	e.g	_	
134-41	19678-19679	.	_	
134-42	19679-19680	,	_	
134-43	19681-19684	the	_	
134-44	19685-19692	lingual	_	
134-45	19693-19698	gyrus	_	
134-46	19698-19699	,	_	
134-47	19700-19703	the	_	
134-48	19704-19713	calcarine	_	
134-49	19714-19719	gyrus	_	
134-50	19719-19720	,	_	
134-51	19721-19724	and	_	
134-52	19725-19728	the	_	
134-53	19729-19740	postcentral	_	
134-54	19741-19746	gyrus	_	
134-55	19746-19747	)	_	
134-56	19748-19759	demonstrate	_	
134-57	19760-19765	lower	_	
134-58	19766-19772	SampEn	_	
134-59	19772-19773	.	_	

#Text=The mean SampEn of each RSN across all healthy subjects is shown in Fig. 3b.
135-1	19774-19777	The	_	
135-2	19778-19782	mean	_	
135-3	19783-19789	SampEn	_	
135-4	19790-19792	of	_	
135-5	19793-19797	each	_	
135-6	19798-19801	RSN	_	
135-7	19802-19808	across	_	
135-8	19809-19812	all	_	
135-9	19813-19820	healthy	_	
135-10	19821-19829	subjects	_	
135-11	19830-19832	is	_	
135-12	19833-19838	shown	_	
135-13	19839-19841	in	_	
135-14	19842-19845	Fig	_	
135-15	19845-19846	.	_	
135-16	19846-19847	 	_	
135-17	19847-19849	3b	_	
135-18	19849-19850	.	_	

#Text=We found that the subcortical network and the auditory network show higher SampEn, whereas the sensorimotor network and the visual recognition network demonstrate lower SampEn.
136-1	19851-19853	We	_	
136-2	19854-19859	found	_	
136-3	19860-19864	that	_	
136-4	19865-19868	the	_	
136-5	19869-19880	subcortical	_	
136-6	19881-19888	network	_	
136-7	19889-19892	and	_	
136-8	19893-19896	the	_	
136-9	19897-19905	auditory	_	
136-10	19906-19913	network	_	
136-11	19914-19918	show	_	
136-12	19919-19925	higher	_	
136-13	19926-19932	SampEn	_	
136-14	19932-19933	,	_	
136-15	19934-19941	whereas	_	
136-16	19942-19945	the	_	
136-17	19946-19958	sensorimotor	_	
136-18	19959-19966	network	_	
136-19	19967-19970	and	_	
136-20	19971-19974	the	_	
136-21	19975-19981	visual	_	
136-22	19982-19993	recognition	_	
136-23	19994-20001	network	_	
136-24	20002-20013	demonstrate	_	
136-25	20014-20019	lower	_	
136-26	20020-20026	SampEn	_	
136-27	20026-20027	.	_	

#Text=SampEn decreases during the normal aging process
#Text=Associations between age and SampEn of RSNs and ROIs in healthy subjects.
137-1	20029-20035	SampEn	_	
137-2	20036-20045	decreases	_	
137-3	20046-20052	during	_	
137-4	20053-20056	the	_	
137-5	20057-20063	normal	_	
137-6	20064-20069	aging	_	
137-7	20070-20077	process	_	
137-8	20078-20090	Associations	_	
137-9	20091-20098	between	_	
137-10	20099-20102	age	_	
137-11	20103-20106	and	_	
137-12	20107-20113	SampEn	_	
137-13	20114-20116	of	_	
137-14	20117-20121	RSNs	_	
137-15	20122-20125	and	_	
137-16	20126-20130	ROIs	_	
137-17	20131-20133	in	_	
137-18	20134-20141	healthy	_	
137-19	20142-20150	subjects	_	
137-20	20150-20151	.	_	

#Text=R is the partial correlation coefficient.
138-1	20152-20153	R	_	
138-2	20154-20156	is	_	
138-3	20157-20160	the	_	
138-4	20161-20168	partial	_	
138-5	20169-20180	correlation	_	
138-6	20181-20192	coefficient	_	
138-7	20192-20193	.	_	

#Text=RSN 6, the subcortical network; AMYG, amygdala; PAL, pallidum; THA, thalamus; CAU, caudate; L, left; R, right.
139-1	20194-20197	RSN	_	
139-2	20198-20199	6	_	
139-3	20199-20200	,	_	
139-4	20201-20204	the	_	
139-5	20205-20216	subcortical	_	
139-6	20217-20224	network	_	
139-7	20224-20225	;	_	
139-8	20226-20230	AMYG	_	
139-9	20230-20231	,	_	
139-10	20232-20240	amygdala	_	
139-11	20240-20241	;	_	
139-12	20242-20245	PAL	_	
139-13	20245-20246	,	_	
139-14	20247-20255	pallidum	_	
139-15	20255-20256	;	_	
139-16	20257-20260	THA	_	
139-17	20260-20261	,	_	
139-18	20262-20270	thalamus	_	
139-19	20270-20271	;	_	
139-20	20272-20275	CAU	_	
139-21	20275-20276	,	_	
139-22	20277-20284	caudate	_	
139-23	20284-20285	;	_	
139-24	20286-20287	L	_	
139-25	20287-20288	,	_	
139-26	20289-20293	left	_	
139-27	20293-20294	;	_	
139-28	20295-20296	R	_	
139-29	20296-20297	,	_	
139-30	20298-20303	right	_	
139-31	20303-20304	.	_	

#Text=RSNs and ROIs\tR\tP value\t \tRSNs\t \t RSN6\t−0.3744\t0.0022\t \tROIs\t \t AMYG.
140-1	20305-20309	RSNs	_	
140-2	20310-20313	and	_	
140-3	20314-20318	ROIs	_	
140-4	20319-20320	R	_	
140-5	20321-20322	P	_	
140-6	20323-20328	value	_	
140-7	20331-20335	RSNs	_	
140-8	20338-20339	 	_	
140-9	20339-20343	RSN6	_	
140-10	20344-20345	−	_	
140-11	20345-20351	0.3744	_	
140-12	20352-20358	0.0022	_	
140-13	20361-20365	ROIs	_	
140-14	20368-20369	 	_	
140-15	20369-20373	AMYG	_	
140-16	20373-20374	.	_	

#Text=R\t−0.4234\t0.0006\t \t PAL.
141-1	20375-20376	R	_	
141-2	20377-20378	−	_	
141-3	20378-20384	0.4234	_	
141-4	20385-20391	0.0006	_	
141-5	20394-20395	 	_	
141-6	20395-20398	PAL	_	
141-7	20398-20399	.	_	

#Text=R\t−0.3753\t0.0022\t \t AMYG.
142-1	20400-20401	R	_	
142-2	20402-20403	−	_	
142-3	20403-20409	0.3753	_	
142-4	20410-20416	0.0022	_	
142-5	20419-20420	 	_	
142-6	20420-20424	AMYG	_	
142-7	20424-20425	.	_	

#Text=L\t−0.3694\t0.0025\t \t THA.
143-1	20426-20427	L	_	
143-2	20428-20429	−	_	
143-3	20429-20435	0.3694	_	
143-4	20436-20442	0.0025	_	
143-5	20445-20446	 	_	
143-6	20446-20449	THA	_	
143-7	20449-20450	.	_	

#Text=L\t−0.3704\t0.0025\t \t THA.
144-1	20451-20452	L	_	
144-2	20453-20454	−	_	
144-3	20454-20460	0.3704	_	
144-4	20461-20467	0.0025	_	
144-5	20470-20471	 	_	
144-6	20471-20474	THA	_	
144-7	20474-20475	.	_	

#Text=R\t−0.3592\t0.0033\t \t CAU.
145-1	20476-20477	R	_	
145-2	20478-20479	−	_	
145-3	20479-20485	0.3592	_	
145-4	20486-20492	0.0033	_	
145-5	20495-20496	 	_	
145-6	20496-20499	CAU	_	
145-7	20499-20500	.	_	

#Text=L\t−0.3005\t0.0122\t \t
#Text=Associations between age and SampEn of functional connections in healthy subjects and patients with schizophrenia.
146-1	20501-20502	L	_	
146-2	20503-20504	−	_	
146-3	20504-20510	0.3005	_	
146-4	20511-20517	0.0122	_	
146-5	20521-20533	Associations	_	
146-6	20534-20541	between	_	
146-7	20542-20545	age	_	
146-8	20546-20549	and	_	
146-9	20550-20556	SampEn	_	
146-10	20557-20559	of	_	
146-11	20560-20570	functional	_	
146-12	20571-20582	connections	_	
146-13	20583-20585	in	_	
146-14	20586-20593	healthy	_	
146-15	20594-20602	subjects	_	
146-16	20603-20606	and	_	
146-17	20607-20615	patients	_	
146-18	20616-20620	with	_	
146-19	20621-20634	schizophrenia	_	
146-20	20634-20635	.	_	

#Text=For the difference between R
#Text=SZ and R
#Text=HC, P values that could survive FDR correction are marked in bold.
147-1	20636-20639	For	_	
147-2	20640-20643	the	_	
147-3	20644-20654	difference	_	
147-4	20655-20662	between	_	
147-5	20663-20664	R	_	
147-6	20665-20667	SZ	_	
147-7	20668-20671	and	_	
147-8	20672-20673	R	_	
147-9	20674-20676	HC	_	
147-10	20676-20677	,	_	
147-11	20678-20679	P	_	
147-12	20680-20686	values	_	
147-13	20687-20691	that	_	
147-14	20692-20697	could	_	
147-15	20698-20705	survive	_	
147-16	20706-20709	FDR	_	
147-17	20710-20720	correction	_	
147-18	20721-20724	are	_	
147-19	20725-20731	marked	_	
147-20	20732-20734	in	_	
147-21	20735-20739	bold	_	
147-22	20739-20740	.	_	

#Text=HC, healthy subjects; SZ, patients with schizophrenia; R
#Text=HC, partial correlation coefficient of the healthy group; R
#Text=SZ, partial correlation coefficient of the patient group; AMYG, amygdala; ORBsup, superior orbital frontal gyrus; MFG, middle frontal gyrus; SPG, superior parietal gyrus; PCL, paracentral lobule; IPL, inferior parietal gyrus; L, left; R, right.
148-1	20741-20743	HC	_	
148-2	20743-20744	,	_	
148-3	20745-20752	healthy	_	
148-4	20753-20761	subjects	_	
148-5	20761-20762	;	_	
148-6	20763-20765	SZ	_	
148-7	20765-20766	,	_	
148-8	20767-20775	patients	_	
148-9	20776-20780	with	_	
148-10	20781-20794	schizophrenia	_	
148-11	20794-20795	;	_	
148-12	20796-20797	R	_	
148-13	20798-20800	HC	_	
148-14	20800-20801	,	_	
148-15	20802-20809	partial	_	
148-16	20810-20821	correlation	_	
148-17	20822-20833	coefficient	_	
148-18	20834-20836	of	_	
148-19	20837-20840	the	_	
148-20	20841-20848	healthy	_	
148-21	20849-20854	group	_	
148-22	20854-20855	;	_	
148-23	20856-20857	R	_	
148-24	20858-20860	SZ	_	
148-25	20860-20861	,	_	
148-26	20862-20869	partial	_	
148-27	20870-20881	correlation	_	
148-28	20882-20893	coefficient	_	
148-29	20894-20896	of	_	
148-30	20897-20900	the	_	
148-31	20901-20908	patient	_	
148-32	20909-20914	group	_	
148-33	20914-20915	;	_	
148-34	20916-20920	AMYG	_	
148-35	20920-20921	,	_	
148-36	20922-20930	amygdala	_	
148-37	20930-20931	;	_	
148-38	20932-20938	ORBsup	_	
148-39	20938-20939	,	_	
148-40	20940-20948	superior	_	
148-41	20949-20956	orbital	_	
148-42	20957-20964	frontal	_	
148-43	20965-20970	gyrus	_	
148-44	20970-20971	;	_	
148-45	20972-20975	MFG	_	
148-46	20975-20976	,	_	
148-47	20977-20983	middle	_	
148-48	20984-20991	frontal	_	
148-49	20992-20997	gyrus	_	
148-50	20997-20998	;	_	
148-51	20999-21002	SPG	_	
148-52	21002-21003	,	_	
148-53	21004-21012	superior	_	
148-54	21013-21021	parietal	_	
148-55	21022-21027	gyrus	_	
148-56	21027-21028	;	_	
148-57	21029-21032	PCL	_	
148-58	21032-21033	,	_	
148-59	21034-21045	paracentral	_	
148-60	21046-21052	lobule	_	
148-61	21052-21053	;	_	
148-62	21054-21057	IPL	_	
148-63	21057-21058	,	_	
148-64	21059-21067	inferior	_	
148-65	21068-21076	parietal	_	
148-66	21077-21082	gyrus	_	
148-67	21082-21083	;	_	
148-68	21084-21085	L	_	
148-69	21085-21086	,	_	
148-70	21087-21091	left	_	
148-71	21091-21092	;	_	
148-72	21093-21094	R	_	
148-73	21094-21095	,	_	
148-74	21096-21101	right	_	
148-75	21101-21102	.	_	

#Text=Functional connections\tHC\tSZ\tRSZ > RHC\t \tRHC\tP value\tRSZ\tP value\tZ value\tP value\t \tAMYG.
149-1	21103-21113	Functional	_	
149-2	21114-21125	connections	_	
149-3	21126-21128	HC	_	
149-4	21129-21131	SZ	_	
149-5	21132-21135	RSZ	_	
149-6	21136-21137	>	_	
149-7	21138-21141	RHC	_	
149-8	21144-21147	RHC	_	
149-9	21148-21149	P	_	
149-10	21150-21155	value	_	
149-11	21156-21159	RSZ	_	
149-12	21160-21161	P	_	
149-13	21162-21167	value	_	
149-14	21168-21169	Z	_	
149-15	21170-21175	value	_	
149-16	21176-21177	P	_	
149-17	21178-21183	value	_	
149-18	21186-21190	AMYG	_	
149-19	21190-21191	.	_	

#Text=R - ORBsup.
150-1	21192-21193	R	_	
150-2	21194-21195	-	_	
150-3	21196-21202	ORBsup	_	
150-4	21202-21203	.	_	

#Text=R\t−0.4459\t0.0003\t0.0159\t0.5488\t2.73\t0.0052\t \tAMYG.
151-1	21204-21205	R	_	
151-2	21206-21207	−	_	
151-3	21207-21213	0.4459	_	
151-4	21214-21220	0.0003	_	
151-5	21221-21227	0.0159	_	
151-6	21228-21234	0.5488	_	
151-7	21235-21239	2.73	_	
151-8	21240-21246	0.0052	_	
151-9	21249-21253	AMYG	_	
151-10	21253-21254	.	_	

#Text=R - MFG.
152-1	21255-21256	R	_	
152-2	21257-21258	-	_	
152-3	21259-21262	MFG	_	
152-4	21262-21263	.	_	

#Text=L\t−0.4241\t0.0006\t−0.2489\t0.0255\t1.09\t0.1379\t \tAMYG.
153-1	21264-21265	L	_	
153-2	21266-21267	−	_	
153-3	21267-21273	0.4241	_	
153-4	21274-21280	0.0006	_	
153-5	21281-21282	−	_	
153-6	21282-21288	0.2489	_	
153-7	21289-21295	0.0255	_	
153-8	21296-21300	1.09	_	
153-9	21301-21307	0.1379	_	
153-10	21310-21314	AMYG	_	
153-11	21314-21315	.	_	

#Text=R - SPG.
154-1	21316-21317	R	_	
154-2	21318-21319	-	_	
154-3	21320-21323	SPG	_	
154-4	21323-21324	.	_	

#Text=R\t−0.4204\t0.0006\t−0.0751\t0.2809\t2.06\t0.0197\t \tAMYG.
155-1	21325-21326	R	_	
155-2	21327-21328	−	_	
155-3	21328-21334	0.4204	_	
155-4	21335-21341	0.0006	_	
155-5	21342-21343	−	_	
155-6	21343-21349	0.0751	_	
155-7	21350-21356	0.2809	_	
155-8	21357-21361	2.06	_	
155-9	21362-21368	0.0197	_	
155-10	21371-21375	AMYG	_	
155-11	21375-21376	.	_	

#Text=R - PCL.
156-1	21377-21378	R	_	
156-2	21379-21380	-	_	
156-3	21381-21384	PCL	_	
156-4	21384-21385	.	_	

#Text=R\t−0.4044\t0.0010\t−0.0378\t0.3852\t2.16\t0.0154\t \tAMYG.
157-1	21386-21387	R	_	
157-2	21388-21389	−	_	
157-3	21389-21395	0.4044	_	
157-4	21396-21402	0.0010	_	
157-5	21403-21404	−	_	
157-6	21404-21410	0.0378	_	
157-7	21411-21417	0.3852	_	
157-8	21418-21422	2.16	_	
157-9	21423-21429	0.0154	_	
157-10	21432-21436	AMYG	_	
157-11	21436-21437	.	_	

#Text=R - IPL.
158-1	21438-21439	R	_	
158-2	21440-21441	-	_	
158-3	21442-21445	IPL	_	
158-4	21445-21446	.	_	

#Text=L\t−0.3847\t0.0017\t−0.0304\t0.4073\t2.07\t0.0192\t \t
#Text=Associations between age and SampEn of functional connections in healthy subjects and patients with schizophrenia.
159-1	21447-21448	L	_	
159-2	21449-21450	−	_	
159-3	21450-21456	0.3847	_	
159-4	21457-21463	0.0017	_	
159-5	21464-21465	−	_	
159-6	21465-21471	0.0304	_	
159-7	21472-21478	0.4073	_	
159-8	21479-21483	2.07	_	
159-9	21484-21490	0.0192	_	
159-10	21494-21506	Associations	_	
159-11	21507-21514	between	_	
159-12	21515-21518	age	_	
159-13	21519-21522	and	_	
159-14	21523-21529	SampEn	_	
159-15	21530-21532	of	_	
159-16	21533-21543	functional	_	
159-17	21544-21555	connections	_	
159-18	21556-21558	in	_	
159-19	21559-21566	healthy	_	
159-20	21567-21575	subjects	_	
159-21	21576-21579	and	_	
159-22	21580-21588	patients	_	
159-23	21589-21593	with	_	
159-24	21594-21607	schizophrenia	_	
159-25	21607-21608	.	_	

#Text=AMYG, amygdala; ORBsup, superior orbital frontal gyrus; MFG, middle frontal gyrus; SPG, superior parietal gyrus; PCL, paracentral lobule; IPL, inferior parietal gyrus; L, left; R, right.
160-1	21609-21613	AMYG	_	
160-2	21613-21614	,	_	
160-3	21615-21623	amygdala	_	
160-4	21623-21624	;	_	
160-5	21625-21631	ORBsup	_	
160-6	21631-21632	,	_	
160-7	21633-21641	superior	_	
160-8	21642-21649	orbital	_	
160-9	21650-21657	frontal	_	
160-10	21658-21663	gyrus	_	
160-11	21663-21664	;	_	
160-12	21665-21668	MFG	_	
160-13	21668-21669	,	_	
160-14	21670-21676	middle	_	
160-15	21677-21684	frontal	_	
160-16	21685-21690	gyrus	_	
160-17	21690-21691	;	_	
160-18	21692-21695	SPG	_	
160-19	21695-21696	,	_	
160-20	21697-21705	superior	_	
160-21	21706-21714	parietal	_	
160-22	21715-21720	gyrus	_	
160-23	21720-21721	;	_	
160-24	21722-21725	PCL	_	
160-25	21725-21726	,	_	
160-26	21727-21738	paracentral	_	
160-27	21739-21745	lobule	_	
160-28	21745-21746	;	_	
160-29	21747-21750	IPL	_	
160-30	21750-21751	,	_	
160-31	21752-21760	inferior	_	
160-32	21761-21769	parietal	_	
160-33	21770-21775	gyrus	_	
160-34	21775-21776	;	_	
160-35	21777-21778	L	_	
160-36	21778-21779	,	_	
160-37	21780-21784	left	_	
160-38	21784-21785	;	_	
160-39	21786-21787	R	_	
160-40	21787-21788	,	_	
160-41	21789-21794	right	_	
160-42	21794-21795	.	_	

#Text=First, we detected a negative association between age and SampEn of the subcortical network in healthy subjects (P = 0.0022, R = −0.3744, FDR corrected; Table 2 and Supplementary Fig. 
161-1	21796-21801	First	_	
161-2	21801-21802	,	_	
161-3	21803-21805	we	_	
161-4	21806-21814	detected	_	
161-5	21815-21816	a	_	
161-6	21817-21825	negative	_	
161-7	21826-21837	association	_	
161-8	21838-21845	between	_	
161-9	21846-21849	age	_	
161-10	21850-21853	and	_	
161-11	21854-21860	SampEn	_	
161-12	21861-21863	of	_	
161-13	21864-21867	the	_	
161-14	21868-21879	subcortical	_	
161-15	21880-21887	network	_	
161-16	21888-21890	in	_	
161-17	21891-21898	healthy	_	
161-18	21899-21907	subjects	_	
161-19	21908-21909	(	_	
161-20	21909-21910	P	_	
161-21	21911-21912	=	_	
161-22	21913-21919	0.0022	_	
161-23	21919-21920	,	_	
161-24	21921-21922	R	_	
161-25	21923-21924	=	_	
161-26	21925-21926	−	_	
161-27	21926-21932	0.3744	_	
161-28	21932-21933	,	_	
161-29	21934-21937	FDR	_	
161-30	21938-21947	corrected	_	
161-31	21947-21948	;	_	
161-32	21949-21954	Table	_	
161-33	21954-21955	 	_	
161-34	21955-21956	2	_	
161-35	21957-21960	and	_	
161-36	21961-21974	Supplementary	_	
161-37	21975-21978	Fig	_	
161-38	21978-21979	.	_	
161-39	21979-21980	 	_	

#Text=S2).
162-1	21980-21982	S2	_	
162-2	21982-21983	)	_	
162-3	21983-21984	.	_	

#Text=Second, for ROIs in the subcortical network, we found that SampEn of the bilateral amygdala, the right pallidum, the bilateral thalamus, and the left caudate negatively associates with age (P < 0.05, FDR corrected; Table 2 and Supplementary Fig. 
163-1	21985-21991	Second	_	
163-2	21991-21992	,	_	
163-3	21993-21996	for	_	
163-4	21997-22001	ROIs	_	
163-5	22002-22004	in	_	
163-6	22005-22008	the	_	
163-7	22009-22020	subcortical	_	
163-8	22021-22028	network	_	
163-9	22028-22029	,	_	
163-10	22030-22032	we	_	
163-11	22033-22038	found	_	
163-12	22039-22043	that	_	
163-13	22044-22050	SampEn	_	
163-14	22051-22053	of	_	
163-15	22054-22057	the	_	
163-16	22058-22067	bilateral	_	
163-17	22068-22076	amygdala	_	
163-18	22076-22077	,	_	
163-19	22078-22081	the	_	
163-20	22082-22087	right	_	
163-21	22088-22096	pallidum	_	
163-22	22096-22097	,	_	
163-23	22098-22101	the	_	
163-24	22102-22111	bilateral	_	
163-25	22112-22120	thalamus	_	
163-26	22120-22121	,	_	
163-27	22122-22125	and	_	
163-28	22126-22129	the	_	
163-29	22130-22134	left	_	
163-30	22135-22142	caudate	_	
163-31	22143-22153	negatively	_	
163-32	22154-22164	associates	_	
163-33	22165-22169	with	_	
163-34	22170-22173	age	_	
163-35	22174-22175	(	_	
163-36	22175-22176	P	_	
163-37	22177-22178	<	_	
163-38	22179-22183	0.05	_	
163-39	22183-22184	,	_	
163-40	22185-22188	FDR	_	
163-41	22189-22198	corrected	_	
163-42	22198-22199	;	_	
163-43	22200-22205	Table	_	
163-44	22205-22206	 	_	
163-45	22206-22207	2	_	
163-46	22208-22211	and	_	
163-47	22212-22225	Supplementary	_	
163-48	22226-22229	Fig	_	
163-49	22229-22230	.	_	
163-50	22230-22231	 	_	

#Text=S2).
164-1	22231-22233	S2	_	
164-2	22233-22234	)	_	
164-3	22234-22235	.	_	

#Text=Finally, for functional connections corresponding to these six ROIs in the subcortical network, we identified negative associations between age and SampEn of the functional connectivity between the right amygdala and the right superior orbital frontal gyrus, the left middle frontal gyrus, the right superior parietal gyrus, the right paracentral lobule, and the left inferior parietal gyrus (P < 0.05, FDR corrected; Table 3 and Fig. 4).
165-1	22236-22243	Finally	_	
165-2	22243-22244	,	_	
165-3	22245-22248	for	_	
165-4	22249-22259	functional	_	
165-5	22260-22271	connections	_	
165-6	22272-22285	corresponding	_	
165-7	22286-22288	to	_	
165-8	22289-22294	these	_	
165-9	22295-22298	six	_	
165-10	22299-22303	ROIs	_	
165-11	22304-22306	in	_	
165-12	22307-22310	the	_	
165-13	22311-22322	subcortical	_	
165-14	22323-22330	network	_	
165-15	22330-22331	,	_	
165-16	22332-22334	we	_	
165-17	22335-22345	identified	_	
165-18	22346-22354	negative	_	
165-19	22355-22367	associations	_	
165-20	22368-22375	between	_	
165-21	22376-22379	age	_	
165-22	22380-22383	and	_	
165-23	22384-22390	SampEn	_	
165-24	22391-22393	of	_	
165-25	22394-22397	the	_	
165-26	22398-22408	functional	_	
165-27	22409-22421	connectivity	_	
165-28	22422-22429	between	_	
165-29	22430-22433	the	_	
165-30	22434-22439	right	_	
165-31	22440-22448	amygdala	_	
165-32	22449-22452	and	_	
165-33	22453-22456	the	_	
165-34	22457-22462	right	_	
165-35	22463-22471	superior	_	
165-36	22472-22479	orbital	_	
165-37	22480-22487	frontal	_	
165-38	22488-22493	gyrus	_	
165-39	22493-22494	,	_	
165-40	22495-22498	the	_	
165-41	22499-22503	left	_	
165-42	22504-22510	middle	_	
165-43	22511-22518	frontal	_	
165-44	22519-22524	gyrus	_	
165-45	22524-22525	,	_	
165-46	22526-22529	the	_	
165-47	22530-22535	right	_	
165-48	22536-22544	superior	_	
165-49	22545-22553	parietal	_	
165-50	22554-22559	gyrus	_	
165-51	22559-22560	,	_	
165-52	22561-22564	the	_	
165-53	22565-22570	right	_	
165-54	22571-22582	paracentral	_	
165-55	22583-22589	lobule	_	
165-56	22589-22590	,	_	
165-57	22591-22594	and	_	
165-58	22595-22598	the	_	
165-59	22599-22603	left	_	
165-60	22604-22612	inferior	_	
165-61	22613-22621	parietal	_	
165-62	22622-22627	gyrus	_	
165-63	22628-22629	(	_	
165-64	22629-22630	P	_	
165-65	22631-22632	<	_	
165-66	22633-22637	0.05	_	
165-67	22637-22638	,	_	
165-68	22639-22642	FDR	_	
165-69	22643-22652	corrected	_	
165-70	22652-22653	;	_	
165-71	22654-22659	Table	_	
165-72	22659-22660	 	_	
165-73	22660-22661	3	_	
165-74	22662-22665	and	_	
165-75	22666-22669	Fig	_	
165-76	22669-22670	.	_	
165-77	22670-22671	 	_	
165-78	22671-22672	4	_	
165-79	22672-22673	)	_	
165-80	22673-22674	.	_	

#Text=Schizophrenia uncouples SampEn and age
#Text=Associations between SampEn of functional connections and clinical variables.
166-1	22678-22691	Schizophrenia	_	
166-2	22692-22701	uncouples	_	
166-3	22702-22708	SampEn	_	
166-4	22709-22712	and	_	
166-5	22713-22716	age	_	
166-6	22717-22729	Associations	_	
166-7	22730-22737	between	_	
166-8	22738-22744	SampEn	_	
166-9	22745-22747	of	_	
166-10	22748-22758	functional	_	
166-11	22759-22770	connections	_	
166-12	22771-22774	and	_	
166-13	22775-22783	clinical	_	
166-14	22784-22793	variables	_	
166-15	22793-22794	.	_	

#Text=R is the partial correlation coefficient.
167-1	22795-22796	R	_	
167-2	22797-22799	is	_	
167-3	22800-22803	the	_	
167-4	22804-22811	partial	_	
167-5	22812-22823	correlation	_	
167-6	22824-22835	coefficient	_	
167-7	22835-22836	.	_	

#Text=P values less than 0.05 are marked in bold.
168-1	22837-22838	P	_	
168-2	22839-22845	values	_	
168-3	22846-22850	less	_	
168-4	22851-22855	than	_	
168-5	22856-22860	0.05	_	
168-6	22861-22864	are	_	
168-7	22865-22871	marked	_	
168-8	22872-22874	in	_	
168-9	22875-22879	bold	_	
168-10	22879-22880	.	_	

#Text=AMYG, amygdala; ORBsup, superior orbital frontal gyrus; SPG, superior parietal gyrus; PCL, paracentral lobule; IPL, inferior parietal gyrus; L, left; R, right.
169-1	22881-22885	AMYG	_	
169-2	22885-22886	,	_	
169-3	22887-22895	amygdala	_	
169-4	22895-22896	;	_	
169-5	22897-22903	ORBsup	_	
169-6	22903-22904	,	_	
169-7	22905-22913	superior	_	
169-8	22914-22921	orbital	_	
169-9	22922-22929	frontal	_	
169-10	22930-22935	gyrus	_	
169-11	22935-22936	;	_	
169-12	22937-22940	SPG	_	
169-13	22940-22941	,	_	
169-14	22942-22950	superior	_	
169-15	22951-22959	parietal	_	
169-16	22960-22965	gyrus	_	
169-17	22965-22966	;	_	
169-18	22967-22970	PCL	_	
169-19	22970-22971	,	_	
169-20	22972-22983	paracentral	_	
169-21	22984-22990	lobule	_	
169-22	22990-22991	;	_	
169-23	22992-22995	IPL	_	
169-24	22995-22996	,	_	
169-25	22997-23005	inferior	_	
169-26	23006-23014	parietal	_	
169-27	23015-23020	gyrus	_	
169-28	23020-23021	;	_	
169-29	23022-23023	L	_	
169-30	23023-23024	,	_	
169-31	23025-23029	left	_	
169-32	23029-23030	;	_	
169-33	23031-23032	R	_	
169-34	23032-23033	,	_	
169-35	23034-23039	right	_	
169-36	23039-23040	.	_	

#Text=Functional connections\tPositive scale\tNegative scale\tGeneral scale\tIllness duration\t \tR\tP value\tR\tP value\tR\tP value\tR\tP value\t \tAMYG.
170-1	23041-23051	Functional	_	
170-2	23052-23063	connections	_	
170-3	23064-23072	Positive	_	
170-4	23073-23078	scale	_	
170-5	23079-23087	Negative	_	
170-6	23088-23093	scale	_	
170-7	23094-23101	General	_	
170-8	23102-23107	scale	_	
170-9	23108-23115	Illness	_	
170-10	23116-23124	duration	_	
170-11	23127-23128	R	_	
170-12	23129-23130	P	_	
170-13	23131-23136	value	_	
170-14	23137-23138	R	_	
170-15	23139-23140	P	_	
170-16	23141-23146	value	_	
170-17	23147-23148	R	_	
170-18	23149-23150	P	_	
170-19	23151-23156	value	_	
170-20	23157-23158	R	_	
170-21	23159-23160	P	_	
170-22	23161-23166	value	_	
170-23	23169-23173	AMYG	_	
170-24	23173-23174	.	_	

#Text=R - ORBsup.
171-1	23175-23176	R	_	
171-2	23177-23178	-	_	
171-3	23179-23185	ORBsup	_	
171-4	23185-23186	.	_	

#Text=R\t−0.1329\t0.1537\t−0.0931\t0.2378\t0.1168\t0.1851\t0.2596\t0.0208\t \tAMYG.
172-1	23187-23188	R	_	
172-2	23189-23190	−	_	
172-3	23190-23196	0.1329	_	
172-4	23197-23203	0.1537	_	
172-5	23204-23205	−	_	
172-6	23205-23211	0.0931	_	
172-7	23212-23218	0.2378	_	
172-8	23219-23225	0.1168	_	
172-9	23226-23232	0.1851	_	
172-10	23233-23239	0.2596	_	
172-11	23240-23246	0.0208	_	
172-12	23249-23253	AMYG	_	
172-13	23253-23254	.	_	

#Text=R - SPG.
173-1	23255-23256	R	_	
173-2	23257-23258	-	_	
173-3	23259-23262	SPG	_	
173-4	23262-23263	.	_	

#Text=R\t0.0757\t0.2811\t0.0936\t0.2365\t0.1620\t0.1062\t−0.1766\t0.0849\t \tAMYG.
174-1	23264-23265	R	_	
174-2	23266-23272	0.0757	_	
174-3	23273-23279	0.2811	_	
174-4	23280-23286	0.0936	_	
174-5	23287-23293	0.2365	_	
174-6	23294-23300	0.1620	_	
174-7	23301-23307	0.1062	_	
174-8	23308-23309	−	_	
174-9	23309-23315	0.1766	_	
174-10	23316-23322	0.0849	_	
174-11	23325-23329	AMYG	_	
174-12	23329-23330	.	_	

#Text=R - PCL.
175-1	23331-23332	R	_	
175-2	23333-23334	-	_	
175-3	23335-23338	PCL	_	
175-4	23338-23339	.	_	

#Text=R\t0.0259\t0.4216\t−0.0112\t0.4660\t−0.0628\t0.3155\t0.0058\t0.4820\t \tAMYG.
176-1	23340-23341	R	_	
176-2	23342-23348	0.0259	_	
176-3	23349-23355	0.4216	_	
176-4	23356-23357	−	_	
176-5	23357-23363	0.0112	_	
176-6	23364-23370	0.4660	_	
176-7	23371-23372	−	_	
176-8	23372-23378	0.0628	_	
176-9	23379-23385	0.3155	_	
176-10	23386-23392	0.0058	_	
176-11	23393-23399	0.4820	_	
176-12	23402-23406	AMYG	_	
176-13	23406-23407	.	_	

#Text=R - IPL.
177-1	23408-23409	R	_	
177-2	23410-23411	-	_	
177-3	23412-23415	IPL	_	
177-4	23415-23416	.	_	

#Text=L\t0.1711\t0.0937\t0.0800\t0.2701\t0.3106\t0.0075\t−0.2759\t0.0150\t \t
#Text=For these five functional connections that show significant effects in healthy subjects, SampEn of four functional connections is disassociated with age (P > 0.05; Table 3 and Fig. 4), including the functional connectivity between the right amygdala and the right superior orbital frontal gyrus, the right superior parietal gyrus, the right paracentral lobule, and the left inferior parietal gyrus.
178-1	23417-23418	L	_	
178-2	23419-23425	0.1711	_	
178-3	23426-23432	0.0937	_	
178-4	23433-23439	0.0800	_	
178-5	23440-23446	0.2701	_	
178-6	23447-23453	0.3106	_	
178-7	23454-23460	0.0075	_	
178-8	23461-23462	−	_	
178-9	23462-23468	0.2759	_	
178-10	23469-23475	0.0150	_	
178-11	23479-23482	For	_	
178-12	23483-23488	these	_	
178-13	23489-23493	five	_	
178-14	23494-23504	functional	_	
178-15	23505-23516	connections	_	
178-16	23517-23521	that	_	
178-17	23522-23526	show	_	
178-18	23527-23538	significant	_	
178-19	23539-23546	effects	_	
178-20	23547-23549	in	_	
178-21	23550-23557	healthy	_	
178-22	23558-23566	subjects	_	
178-23	23566-23567	,	_	
178-24	23568-23574	SampEn	_	
178-25	23575-23577	of	_	
178-26	23578-23582	four	_	
178-27	23583-23593	functional	_	
178-28	23594-23605	connections	_	
178-29	23606-23608	is	_	
178-30	23609-23622	disassociated	_	
178-31	23623-23627	with	_	
178-32	23628-23631	age	_	
178-33	23632-23633	(	_	
178-34	23633-23634	P	_	
178-35	23635-23636	>	_	
178-36	23637-23641	0.05	_	
178-37	23641-23642	;	_	
178-38	23643-23648	Table	_	
178-39	23648-23649	 	_	
178-40	23649-23650	3	_	
178-41	23651-23654	and	_	
178-42	23655-23658	Fig	_	
178-43	23658-23659	.	_	
178-44	23659-23660	 	_	
178-45	23660-23661	4	_	
178-46	23661-23662	)	_	
178-47	23662-23663	,	_	
178-48	23664-23673	including	_	
178-49	23674-23677	the	_	
178-50	23678-23688	functional	_	
178-51	23689-23701	connectivity	_	
178-52	23702-23709	between	_	
178-53	23710-23713	the	_	
178-54	23714-23719	right	_	
178-55	23720-23728	amygdala	_	
178-56	23729-23732	and	_	
178-57	23733-23736	the	_	
178-58	23737-23742	right	_	
178-59	23743-23751	superior	_	
178-60	23752-23759	orbital	_	
178-61	23760-23767	frontal	_	
178-62	23768-23773	gyrus	_	
178-63	23773-23774	,	_	
178-64	23775-23778	the	_	
178-65	23779-23784	right	_	
178-66	23785-23793	superior	_	
178-67	23794-23802	parietal	_	
178-68	23803-23808	gyrus	_	
178-69	23808-23809	,	_	
178-70	23810-23813	the	_	
178-71	23814-23819	right	_	
178-72	23820-23831	paracentral	_	
178-73	23832-23838	lobule	_	
178-74	23838-23839	,	_	
178-75	23840-23843	and	_	
178-76	23844-23847	the	_	
178-77	23848-23852	left	_	
178-78	23853-23861	inferior	_	
178-79	23862-23870	parietal	_	
178-80	23871-23876	gyrus	_	
178-81	23876-23877	.	_	

#Text=For each of these four functional connections, the partial correlation coefficient of the patient group is significantly larger than that of the healthy group (P < 0.05, FDR corrected; Table 3).
179-1	23878-23881	For	_	
179-2	23882-23886	each	_	
179-3	23887-23889	of	_	
179-4	23890-23895	these	_	
179-5	23896-23900	four	_	
179-6	23901-23911	functional	_	
179-7	23912-23923	connections	_	
179-8	23923-23924	,	_	
179-9	23925-23928	the	_	
179-10	23929-23936	partial	_	
179-11	23937-23948	correlation	_	
179-12	23949-23960	coefficient	_	
179-13	23961-23963	of	_	
179-14	23964-23967	the	_	
179-15	23968-23975	patient	_	
179-16	23976-23981	group	_	
179-17	23982-23984	is	_	
179-18	23985-23998	significantly	_	
179-19	23999-24005	larger	_	
179-20	24006-24010	than	_	
179-21	24011-24015	that	_	
179-22	24016-24018	of	_	
179-23	24019-24022	the	_	
179-24	24023-24030	healthy	_	
179-25	24031-24036	group	_	
179-26	24037-24038	(	_	
179-27	24038-24039	P	_	
179-28	24040-24041	<	_	
179-29	24042-24046	0.05	_	
179-30	24046-24047	,	_	
179-31	24048-24051	FDR	_	
179-32	24052-24061	corrected	_	
179-33	24061-24062	;	_	
179-34	24063-24068	Table	_	
179-35	24068-24069	 	_	
179-36	24069-24070	3	_	
179-37	24070-24071	)	_	
179-38	24071-24072	.	_	

#Text=Further association analysis between SampEn and clinical variables showed that SampEn of the functional connectivity between the right amygdala and the right superior orbital frontal gyrus is associated with the illness duration, whereas SampEn of the functional connectivity between the right amygdala and the left inferior parietal gyrus is associated with the general scale and the illness duration (Table 4).
180-1	24073-24080	Further	_	
180-2	24081-24092	association	_	
180-3	24093-24101	analysis	_	
180-4	24102-24109	between	_	
180-5	24110-24116	SampEn	_	
180-6	24117-24120	and	_	
180-7	24121-24129	clinical	_	
180-8	24130-24139	variables	_	
180-9	24140-24146	showed	_	
180-10	24147-24151	that	_	
180-11	24152-24158	SampEn	_	
180-12	24159-24161	of	_	
180-13	24162-24165	the	_	
180-14	24166-24176	functional	_	
180-15	24177-24189	connectivity	_	
180-16	24190-24197	between	_	
180-17	24198-24201	the	_	
180-18	24202-24207	right	_	
180-19	24208-24216	amygdala	_	
180-20	24217-24220	and	_	
180-21	24221-24224	the	_	
180-22	24225-24230	right	_	
180-23	24231-24239	superior	_	
180-24	24240-24247	orbital	_	
180-25	24248-24255	frontal	_	
180-26	24256-24261	gyrus	_	
180-27	24262-24264	is	_	
180-28	24265-24275	associated	_	
180-29	24276-24280	with	_	
180-30	24281-24284	the	_	
180-31	24285-24292	illness	_	
180-32	24293-24301	duration	_	
180-33	24301-24302	,	_	
180-34	24303-24310	whereas	_	
180-35	24311-24317	SampEn	_	
180-36	24318-24320	of	_	
180-37	24321-24324	the	_	
180-38	24325-24335	functional	_	
180-39	24336-24348	connectivity	_	
180-40	24349-24356	between	_	
180-41	24357-24360	the	_	
180-42	24361-24366	right	_	
180-43	24367-24375	amygdala	_	
180-44	24376-24379	and	_	
180-45	24380-24383	the	_	
180-46	24384-24388	left	_	
180-47	24389-24397	inferior	_	
180-48	24398-24406	parietal	_	
180-49	24407-24412	gyrus	_	
180-50	24413-24415	is	_	
180-51	24416-24426	associated	_	
180-52	24427-24431	with	_	
180-53	24432-24435	the	_	
180-54	24436-24443	general	_	
180-55	24444-24449	scale	_	
180-56	24450-24453	and	_	
180-57	24454-24457	the	_	
180-58	24458-24465	illness	_	
180-59	24466-24474	duration	_	
180-60	24475-24476	(	_	
180-61	24476-24481	Table	_	
180-62	24481-24482	 	_	
180-63	24482-24483	4	_	
180-64	24483-24484	)	_	
180-65	24484-24485	.	_	

#Text=Discussion
#Text=In summary, we applied SampEn to characterize the complexity within the dynamic functional connectivity.
181-1	24487-24497	Discussion	_	
181-2	24498-24500	In	_	
181-3	24501-24508	summary	_	
181-4	24508-24509	,	_	
181-5	24510-24512	we	_	
181-6	24513-24520	applied	_	
181-7	24521-24527	SampEn	_	
181-8	24528-24530	to	_	
181-9	24531-24543	characterize	_	
181-10	24544-24547	the	_	
181-11	24548-24558	complexity	_	
181-12	24559-24565	within	_	
181-13	24566-24569	the	_	
181-14	24570-24577	dynamic	_	
181-15	24578-24588	functional	_	
181-16	24589-24601	connectivity	_	
181-17	24601-24602	.	_	

#Text=This is different from previous studies on the complexity within BOLD signals.
182-1	24603-24607	This	_	
182-2	24608-24610	is	_	
182-3	24611-24620	different	_	
182-4	24621-24625	from	_	
182-5	24626-24634	previous	_	
182-6	24635-24642	studies	_	
182-7	24643-24645	on	_	
182-8	24646-24649	the	_	
182-9	24650-24660	complexity	_	
182-10	24661-24667	within	_	
182-11	24668-24672	BOLD	_	
182-12	24673-24680	signals	_	
182-13	24680-24681	.	_	

#Text=Such characterization is important because it enables us to investigate the biological implications of changes in brain functional architecture.
183-1	24682-24686	Such	_	
183-2	24687-24703	characterization	_	
183-3	24704-24706	is	_	
183-4	24707-24716	important	_	
183-5	24717-24724	because	_	
183-6	24725-24727	it	_	
183-7	24728-24735	enables	_	
183-8	24736-24738	us	_	
183-9	24739-24741	to	_	
183-10	24742-24753	investigate	_	
183-11	24754-24757	the	_	
183-12	24758-24768	biological	_	
183-13	24769-24781	implications	_	
183-14	24782-24784	of	_	
183-15	24785-24792	changes	_	
183-16	24793-24795	in	_	
183-17	24796-24801	brain	_	
183-18	24802-24812	functional	_	
183-19	24813-24825	architecture	_	
183-20	24825-24826	.	_	

#Text=As a demonstration, we established a SampEn map of the dynamic brain, and identified an age-related reduction in SampEn, suggesting that not only SampEn of the activation in some brain regions but also SampEn of the dynamic functional connectivity evolves with age.
184-1	24827-24829	As	_	
184-2	24830-24831	a	_	
184-3	24832-24845	demonstration	_	
184-4	24845-24846	,	_	
184-5	24847-24849	we	_	
184-6	24850-24861	established	_	
184-7	24862-24863	a	_	
184-8	24864-24870	SampEn	_	
184-9	24871-24874	map	_	
184-10	24875-24877	of	_	
184-11	24878-24881	the	_	
184-12	24882-24889	dynamic	_	
184-13	24890-24895	brain	_	
184-14	24895-24896	,	_	
184-15	24897-24900	and	_	
184-16	24901-24911	identified	_	
184-17	24912-24914	an	_	
184-18	24915-24926	age-related	_	
184-19	24927-24936	reduction	_	
184-20	24937-24939	in	_	
184-21	24940-24946	SampEn	_	
184-22	24946-24947	,	_	
184-23	24948-24958	suggesting	_	
184-24	24959-24963	that	_	
184-25	24964-24967	not	_	
184-26	24968-24972	only	_	
184-27	24973-24979	SampEn	_	
184-28	24980-24982	of	_	
184-29	24983-24986	the	_	
184-30	24987-24997	activation	_	
184-31	24998-25000	in	_	
184-32	25001-25005	some	_	
184-33	25006-25011	brain	_	
184-34	25012-25019	regions	_	
184-35	25020-25023	but	_	
184-36	25024-25028	also	_	
184-37	25029-25035	SampEn	_	
184-38	25036-25038	of	_	
184-39	25039-25042	the	_	
184-40	25043-25050	dynamic	_	
184-41	25051-25061	functional	_	
184-42	25062-25074	connectivity	_	
184-43	25075-25082	evolves	_	
184-44	25083-25087	with	_	
184-45	25088-25091	age	_	
184-46	25091-25092	.	_	

#Text=Moreover, we found that the age-related reduction in SampEn could be altered by schizophrenia, calling for further research of schizophrenia on the dynamics of the amygdala-cortical functional connections, which show significant alterations in our study.
185-1	25093-25101	Moreover	_	
185-2	25101-25102	,	_	
185-3	25103-25105	we	_	
185-4	25106-25111	found	_	
185-5	25112-25116	that	_	
185-6	25117-25120	the	_	
185-7	25121-25132	age-related	_	
185-8	25133-25142	reduction	_	
185-9	25143-25145	in	_	
185-10	25146-25152	SampEn	_	
185-11	25153-25158	could	_	
185-12	25159-25161	be	_	
185-13	25162-25169	altered	_	
185-14	25170-25172	by	_	
185-15	25173-25186	schizophrenia	_	
185-16	25186-25187	,	_	
185-17	25188-25195	calling	_	
185-18	25196-25199	for	_	
185-19	25200-25207	further	_	
185-20	25208-25216	research	_	
185-21	25217-25219	of	_	
185-22	25220-25233	schizophrenia	_	
185-23	25234-25236	on	_	
185-24	25237-25240	the	_	
185-25	25241-25249	dynamics	_	
185-26	25250-25252	of	_	
185-27	25253-25256	the	_	
185-28	25257-25274	amygdala-cortical	_	
185-29	25275-25285	functional	_	
185-30	25286-25297	connections	_	
185-31	25297-25298	,	_	
185-32	25299-25304	which	_	
185-33	25305-25309	show	_	
185-34	25310-25321	significant	_	
185-35	25322-25333	alterations	_	
185-36	25334-25336	in	_	
185-37	25337-25340	our	_	
185-38	25341-25346	study	_	
185-39	25346-25347	.	_	

#Text=The brain is a complex dynamic system, and how to characterize the dynamics in the brain is nontrivial.
186-1	25348-25351	The	_	
186-2	25352-25357	brain	_	
186-3	25358-25360	is	_	
186-4	25361-25362	a	_	
186-5	25363-25370	complex	_	
186-6	25371-25378	dynamic	_	
186-7	25379-25385	system	_	
186-8	25385-25386	,	_	
186-9	25387-25390	and	_	
186-10	25391-25394	how	_	
186-11	25395-25397	to	_	
186-12	25398-25410	characterize	_	
186-13	25411-25414	the	_	
186-14	25415-25423	dynamics	_	
186-15	25424-25426	in	_	
186-16	25427-25430	the	_	
186-17	25431-25436	brain	_	
186-18	25437-25439	is	_	
186-19	25440-25450	nontrivial	_	
186-20	25450-25451	.	_	

#Text=In the current study, we proposed the use of a well-defined measure named SampEn to characterize the complexity within the dynamic functional connectivity estimated by applying the sliding-window correlation technique.
187-1	25452-25454	In	_	
187-2	25455-25458	the	_	
187-3	25459-25466	current	_	
187-4	25467-25472	study	_	
187-5	25472-25473	,	_	
187-6	25474-25476	we	_	
187-7	25477-25485	proposed	_	
187-8	25486-25489	the	_	
187-9	25490-25493	use	_	
187-10	25494-25496	of	_	
187-11	25497-25498	a	_	
187-12	25499-25511	well-defined	_	
187-13	25512-25519	measure	_	
187-14	25520-25525	named	_	
187-15	25526-25532	SampEn	_	
187-16	25533-25535	to	_	
187-17	25536-25548	characterize	_	
187-18	25549-25552	the	_	
187-19	25553-25563	complexity	_	
187-20	25564-25570	within	_	
187-21	25571-25574	the	_	
187-22	25575-25582	dynamic	_	
187-23	25583-25593	functional	_	
187-24	25594-25606	connectivity	_	
187-25	25607-25616	estimated	_	
187-26	25617-25619	by	_	
187-27	25620-25628	applying	_	
187-28	25629-25632	the	_	
187-29	25633-25647	sliding-window	_	
187-30	25648-25659	correlation	_	
187-31	25660-25669	technique	_	
187-32	25669-25670	.	_	

#Text=The dynamical functional connectivity, however, might be induced by nonneuronal signals, including cardiac and respiratory signals.
188-1	25671-25674	The	_	
188-2	25675-25684	dynamical	_	
188-3	25685-25695	functional	_	
188-4	25696-25708	connectivity	_	
188-5	25708-25709	,	_	
188-6	25710-25717	however	_	
188-7	25717-25718	,	_	
188-8	25719-25724	might	_	
188-9	25725-25727	be	_	
188-10	25728-25735	induced	_	
188-11	25736-25738	by	_	
188-12	25739-25750	nonneuronal	_	
188-13	25751-25758	signals	_	
188-14	25758-25759	,	_	
188-15	25760-25769	including	_	
188-16	25770-25777	cardiac	_	
188-17	25778-25781	and	_	
188-18	25782-25793	respiratory	_	
188-19	25794-25801	signals	_	
188-20	25801-25802	.	_	

#Text=This may cause potential problems in many measures characterizing dynamic properties of the dynamic functional connectivity, especially when these confounding processes are periodic, because a periodic signal is considered to be variable regardless of its amplitude.
189-1	25803-25807	This	_	
189-2	25808-25811	may	_	
189-3	25812-25817	cause	_	
189-4	25818-25827	potential	_	
189-5	25828-25836	problems	_	
189-6	25837-25839	in	_	
189-7	25840-25844	many	_	
189-8	25845-25853	measures	_	
189-9	25854-25868	characterizing	_	
189-10	25869-25876	dynamic	_	
189-11	25877-25887	properties	_	
189-12	25888-25890	of	_	
189-13	25891-25894	the	_	
189-14	25895-25902	dynamic	_	
189-15	25903-25913	functional	_	
189-16	25914-25926	connectivity	_	
189-17	25926-25927	,	_	
189-18	25928-25938	especially	_	
189-19	25939-25943	when	_	
189-20	25944-25949	these	_	
189-21	25950-25961	confounding	_	
189-22	25962-25971	processes	_	
189-23	25972-25975	are	_	
189-24	25976-25984	periodic	_	
189-25	25984-25985	,	_	
189-26	25986-25993	because	_	
189-27	25994-25995	a	_	
189-28	25996-26004	periodic	_	
189-29	26005-26011	signal	_	
189-30	26012-26014	is	_	
189-31	26015-26025	considered	_	
189-32	26026-26028	to	_	
189-33	26029-26031	be	_	
189-34	26032-26040	variable	_	
189-35	26041-26051	regardless	_	
189-36	26052-26054	of	_	
189-37	26055-26058	its	_	
189-38	26059-26068	amplitude	_	
189-39	26068-26069	.	_	

#Text=Unlike these previous studies, we analyzed SampEn of the dynamic functional connectivity.
190-1	26070-26076	Unlike	_	
190-2	26077-26082	these	_	
190-3	26083-26091	previous	_	
190-4	26092-26099	studies	_	
190-5	26099-26100	,	_	
190-6	26101-26103	we	_	
190-7	26104-26112	analyzed	_	
190-8	26113-26119	SampEn	_	
190-9	26120-26122	of	_	
190-10	26123-26126	the	_	
190-11	26127-26134	dynamic	_	
190-12	26135-26145	functional	_	
190-13	26146-26158	connectivity	_	
190-14	26158-26159	.	_	

#Text=According to the physical interpretation of SampEn, larger SampEn corresponds to greater irregularity in the dynamic functional connectivity.
191-1	26160-26169	According	_	
191-2	26170-26172	to	_	
191-3	26173-26176	the	_	
191-4	26177-26185	physical	_	
191-5	26186-26200	interpretation	_	
191-6	26201-26203	of	_	
191-7	26204-26210	SampEn	_	
191-8	26210-26211	,	_	
191-9	26212-26218	larger	_	
191-10	26219-26225	SampEn	_	
191-11	26226-26237	corresponds	_	
191-12	26238-26240	to	_	
191-13	26241-26248	greater	_	
191-14	26249-26261	irregularity	_	
191-15	26262-26264	in	_	
191-16	26265-26268	the	_	
191-17	26269-26276	dynamic	_	
191-18	26277-26287	functional	_	
191-19	26288-26300	connectivity	_	
191-20	26300-26301	.	_	

#Text=Because periodic signals are characterized by regularity, SampEn of periodic signals is relatively low, and thereby, we could control the confounding effects of periodic signals in our analysis.
192-1	26302-26309	Because	_	
192-2	26310-26318	periodic	_	
192-3	26319-26326	signals	_	
192-4	26327-26330	are	_	
192-5	26331-26344	characterized	_	
192-6	26345-26347	by	_	
192-7	26348-26358	regularity	_	
192-8	26358-26359	,	_	
192-9	26360-26366	SampEn	_	
192-10	26367-26369	of	_	
192-11	26370-26378	periodic	_	
192-12	26379-26386	signals	_	
192-13	26387-26389	is	_	
192-14	26390-26400	relatively	_	
192-15	26401-26404	low	_	
192-16	26404-26405	,	_	
192-17	26406-26409	and	_	
192-18	26410-26417	thereby	_	
192-19	26417-26418	,	_	
192-20	26419-26421	we	_	
192-21	26422-26427	could	_	
192-22	26428-26435	control	_	
192-23	26436-26439	the	_	
192-24	26440-26451	confounding	_	
192-25	26452-26459	effects	_	
192-26	26460-26462	of	_	
192-27	26463-26471	periodic	_	
192-28	26472-26479	signals	_	
192-29	26480-26482	in	_	
192-30	26483-26486	our	_	
192-31	26487-26495	analysis	_	
192-32	26495-26496	.	_	

#Text=Remarkably, SampEn map of the dynamic brain captures the functionalities of different brain regions reported in the literature.
193-1	26497-26507	Remarkably	_	
193-2	26507-26508	,	_	
193-3	26509-26515	SampEn	_	
193-4	26516-26519	map	_	
193-5	26520-26522	of	_	
193-6	26523-26526	the	_	
193-7	26527-26534	dynamic	_	
193-8	26535-26540	brain	_	
193-9	26541-26549	captures	_	
193-10	26550-26553	the	_	
193-11	26554-26569	functionalities	_	
193-12	26570-26572	of	_	
193-13	26573-26582	different	_	
193-14	26583-26588	brain	_	
193-15	26589-26596	regions	_	
193-16	26597-26605	reported	_	
193-17	26606-26608	in	_	
193-18	26609-26612	the	_	
193-19	26613-26623	literature	_	
193-20	26623-26624	.	_	

#Text=We found that most of the brain regions with high SampEn have been implicated in key aspects of learning.
194-1	26625-26627	We	_	
194-2	26628-26633	found	_	
194-3	26634-26638	that	_	
194-4	26639-26643	most	_	
194-5	26644-26646	of	_	
194-6	26647-26650	the	_	
194-7	26651-26656	brain	_	
194-8	26657-26664	regions	_	
194-9	26665-26669	with	_	
194-10	26670-26674	high	_	
194-11	26675-26681	SampEn	_	
194-12	26682-26686	have	_	
194-13	26687-26691	been	_	
194-14	26692-26702	implicated	_	
194-15	26703-26705	in	_	
194-16	26706-26709	key	_	
194-17	26710-26717	aspects	_	
194-18	26718-26720	of	_	
194-19	26721-26729	learning	_	
194-20	26729-26730	.	_	

#Text=For instance, the caudate is implicated in reinforcement-based associative learning and classification learning, the olfactory cortex in olfactory learning, the amygdala in emotional learning, the hippocampus in many aspects of learning and memory, and the temporal pole in visual learning.
195-1	26731-26734	For	_	
195-2	26735-26743	instance	_	
195-3	26743-26744	,	_	
195-4	26745-26748	the	_	
195-5	26749-26756	caudate	_	
195-6	26757-26759	is	_	
195-7	26760-26770	implicated	_	
195-8	26771-26773	in	_	
195-9	26774-26793	reinforcement-based	_	
195-10	26794-26805	associative	_	
195-11	26806-26814	learning	_	
195-12	26815-26818	and	_	
195-13	26819-26833	classification	_	
195-14	26834-26842	learning	_	
195-15	26842-26843	,	_	
195-16	26844-26847	the	_	
195-17	26848-26857	olfactory	_	
195-18	26858-26864	cortex	_	
195-19	26865-26867	in	_	
195-20	26868-26877	olfactory	_	
195-21	26878-26886	learning	_	
195-22	26886-26887	,	_	
195-23	26888-26891	the	_	
195-24	26892-26900	amygdala	_	
195-25	26901-26903	in	_	
195-26	26904-26913	emotional	_	
195-27	26914-26922	learning	_	
195-28	26922-26923	,	_	
195-29	26924-26927	the	_	
195-30	26928-26939	hippocampus	_	
195-31	26940-26942	in	_	
195-32	26943-26947	many	_	
195-33	26948-26955	aspects	_	
195-34	26956-26958	of	_	
195-35	26959-26967	learning	_	
195-36	26968-26971	and	_	
195-37	26972-26978	memory	_	
195-38	26978-26979	,	_	
195-39	26980-26983	and	_	
195-40	26984-26987	the	_	
195-41	26988-26996	temporal	_	
195-42	26997-27001	pole	_	
195-43	27002-27004	in	_	
195-44	27005-27011	visual	_	
195-45	27012-27020	learning	_	
195-46	27020-27021	.	_	

#Text=In contrast, we observed that sensorimotor and visual areas show low SampEn.
196-1	27022-27024	In	_	
196-2	27025-27033	contrast	_	
196-3	27033-27034	,	_	
196-4	27035-27037	we	_	
196-5	27038-27046	observed	_	
196-6	27047-27051	that	_	
196-7	27052-27064	sensorimotor	_	
196-8	27065-27068	and	_	
196-9	27069-27075	visual	_	
196-10	27076-27081	areas	_	
196-11	27082-27086	show	_	
196-12	27087-27090	low	_	
196-13	27091-27097	SampEn	_	
196-14	27097-27098	.	_	

#Text=These results add SampEn of the dynamic functional connectivity as a new aspect to the literature, reporting that flexibility of the brain is an important factor predicting learning and that primary sensorimotor and visual areas show low flexibility during motor learning task.
197-1	27099-27104	These	_	
197-2	27105-27112	results	_	
197-3	27113-27116	add	_	
197-4	27117-27123	SampEn	_	
197-5	27124-27126	of	_	
197-6	27127-27130	the	_	
197-7	27131-27138	dynamic	_	
197-8	27139-27149	functional	_	
197-9	27150-27162	connectivity	_	
197-10	27163-27165	as	_	
197-11	27166-27167	a	_	
197-12	27168-27171	new	_	
197-13	27172-27178	aspect	_	
197-14	27179-27181	to	_	
197-15	27182-27185	the	_	
197-16	27186-27196	literature	_	
197-17	27196-27197	,	_	
197-18	27198-27207	reporting	_	
197-19	27208-27212	that	_	
197-20	27213-27224	flexibility	_	
197-21	27225-27227	of	_	
197-22	27228-27231	the	_	
197-23	27232-27237	brain	_	
197-24	27238-27240	is	_	
197-25	27241-27243	an	_	
197-26	27244-27253	important	_	
197-27	27254-27260	factor	_	
197-28	27261-27271	predicting	_	
197-29	27272-27280	learning	_	
197-30	27281-27284	and	_	
197-31	27285-27289	that	_	
197-32	27290-27297	primary	_	
197-33	27298-27310	sensorimotor	_	
197-34	27311-27314	and	_	
197-35	27315-27321	visual	_	
197-36	27322-27327	areas	_	
197-37	27328-27332	show	_	
197-38	27333-27336	low	_	
197-39	27337-27348	flexibility	_	
197-40	27349-27355	during	_	
197-41	27356-27361	motor	_	
197-42	27362-27370	learning	_	
197-43	27371-27375	task	_	
197-44	27375-27376	.	_	

#Text=Aging is a fundamental process in the human brain, and deviations from the normal aging process would result in mental disorders.
198-1	27377-27382	Aging	_	
198-2	27383-27385	is	_	
198-3	27386-27387	a	_	
198-4	27388-27399	fundamental	_	
198-5	27400-27407	process	_	
198-6	27408-27410	in	_	
198-7	27411-27414	the	_	
198-8	27415-27420	human	_	
198-9	27421-27426	brain	_	
198-10	27426-27427	,	_	
198-11	27428-27431	and	_	
198-12	27432-27442	deviations	_	
198-13	27443-27447	from	_	
198-14	27448-27451	the	_	
198-15	27452-27458	normal	_	
198-16	27459-27464	aging	_	
198-17	27465-27472	process	_	
198-18	27473-27478	would	_	
198-19	27479-27485	result	_	
198-20	27486-27488	in	_	
198-21	27489-27495	mental	_	
198-22	27496-27505	disorders	_	
198-23	27505-27506	.	_	

#Text=With advancing age, the complexity within the temporal dynamics of brain signals measured by EEG, MEG, and BOLD fMRI appears to decrease.
199-1	27507-27511	With	_	
199-2	27512-27521	advancing	_	
199-3	27522-27525	age	_	
199-4	27525-27526	,	_	
199-5	27527-27530	the	_	
199-6	27531-27541	complexity	_	
199-7	27542-27548	within	_	
199-8	27549-27552	the	_	
199-9	27553-27561	temporal	_	
199-10	27562-27570	dynamics	_	
199-11	27571-27573	of	_	
199-12	27574-27579	brain	_	
199-13	27580-27587	signals	_	
199-14	27588-27596	measured	_	
199-15	27597-27599	by	_	
199-16	27600-27603	EEG	_	
199-17	27603-27604	,	_	
199-18	27605-27608	MEG	_	
199-19	27608-27609	,	_	
199-20	27610-27613	and	_	
199-21	27614-27618	BOLD	_	
199-22	27619-27623	fMRI	_	
199-23	27624-27631	appears	_	
199-24	27632-27634	to	_	
199-25	27635-27643	decrease	_	
199-26	27643-27644	.	_	

#Text=Consistently, we found that SampEn of the dynamic brain also decreases with advancing age.
200-1	27645-27657	Consistently	_	
200-2	27657-27658	,	_	
200-3	27659-27661	we	_	
200-4	27662-27667	found	_	
200-5	27668-27672	that	_	
200-6	27673-27679	SampEn	_	
200-7	27680-27682	of	_	
200-8	27683-27686	the	_	
200-9	27687-27694	dynamic	_	
200-10	27695-27700	brain	_	
200-11	27701-27705	also	_	
200-12	27706-27715	decreases	_	
200-13	27716-27720	with	_	
200-14	27721-27730	advancing	_	
200-15	27731-27734	age	_	
200-16	27734-27735	.	_	

#Text=These decreases may relate to the decline in capacity of learning and memory with normal aging that is caused by alterations in neuronal structure and losses of synapses.
201-1	27736-27741	These	_	
201-2	27742-27751	decreases	_	
201-3	27752-27755	may	_	
201-4	27756-27762	relate	_	
201-5	27763-27765	to	_	
201-6	27766-27769	the	_	
201-7	27770-27777	decline	_	
201-8	27778-27780	in	_	
201-9	27781-27789	capacity	_	
201-10	27790-27792	of	_	
201-11	27793-27801	learning	_	
201-12	27802-27805	and	_	
201-13	27806-27812	memory	_	
201-14	27813-27817	with	_	
201-15	27818-27824	normal	_	
201-16	27825-27830	aging	_	
201-17	27831-27835	that	_	
201-18	27836-27838	is	_	
201-19	27839-27845	caused	_	
201-20	27846-27848	by	_	
201-21	27849-27860	alterations	_	
201-22	27861-27863	in	_	
201-23	27864-27872	neuronal	_	
201-24	27873-27882	structure	_	
201-25	27883-27886	and	_	
201-26	27887-27893	losses	_	
201-27	27894-27896	of	_	
201-28	27897-27905	synapses	_	
201-29	27905-27906	.	_	

#Text=Moreover, we identified that the reduction in SampEn of the dynamic brain is driven mainly by the amygdala-cortical functional connectivity.
202-1	27907-27915	Moreover	_	
202-2	27915-27916	,	_	
202-3	27917-27919	we	_	
202-4	27920-27930	identified	_	
202-5	27931-27935	that	_	
202-6	27936-27939	the	_	
202-7	27940-27949	reduction	_	
202-8	27950-27952	in	_	
202-9	27953-27959	SampEn	_	
202-10	27960-27962	of	_	
202-11	27963-27966	the	_	
202-12	27967-27974	dynamic	_	
202-13	27975-27980	brain	_	
202-14	27981-27983	is	_	
202-15	27984-27990	driven	_	
202-16	27991-27997	mainly	_	
202-17	27998-28000	by	_	
202-18	28001-28004	the	_	
202-19	28005-28022	amygdala-cortical	_	
202-20	28023-28033	functional	_	
202-21	28034-28046	connectivity	_	
202-22	28046-28047	.	_	

#Text=The amygdala-cortical connectivity has been reported to be age-related in both structural and functional neuroimaging studies, but the current study revealed the negative association between SampEn of the amygdala-cortical functional connectivity and age.
203-1	28048-28051	The	_	
203-2	28052-28069	amygdala-cortical	_	
203-3	28070-28082	connectivity	_	
203-4	28083-28086	has	_	
203-5	28087-28091	been	_	
203-6	28092-28100	reported	_	
203-7	28101-28103	to	_	
203-8	28104-28106	be	_	
203-9	28107-28118	age-related	_	
203-10	28119-28121	in	_	
203-11	28122-28126	both	_	
203-12	28127-28137	structural	_	
203-13	28138-28141	and	_	
203-14	28142-28152	functional	_	
203-15	28153-28165	neuroimaging	_	
203-16	28166-28173	studies	_	
203-17	28173-28174	,	_	
203-18	28175-28178	but	_	
203-19	28179-28182	the	_	
203-20	28183-28190	current	_	
203-21	28191-28196	study	_	
203-22	28197-28205	revealed	_	
203-23	28206-28209	the	_	
203-24	28210-28218	negative	_	
203-25	28219-28230	association	_	
203-26	28231-28238	between	_	
203-27	28239-28245	SampEn	_	
203-28	28246-28248	of	_	
203-29	28249-28252	the	_	
203-30	28253-28270	amygdala-cortical	_	
203-31	28271-28281	functional	_	
203-32	28282-28294	connectivity	_	
203-33	28295-28298	and	_	
203-34	28299-28302	age	_	
203-35	28302-28303	.	_	

#Text=This result is complementary to a previous study that showed that increased resting-state functional connectivity between the amygdala and frontal regions is related to superior emotional regulation in aging.
204-1	28304-28308	This	_	
204-2	28309-28315	result	_	
204-3	28316-28318	is	_	
204-4	28319-28332	complementary	_	
204-5	28333-28335	to	_	
204-6	28336-28337	a	_	
204-7	28338-28346	previous	_	
204-8	28347-28352	study	_	
204-9	28353-28357	that	_	
204-10	28358-28364	showed	_	
204-11	28365-28369	that	_	
204-12	28370-28379	increased	_	
204-13	28380-28393	resting-state	_	
204-14	28394-28404	functional	_	
204-15	28405-28417	connectivity	_	
204-16	28418-28425	between	_	
204-17	28426-28429	the	_	
204-18	28430-28438	amygdala	_	
204-19	28439-28442	and	_	
204-20	28443-28450	frontal	_	
204-21	28451-28458	regions	_	
204-22	28459-28461	is	_	
204-23	28462-28469	related	_	
204-24	28470-28472	to	_	
204-25	28473-28481	superior	_	
204-26	28482-28491	emotional	_	
204-27	28492-28502	regulation	_	
204-28	28503-28505	in	_	
204-29	28506-28511	aging	_	
204-30	28511-28512	.	_	

#Text=Notably, the proposed approach is clinically relevant.
205-1	28513-28520	Notably	_	
205-2	28520-28521	,	_	
205-3	28522-28525	the	_	
205-4	28526-28534	proposed	_	
205-5	28535-28543	approach	_	
205-6	28544-28546	is	_	
205-7	28547-28557	clinically	_	
205-8	28558-28566	relevant	_	
205-9	28566-28567	.	_	

#Text=A most recent study reported that the subcortical-cortical resting-state functional connectivity decreases with advancing age in the general population, and this age-related decrease is insignificant in patients with autism.
206-1	28568-28569	A	_	
206-2	28570-28574	most	_	
206-3	28575-28581	recent	_	
206-4	28582-28587	study	_	
206-5	28588-28596	reported	_	
206-6	28597-28601	that	_	
206-7	28602-28605	the	_	
206-8	28606-28626	subcortical-cortical	_	
206-9	28627-28640	resting-state	_	
206-10	28641-28651	functional	_	
206-11	28652-28664	connectivity	_	
206-12	28665-28674	decreases	_	
206-13	28675-28679	with	_	
206-14	28680-28689	advancing	_	
206-15	28690-28693	age	_	
206-16	28694-28696	in	_	
206-17	28697-28700	the	_	
206-18	28701-28708	general	_	
206-19	28709-28719	population	_	
206-20	28719-28720	,	_	
206-21	28721-28724	and	_	
206-22	28725-28729	this	_	
206-23	28730-28741	age-related	_	
206-24	28742-28750	decrease	_	
206-25	28751-28753	is	_	
206-26	28754-28767	insignificant	_	
206-27	28768-28770	in	_	
206-28	28771-28779	patients	_	
206-29	28780-28784	with	_	
206-30	28785-28791	autism	_	
206-31	28791-28792	.	_	

#Text=These results suggest that the normal aging process is altered by mental disorders.
207-1	28793-28798	These	_	
207-2	28799-28806	results	_	
207-3	28807-28814	suggest	_	
207-4	28815-28819	that	_	
207-5	28820-28823	the	_	
207-6	28824-28830	normal	_	
207-7	28831-28836	aging	_	
207-8	28837-28844	process	_	
207-9	28845-28847	is	_	
207-10	28848-28855	altered	_	
207-11	28856-28858	by	_	
207-12	28859-28865	mental	_	
207-13	28866-28875	disorders	_	
207-14	28875-28876	.	_	

#Text=In the current study, we found a similar deviation from the normal aging process as the association between SampEn and age significantly decreases in patients with schizophrenia.
208-1	28877-28879	In	_	
208-2	28880-28883	the	_	
208-3	28884-28891	current	_	
208-4	28892-28897	study	_	
208-5	28897-28898	,	_	
208-6	28899-28901	we	_	
208-7	28902-28907	found	_	
208-8	28908-28909	a	_	
208-9	28910-28917	similar	_	
208-10	28918-28927	deviation	_	
208-11	28928-28932	from	_	
208-12	28933-28936	the	_	
208-13	28937-28943	normal	_	
208-14	28944-28949	aging	_	
208-15	28950-28957	process	_	
208-16	28958-28960	as	_	
208-17	28961-28964	the	_	
208-18	28965-28976	association	_	
208-19	28977-28984	between	_	
208-20	28985-28991	SampEn	_	
208-21	28992-28995	and	_	
208-22	28996-28999	age	_	
208-23	29000-29013	significantly	_	
208-24	29014-29023	decreases	_	
208-25	29024-29026	in	_	
208-26	29027-29035	patients	_	
208-27	29036-29040	with	_	
208-28	29041-29054	schizophrenia	_	
208-29	29054-29055	.	_	

#Text=Interestingly, the most significant deviation was identified in SampEn of functional connectivity between the right amygdala and the right superior orbital frontal cortex.
209-1	29056-29069	Interestingly	_	
209-2	29069-29070	,	_	
209-3	29071-29074	the	_	
209-4	29075-29079	most	_	
209-5	29080-29091	significant	_	
209-6	29092-29101	deviation	_	
209-7	29102-29105	was	_	
209-8	29106-29116	identified	_	
209-9	29117-29119	in	_	
209-10	29120-29126	SampEn	_	
209-11	29127-29129	of	_	
209-12	29130-29140	functional	_	
209-13	29141-29153	connectivity	_	
209-14	29154-29161	between	_	
209-15	29162-29165	the	_	
209-16	29166-29171	right	_	
209-17	29172-29180	amygdala	_	
209-18	29181-29184	and	_	
209-19	29185-29188	the	_	
209-20	29189-29194	right	_	
209-21	29195-29203	superior	_	
209-22	29204-29211	orbital	_	
209-23	29212-29219	frontal	_	
209-24	29220-29226	cortex	_	
209-25	29226-29227	.	_	

#Text=This is consistent with a previous study that reported the association between the decreased amygdala-frontal functional connectivity and emotional abnormalities in patients with schizophrenia.
210-1	29228-29232	This	_	
210-2	29233-29235	is	_	
210-3	29236-29246	consistent	_	
210-4	29247-29251	with	_	
210-5	29252-29253	a	_	
210-6	29254-29262	previous	_	
210-7	29263-29268	study	_	
210-8	29269-29273	that	_	
210-9	29274-29282	reported	_	
210-10	29283-29286	the	_	
210-11	29287-29298	association	_	
210-12	29299-29306	between	_	
210-13	29307-29310	the	_	
210-14	29311-29320	decreased	_	
210-15	29321-29337	amygdala-frontal	_	
210-16	29338-29348	functional	_	
210-17	29349-29361	connectivity	_	
210-18	29362-29365	and	_	
210-19	29366-29375	emotional	_	
210-20	29376-29389	abnormalities	_	
210-21	29390-29392	in	_	
210-22	29393-29401	patients	_	
210-23	29402-29406	with	_	
210-24	29407-29420	schizophrenia	_	
210-25	29420-29421	.	_	

#Text=Moreover, we found that SampEn of the functional connectivity between the right amygdala and the right superior orbital frontal gyrus is lower in healthy elderly subjects compared with healthy young subjects, and is also lower in patients with schizophrenia compared with healthy subjects (Supplementary Fig. 
211-1	29422-29430	Moreover	_	
211-2	29430-29431	,	_	
211-3	29432-29434	we	_	
211-4	29435-29440	found	_	
211-5	29441-29445	that	_	
211-6	29446-29452	SampEn	_	
211-7	29453-29455	of	_	
211-8	29456-29459	the	_	
211-9	29460-29470	functional	_	
211-10	29471-29483	connectivity	_	
211-11	29484-29491	between	_	
211-12	29492-29495	the	_	
211-13	29496-29501	right	_	
211-14	29502-29510	amygdala	_	
211-15	29511-29514	and	_	
211-16	29515-29518	the	_	
211-17	29519-29524	right	_	
211-18	29525-29533	superior	_	
211-19	29534-29541	orbital	_	
211-20	29542-29549	frontal	_	
211-21	29550-29555	gyrus	_	
211-22	29556-29558	is	_	
211-23	29559-29564	lower	_	
211-24	29565-29567	in	_	
211-25	29568-29575	healthy	_	
211-26	29576-29583	elderly	_	
211-27	29584-29592	subjects	_	
211-28	29593-29601	compared	_	
211-29	29602-29606	with	_	
211-30	29607-29614	healthy	_	
211-31	29615-29620	young	_	
211-32	29621-29629	subjects	_	
211-33	29629-29630	,	_	
211-34	29631-29634	and	_	
211-35	29635-29637	is	_	
211-36	29638-29642	also	_	
211-37	29643-29648	lower	_	
211-38	29649-29651	in	_	
211-39	29652-29660	patients	_	
211-40	29661-29665	with	_	
211-41	29666-29679	schizophrenia	_	
211-42	29680-29688	compared	_	
211-43	29689-29693	with	_	
211-44	29694-29701	healthy	_	
211-45	29702-29710	subjects	_	
211-46	29711-29712	(	_	
211-47	29712-29725	Supplementary	_	
211-48	29726-29729	Fig	_	
211-49	29729-29730	.	_	
211-50	29730-29731	 	_	

#Text=S3).
212-1	29731-29733	S3	_	
212-2	29733-29734	)	_	
212-3	29734-29735	.	_	

#Text=This finding provides new evidence for the accelerated aging in patients with schizophrenia, which already has been demonstrated by previous studies that have reported an accelerated decline in functional brain network efficiency and an accelerated reduction of gray matter volume.
213-1	29736-29740	This	_	
213-2	29741-29748	finding	_	
213-3	29749-29757	provides	_	
213-4	29758-29761	new	_	
213-5	29762-29770	evidence	_	
213-6	29771-29774	for	_	
213-7	29775-29778	the	_	
213-8	29779-29790	accelerated	_	
213-9	29791-29796	aging	_	
213-10	29797-29799	in	_	
213-11	29800-29808	patients	_	
213-12	29809-29813	with	_	
213-13	29814-29827	schizophrenia	_	
213-14	29827-29828	,	_	
213-15	29829-29834	which	_	
213-16	29835-29842	already	_	
213-17	29843-29846	has	_	
213-18	29847-29851	been	_	
213-19	29852-29864	demonstrated	_	
213-20	29865-29867	by	_	
213-21	29868-29876	previous	_	
213-22	29877-29884	studies	_	
213-23	29885-29889	that	_	
213-24	29890-29894	have	_	
213-25	29895-29903	reported	_	
213-26	29904-29906	an	_	
213-27	29907-29918	accelerated	_	
213-28	29919-29926	decline	_	
213-29	29927-29929	in	_	
213-30	29930-29940	functional	_	
213-31	29941-29946	brain	_	
213-32	29947-29954	network	_	
213-33	29955-29965	efficiency	_	
213-34	29966-29969	and	_	
213-35	29970-29972	an	_	
213-36	29973-29984	accelerated	_	
213-37	29985-29994	reduction	_	
213-38	29995-29997	of	_	
213-39	29998-30002	gray	_	
213-40	30003-30009	matter	_	
213-41	30010-30016	volume	_	
213-42	30016-30017	.	_	

#Text=A prominent advantage of our approach is that SampEn of the dynamic functional connectivity does not necessarily depend on the scaling parameter ε.
214-1	30018-30019	A	_	
214-2	30020-30029	prominent	_	
214-3	30030-30039	advantage	_	
214-4	30040-30042	of	_	
214-5	30043-30046	our	_	
214-6	30047-30055	approach	_	
214-7	30056-30058	is	_	
214-8	30059-30063	that	_	
214-9	30064-30070	SampEn	_	
214-10	30071-30073	of	_	
214-11	30074-30077	the	_	
214-12	30078-30085	dynamic	_	
214-13	30086-30096	functional	_	
214-14	30097-30109	connectivity	_	
214-15	30110-30114	does	_	
214-16	30115-30118	not	_	
214-17	30119-30130	necessarily	_	
214-18	30131-30137	depend	_	
214-19	30138-30140	on	_	
214-20	30141-30144	the	_	
214-21	30145-30152	scaling	_	
214-22	30153-30162	parameter	_	
214-23	30163-30164	ε	_	
214-24	30164-30165	.	_	

#Text=As shown in Supplementary Fig. 
215-1	30166-30168	As	_	
215-2	30169-30174	shown	_	
215-3	30175-30177	in	_	
215-4	30178-30191	Supplementary	_	
215-5	30192-30195	Fig	_	
215-6	30195-30196	.	_	
215-7	30196-30197	 	_	

#Text=S4, SampEn of the dynamic functional connectivity obtained at a different value of ε (e.g., 0.12, 0.16, and 0.24) was highly correlated with that obtained at 0.2 (R > 0.97).
216-1	30197-30199	S4	_	
216-2	30199-30200	,	_	
216-3	30201-30207	SampEn	_	
216-4	30208-30210	of	_	
216-5	30211-30214	the	_	
216-6	30215-30222	dynamic	_	
216-7	30223-30233	functional	_	
216-8	30234-30246	connectivity	_	
216-9	30247-30255	obtained	_	
216-10	30256-30258	at	_	
216-11	30259-30260	a	_	
216-12	30261-30270	different	_	
216-13	30271-30276	value	_	
216-14	30277-30279	of	_	
216-15	30280-30281	ε	_	
216-16	30282-30283	(	_	
216-17	30283-30286	e.g	_	
216-18	30286-30287	.	_	
216-19	30287-30288	,	_	
216-20	30289-30293	0.12	_	
216-21	30293-30294	,	_	
216-22	30295-30299	0.16	_	
216-23	30299-30300	,	_	
216-24	30301-30304	and	_	
216-25	30305-30309	0.24	_	
216-26	30309-30310	)	_	
216-27	30311-30314	was	_	
216-28	30315-30321	highly	_	
216-29	30322-30332	correlated	_	
216-30	30333-30337	with	_	
216-31	30338-30342	that	_	
216-32	30343-30351	obtained	_	
216-33	30352-30354	at	_	
216-34	30355-30358	0.2	_	
216-35	30359-30360	(	_	
216-36	30360-30361	R	_	
216-37	30362-30363	>	_	
216-38	30364-30368	0.97	_	
216-39	30368-30369	)	_	
216-40	30369-30370	.	_	

#Text=The interpretation of findings in the present study, however, needs to consider some limitations.
217-1	30371-30374	The	_	
217-2	30375-30389	interpretation	_	
217-3	30390-30392	of	_	
217-4	30393-30401	findings	_	
217-5	30402-30404	in	_	
217-6	30405-30408	the	_	
217-7	30409-30416	present	_	
217-8	30417-30422	study	_	
217-9	30422-30423	,	_	
217-10	30424-30431	however	_	
217-11	30431-30432	,	_	
217-12	30433-30438	needs	_	
217-13	30439-30441	to	_	
217-14	30442-30450	consider	_	
217-15	30451-30455	some	_	
217-16	30456-30467	limitations	_	
217-17	30467-30468	.	_	

#Text=Because noise also shows high SampEn according to the physical interpretation of SampEn, the observational noise in BOLD signals may contribute to SampEn of the dynamic functional connectivity.
218-1	30469-30476	Because	_	
218-2	30477-30482	noise	_	
218-3	30483-30487	also	_	
218-4	30488-30493	shows	_	
218-5	30494-30498	high	_	
218-6	30499-30505	SampEn	_	
218-7	30506-30515	according	_	
218-8	30516-30518	to	_	
218-9	30519-30522	the	_	
218-10	30523-30531	physical	_	
218-11	30532-30546	interpretation	_	
218-12	30547-30549	of	_	
218-13	30550-30556	SampEn	_	
218-14	30556-30557	,	_	
218-15	30558-30561	the	_	
218-16	30562-30575	observational	_	
218-17	30576-30581	noise	_	
218-18	30582-30584	in	_	
218-19	30585-30589	BOLD	_	
218-20	30590-30597	signals	_	
218-21	30598-30601	may	_	
218-22	30602-30612	contribute	_	
218-23	30613-30615	to	_	
218-24	30616-30622	SampEn	_	
218-25	30623-30625	of	_	
218-26	30626-30629	the	_	
218-27	30630-30637	dynamic	_	
218-28	30638-30648	functional	_	
218-29	30649-30661	connectivity	_	
218-30	30661-30662	.	_	

#Text=In the current study, we have associated SampEn with age, which suggests that the contribution of the observational noise to SampEn is not significant.
219-1	30663-30665	In	_	
219-2	30666-30669	the	_	
219-3	30670-30677	current	_	
219-4	30678-30683	study	_	
219-5	30683-30684	,	_	
219-6	30685-30687	we	_	
219-7	30688-30692	have	_	
219-8	30693-30703	associated	_	
219-9	30704-30710	SampEn	_	
219-10	30711-30715	with	_	
219-11	30716-30719	age	_	
219-12	30719-30720	,	_	
219-13	30721-30726	which	_	
219-14	30727-30735	suggests	_	
219-15	30736-30740	that	_	
219-16	30741-30744	the	_	
219-17	30745-30757	contribution	_	
219-18	30758-30760	of	_	
219-19	30761-30764	the	_	
219-20	30765-30778	observational	_	
219-21	30779-30784	noise	_	
219-22	30785-30787	to	_	
219-23	30788-30794	SampEn	_	
219-24	30795-30797	is	_	
219-25	30798-30801	not	_	
219-26	30802-30813	significant	_	
219-27	30813-30814	.	_	

#Text=Additionally, because medical treatment data were not available in the current sample, future analyses on patients with schizophrenia with records of medical treatment would help us to assess the confounding effect of the medical treatment on our findings.
220-1	30815-30827	Additionally	_	
220-2	30827-30828	,	_	
220-3	30829-30836	because	_	
220-4	30837-30844	medical	_	
220-5	30845-30854	treatment	_	
220-6	30855-30859	data	_	
220-7	30860-30864	were	_	
220-8	30865-30868	not	_	
220-9	30869-30878	available	_	
220-10	30879-30881	in	_	
220-11	30882-30885	the	_	
220-12	30886-30893	current	_	
220-13	30894-30900	sample	_	
220-14	30900-30901	,	_	
220-15	30902-30908	future	_	
220-16	30909-30917	analyses	_	
220-17	30918-30920	on	_	
220-18	30921-30929	patients	_	
220-19	30930-30934	with	_	
220-20	30935-30948	schizophrenia	_	
220-21	30949-30953	with	_	
220-22	30954-30961	records	_	
220-23	30962-30964	of	_	
220-24	30965-30972	medical	_	
220-25	30973-30982	treatment	_	
220-26	30983-30988	would	_	
220-27	30989-30993	help	_	
220-28	30994-30996	us	_	
220-29	30997-30999	to	_	
220-30	31000-31006	assess	_	
220-31	31007-31010	the	_	
220-32	31011-31022	confounding	_	
220-33	31023-31029	effect	_	
220-34	31030-31032	of	_	
220-35	31033-31036	the	_	
220-36	31037-31044	medical	_	
220-37	31045-31054	treatment	_	
220-38	31055-31057	on	_	
220-39	31058-31061	our	_	
220-40	31062-31070	findings	_	
220-41	31070-31071	.	_	

#Text=Electronic supplementary material
#Text=Electronic supplementary material
#Text= Supplementary information accompanies this paper at doi:10.1038/s41598-017-08565-y 
#Text= Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
221-1	31072-31082	Electronic	_	
221-2	31083-31096	supplementary	_	
221-3	31097-31105	material	_	
221-4	31106-31116	Electronic	_	
221-5	31117-31130	supplementary	_	
221-6	31131-31139	material	_	
221-7	31141-31154	Supplementary	_	
221-8	31155-31166	information	_	
221-9	31167-31178	accompanies	_	
221-10	31179-31183	this	_	
221-11	31184-31189	paper	_	
221-12	31190-31192	at	_	
221-13	31193-31196	doi	_	
221-14	31196-31197	:	_	
221-15	31197-31204	10.1038	_	
221-16	31204-31205	/	_	
221-17	31205-31211	s41598	_	
221-18	31211-31212	-	_	
221-19	31212-31215	017	_	
221-20	31215-31216	-	_	
221-21	31216-31221	08565	_	
221-22	31221-31222	-	_	
221-23	31222-31223	y	_	
221-24	31226-31237	Publisher's	_	
221-25	31238-31242	note	_	
221-26	31242-31243	:	_	
221-27	31244-31252	Springer	_	
221-28	31253-31259	Nature	_	
221-29	31260-31267	remains	_	
221-30	31268-31275	neutral	_	
221-31	31276-31280	with	_	
221-32	31281-31287	regard	_	
221-33	31288-31290	to	_	
221-34	31291-31305	jurisdictional	_	
221-35	31306-31312	claims	_	
221-36	31313-31315	in	_	
221-37	31316-31325	published	_	
221-38	31326-31330	maps	_	
221-39	31331-31334	and	_	
221-40	31335-31348	institutional	_	
221-41	31349-31361	affiliations	_	
221-42	31361-31362	.	_	

#Text=Author Contributions
#Text=H.G.G. and Q.L. formulated the idea of the research.
222-1	31363-31369	Author	_	
222-2	31370-31383	Contributions	_	
222-3	31384-31389	H.G.G	_	
222-4	31389-31390	.	_	
222-5	31391-31394	and	_	
222-6	31395-31398	Q.L	_	
222-7	31398-31399	.	_	
222-8	31400-31410	formulated	_	
222-9	31411-31414	the	_	
222-10	31415-31419	idea	_	
222-11	31420-31422	of	_	
222-12	31423-31426	the	_	
222-13	31427-31435	research	_	
222-14	31435-31436	.	_	

#Text=Y.B.J., H.G.G., and Q.L. performed the research.
223-1	31437-31442	Y.B.J	_	
223-2	31442-31443	.	_	
223-3	31443-31444	,	_	
223-4	31445-31450	H.G.G	_	
223-5	31450-31451	.	_	
223-6	31451-31452	,	_	
223-7	31453-31456	and	_	
223-8	31457-31460	Q.L	_	
223-9	31460-31461	.	_	
223-10	31462-31471	performed	_	
223-11	31472-31475	the	_	
223-12	31476-31484	research	_	
223-13	31484-31485	.	_	

#Text=Y.B.J. and Q.L. analyzed the data.
224-1	31486-31491	Y.B.J	_	
224-2	31491-31492	.	_	
224-3	31493-31496	and	_	
224-4	31497-31500	Q.L	_	
224-5	31500-31501	.	_	
224-6	31502-31510	analyzed	_	
224-7	31511-31514	the	_	
224-8	31515-31519	data	_	
224-9	31519-31520	.	_	

#Text=Y.B.J., H.G.G., and Q.L. wrote the first draft of the manuscript.
225-1	31521-31526	Y.B.J	_	
225-2	31526-31527	.	_	
225-3	31527-31528	,	_	
225-4	31529-31534	H.G.G	_	
225-5	31534-31535	.	_	
225-6	31535-31536	,	_	
225-7	31537-31540	and	_	
225-8	31541-31544	Q.L	_	
225-9	31544-31545	.	_	
225-10	31546-31551	wrote	_	
225-11	31552-31555	the	_	
225-12	31556-31561	first	_	
225-13	31562-31567	draft	_	
225-14	31568-31570	of	_	
225-15	31571-31574	the	_	
225-16	31575-31585	manuscript	_	
225-17	31585-31586	.	_	

#Text=All authors contributed to and approved the final manuscript.
226-1	31587-31590	All	_	
226-2	31591-31598	authors	_	
226-3	31599-31610	contributed	_	
226-4	31611-31613	to	_	
226-5	31614-31617	and	_	
226-6	31618-31626	approved	_	
226-7	31627-31630	the	_	
226-8	31631-31636	final	_	
226-9	31637-31647	manuscript	_	
226-10	31647-31648	.	_	

#Text=Competing Interests
#Text=The authors declare that they have no competing interests.
227-1	31649-31658	Competing	_	
227-2	31659-31668	Interests	_	
227-3	31669-31672	The	_	
227-4	31673-31680	authors	_	
227-5	31681-31688	declare	_	
227-6	31689-31693	that	_	
227-7	31694-31698	they	_	
227-8	31699-31703	have	_	
227-9	31704-31706	no	_	
227-10	31707-31716	competing	_	
227-11	31717-31726	interests	_	
227-12	31726-31727	.	_	

#Text=References
#Text=Experimental observation of transition from chaotic bursting to chaotic spiking in a neural pacemaker
#Text=Biological experimental demonstration of bifurcations from bursting to spiking predicted by theoretical models
#Text=Autapse-induced multiple coherence resonance in single neurons and neuronal networks
#Text=Altered resting state complexity in schizophrenia
#Text=Brain entropy mapping using fMRI
#Text=Exploiting complexity information for brain activation detection
#Text=Neural complexity as a potential translational biomarker for psychosis
#Text=Dinuzzo, M. et al.
228-1	31728-31738	References	_	
228-2	31739-31751	Experimental	_	
228-3	31752-31763	observation	_	
228-4	31764-31766	of	_	
228-5	31767-31777	transition	_	
228-6	31778-31782	from	_	
228-7	31783-31790	chaotic	_	
228-8	31791-31799	bursting	_	
228-9	31800-31802	to	_	
228-10	31803-31810	chaotic	_	
228-11	31811-31818	spiking	_	
228-12	31819-31821	in	_	
228-13	31822-31823	a	_	
228-14	31824-31830	neural	_	
228-15	31831-31840	pacemaker	_	
228-16	31841-31851	Biological	_	
228-17	31852-31864	experimental	_	
228-18	31865-31878	demonstration	_	
228-19	31879-31881	of	_	
228-20	31882-31894	bifurcations	_	
228-21	31895-31899	from	_	
228-22	31900-31908	bursting	_	
228-23	31909-31911	to	_	
228-24	31912-31919	spiking	_	
228-25	31920-31929	predicted	_	
228-26	31930-31932	by	_	
228-27	31933-31944	theoretical	_	
228-28	31945-31951	models	_	
228-29	31952-31967	Autapse-induced	_	
228-30	31968-31976	multiple	_	
228-31	31977-31986	coherence	_	
228-32	31987-31996	resonance	_	
228-33	31997-31999	in	_	
228-34	32000-32006	single	_	
228-35	32007-32014	neurons	_	
228-36	32015-32018	and	_	
228-37	32019-32027	neuronal	_	
228-38	32028-32036	networks	_	
228-39	32037-32044	Altered	_	
228-40	32045-32052	resting	_	
228-41	32053-32058	state	_	
228-42	32059-32069	complexity	_	
228-43	32070-32072	in	_	
228-44	32073-32086	schizophrenia	_	
228-45	32087-32092	Brain	_	
228-46	32093-32100	entropy	_	
228-47	32101-32108	mapping	_	
228-48	32109-32114	using	_	
228-49	32115-32119	fMRI	_	
228-50	32120-32130	Exploiting	_	
228-51	32131-32141	complexity	_	
228-52	32142-32153	information	_	
228-53	32154-32157	for	_	
228-54	32158-32163	brain	_	
228-55	32164-32174	activation	_	
228-56	32175-32184	detection	_	
228-57	32185-32191	Neural	_	
228-58	32192-32202	complexity	_	
228-59	32203-32205	as	_	
228-60	32206-32207	a	_	
228-61	32208-32217	potential	_	
228-62	32218-32231	translational	_	
228-63	32232-32241	biomarker	_	
228-64	32242-32245	for	_	
228-65	32246-32255	psychosis	_	
228-66	32256-32263	Dinuzzo	_	
228-67	32263-32264	,	_	
228-68	32265-32266	M	_	
228-69	32266-32267	.	_	
228-70	32268-32270	et	_	
228-71	32271-32273	al	_	
228-72	32273-32274	.	_	

#Text=Temporal information entropy of the blood-oxygenation level-dependent signals increases in the activated human primary visual cortex.
229-1	32275-32283	Temporal	_	
229-2	32284-32295	information	_	
229-3	32296-32303	entropy	_	
229-4	32304-32306	of	_	
229-5	32307-32310	the	_	
229-6	32311-32328	blood-oxygenation	_	
229-7	32329-32344	level-dependent	_	
229-8	32345-32352	signals	_	
229-9	32353-32362	increases	_	
229-10	32363-32365	in	_	
229-11	32366-32369	the	_	
229-12	32370-32379	activated	_	
229-13	32380-32385	human	_	
229-14	32386-32393	primary	_	
229-15	32394-32400	visual	_	
229-16	32401-32407	cortex	_	
229-17	32407-32408	.	_	

#Text=Frontiers in Physics5, doi:10.3389/fphy.2017.00007 (2017).
230-1	32409-32418	Frontiers	_	
230-2	32419-32421	in	_	
230-3	32422-32430	Physics5	_	
230-4	32430-32431	,	_	
230-5	32432-32435	doi	_	
230-6	32435-32436	:	_	
230-7	32436-32443	10.3389	_	
230-8	32443-32444	/	_	
230-9	32444-32448	fphy	_	
230-10	32448-32459	.2017.00007	_	
230-11	32460-32461	(	_	
230-12	32461-32465	2017	_	
230-13	32465-32466	)	_	
230-14	32466-32467	.	_	

#Text=Sannino, S., Stramaglia, S., Lacasa, L. & Marinazzo, D.
231-1	32468-32475	Sannino	_	
231-2	32475-32476	,	_	
231-3	32477-32478	S	_	
231-4	32478-32479	.	_	
231-5	32479-32480	,	_	
231-6	32481-32491	Stramaglia	_	
231-7	32491-32492	,	_	
231-8	32493-32494	S	_	
231-9	32494-32495	.	_	
231-10	32495-32496	,	_	
231-11	32497-32503	Lacasa	_	
231-12	32503-32504	,	_	
231-13	32505-32506	L	_	
231-14	32506-32507	.	_	
231-15	32508-32509	&	_	
231-16	32510-32519	Marinazzo	_	
231-17	32519-32520	,	_	
231-18	32521-32522	D	_	
231-19	32522-32523	.	_	

#Text=Visibility graphs for fMRI data: multiplex temporal graphs and their modulations across resting state networks.
232-1	32524-32534	Visibility	_	
232-2	32535-32541	graphs	_	
232-3	32542-32545	for	_	
232-4	32546-32550	fMRI	_	
232-5	32551-32555	data	_	
232-6	32555-32556	:	_	
232-7	32557-32566	multiplex	_	
232-8	32567-32575	temporal	_	
232-9	32576-32582	graphs	_	
232-10	32583-32586	and	_	
232-11	32587-32592	their	_	
232-12	32593-32604	modulations	_	
232-13	32605-32611	across	_	
232-14	32612-32619	resting	_	
232-15	32620-32625	state	_	
232-16	32626-32634	networks	_	
232-17	32634-32635	.	_	

#Text=Network Neuroscience, doi:10.1101/106443 (2017).
233-1	32636-32643	Network	_	
233-2	32644-32656	Neuroscience	_	
233-3	32656-32657	,	_	
233-4	32658-32661	doi	_	
233-5	32661-32662	:	_	
233-6	32662-32669	10.1101	_	
233-7	32669-32670	/	_	
233-8	32670-32676	106443	_	
233-9	32677-32678	(	_	
233-10	32678-32682	2017	_	
233-11	32682-32683	)	_	
233-12	32683-32684	.	_	

#Text=Multi-task connectivity reveals flexible hubs for adaptive task control
#Text=Dynamic reconfiguration of frontal brain networks during executive cognition in humans
#Text=Assessing dynamic brain graphs of time-varying connectivity in fMRI data: application to healthy controls and patients with schizophrenia
#Text=Tracking whole-brain connectivity dynamics in the resting state
#Text=Yin, D. et al.
234-1	32685-32695	Multi-task	_	
234-2	32696-32708	connectivity	_	
234-3	32709-32716	reveals	_	
234-4	32717-32725	flexible	_	
234-5	32726-32730	hubs	_	
234-6	32731-32734	for	_	
234-7	32735-32743	adaptive	_	
234-8	32744-32748	task	_	
234-9	32749-32756	control	_	
234-10	32757-32764	Dynamic	_	
234-11	32765-32780	reconfiguration	_	
234-12	32781-32783	of	_	
234-13	32784-32791	frontal	_	
234-14	32792-32797	brain	_	
234-15	32798-32806	networks	_	
234-16	32807-32813	during	_	
234-17	32814-32823	executive	_	
234-18	32824-32833	cognition	_	
234-19	32834-32836	in	_	
234-20	32837-32843	humans	_	
234-21	32844-32853	Assessing	_	
234-22	32854-32861	dynamic	_	
234-23	32862-32867	brain	_	
234-24	32868-32874	graphs	_	
234-25	32875-32877	of	_	
234-26	32878-32890	time-varying	_	
234-27	32891-32903	connectivity	_	
234-28	32904-32906	in	_	
234-29	32907-32911	fMRI	_	
234-30	32912-32916	data	_	
234-31	32916-32917	:	_	
234-32	32918-32929	application	_	
234-33	32930-32932	to	_	
234-34	32933-32940	healthy	_	
234-35	32941-32949	controls	_	
234-36	32950-32953	and	_	
234-37	32954-32962	patients	_	
234-38	32963-32967	with	_	
234-39	32968-32981	schizophrenia	_	
234-40	32982-32990	Tracking	_	
234-41	32991-33002	whole-brain	_	
234-42	33003-33015	connectivity	_	
234-43	33016-33024	dynamics	_	
234-44	33025-33027	in	_	
234-45	33028-33031	the	_	
234-46	33032-33039	resting	_	
234-47	33040-33045	state	_	
234-48	33046-33049	Yin	_	
234-49	33049-33050	,	_	
234-50	33051-33052	D	_	
234-51	33052-33053	.	_	
234-52	33054-33056	et	_	
234-53	33057-33059	al	_	
234-54	33059-33060	.	_	

#Text=Dissociable changes of frontal and parietal cortices in inherent functional flexibility across the human life span.
235-1	33061-33072	Dissociable	_	
235-2	33073-33080	changes	_	
235-3	33081-33083	of	_	
235-4	33084-33091	frontal	_	
235-5	33092-33095	and	_	
235-6	33096-33104	parietal	_	
235-7	33105-33113	cortices	_	
235-8	33114-33116	in	_	
235-9	33117-33125	inherent	_	
235-10	33126-33136	functional	_	
235-11	33137-33148	flexibility	_	
235-12	33149-33155	across	_	
235-13	33156-33159	the	_	
235-14	33160-33165	human	_	
235-15	33166-33170	life	_	
235-16	33171-33175	span	_	
235-17	33175-33176	.	_	

#Text=Journal of Neuroscience36 (2016).
236-1	33177-33184	Journal	_	
236-2	33185-33187	of	_	
236-3	33188-33202	Neuroscience36	_	
236-4	33203-33204	(	_	
236-5	33204-33208	2016	_	
236-6	33208-33209	)	_	
236-7	33209-33210	.	_	

#Text=Neural, electrophysiological and anatomical basis of brain-network variability and its characteristic changes in mental disorders
#Text=Approximate entropy as a measure of system complexity
#Text=Physiological time-series analysis using approximate entropy and sample entropy
#Text=Sample entropy reveals high discriminative power between young and elderly adults in short fMRI data sets
#Text=Loss of ‘complexity’ and aging
#Text=Physiologic complexity and aging: Implications for physical function and rehabilitation
#Text=Reorganization of brain networks in aging and age-related diseases
#Text=Age-related variation in EEG complexity to photic stimulation: a multiscale entropy analysis
#Text=Complexity of spontaneous BOLD activity in default mode network is correlated with cognitive function in normal male elderly: a multiscale entropy analysis
#Text=The nonlinear theory of schizophrenia
#Text=Complexity and schizophrenia
#Text=Lempel-Ziv complexity in schizophrenia: a MEG study
#Text=Complexity analysis of spontaneous brain activity in Alzheimer disease and mild cognitive impairment: an MEG study
#Text=Complexity analysis of spontaneous brain activity: effects of depression and antidepressant treatment
#Text=Complexity analysis of spontaneous brain activity in attention-deficit/hyperactivity disorder: diagnostic implications
#Text=Voxel-based, brain-wide association study of aberrant functional connectivity in schizophrenia implicates thalamocortical circuitry
#Text=DPARSF: A MATLAB toolbox for “pipeline” data analysis of resting-state fMRI
#Text=The global signal and observed anticorrelated resting state brain networks
#Text=A comprehensive assessment of regional variation in the impact of head micromovements on functional connectomics
#Text=Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion
#Text=Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain
#Text=Decoding wakefulness levels from typical fMRI resting-state data reveals reliable drifts between wakefulness and sleep
#Text=Decoding subject-driven cognitive states with whole-brain connectivity patterns
#Text=Dynamic functional connectomics signatures for characterization and differentiation of PTSD patients
#Text=Assessing serial irregularity and its implications for health
#Text=Physiological time-series analysis: what does regularity quantify?
237-1	33211-33217	Neural	_	
237-2	33217-33218	,	_	
237-3	33219-33239	electrophysiological	_	
237-4	33240-33243	and	_	
237-5	33244-33254	anatomical	_	
237-6	33255-33260	basis	_	
237-7	33261-33263	of	_	
237-8	33264-33277	brain-network	_	
237-9	33278-33289	variability	_	
237-10	33290-33293	and	_	
237-11	33294-33297	its	_	
237-12	33298-33312	characteristic	_	
237-13	33313-33320	changes	_	
237-14	33321-33323	in	_	
237-15	33324-33330	mental	_	
237-16	33331-33340	disorders	_	
237-17	33341-33352	Approximate	_	
237-18	33353-33360	entropy	_	
237-19	33361-33363	as	_	
237-20	33364-33365	a	_	
237-21	33366-33373	measure	_	
237-22	33374-33376	of	_	
237-23	33377-33383	system	_	
237-24	33384-33394	complexity	_	
237-25	33395-33408	Physiological	_	
237-26	33409-33420	time-series	_	
237-27	33421-33429	analysis	_	
237-28	33430-33435	using	_	
237-29	33436-33447	approximate	_	
237-30	33448-33455	entropy	_	
237-31	33456-33459	and	_	
237-32	33460-33466	sample	_	
237-33	33467-33474	entropy	_	
237-34	33475-33481	Sample	_	
237-35	33482-33489	entropy	_	
237-36	33490-33497	reveals	_	
237-37	33498-33502	high	_	
237-38	33503-33517	discriminative	_	
237-39	33518-33523	power	_	
237-40	33524-33531	between	_	
237-41	33532-33537	young	_	
237-42	33538-33541	and	_	
237-43	33542-33549	elderly	_	
237-44	33550-33556	adults	_	
237-45	33557-33559	in	_	
237-46	33560-33565	short	_	
237-47	33566-33570	fMRI	_	
237-48	33571-33575	data	_	
237-49	33576-33580	sets	_	
237-50	33581-33585	Loss	_	
237-51	33586-33588	of	_	
237-52	33589-33590	‘	_	
237-53	33590-33600	complexity	_	
237-54	33600-33601	’	_	
237-55	33602-33605	and	_	
237-56	33606-33611	aging	_	
237-57	33612-33623	Physiologic	_	
237-58	33624-33634	complexity	_	
237-59	33635-33638	and	_	
237-60	33639-33644	aging	_	
237-61	33644-33645	:	_	
237-62	33646-33658	Implications	_	
237-63	33659-33662	for	_	
237-64	33663-33671	physical	_	
237-65	33672-33680	function	_	
237-66	33681-33684	and	_	
237-67	33685-33699	rehabilitation	_	
237-68	33700-33714	Reorganization	_	
237-69	33715-33717	of	_	
237-70	33718-33723	brain	_	
237-71	33724-33732	networks	_	
237-72	33733-33735	in	_	
237-73	33736-33741	aging	_	
237-74	33742-33745	and	_	
237-75	33746-33757	age-related	_	
237-76	33758-33766	diseases	_	
237-77	33767-33778	Age-related	_	
237-78	33779-33788	variation	_	
237-79	33789-33791	in	_	
237-80	33792-33795	EEG	_	
237-81	33796-33806	complexity	_	
237-82	33807-33809	to	_	
237-83	33810-33816	photic	_	
237-84	33817-33828	stimulation	_	
237-85	33828-33829	:	_	
237-86	33830-33831	a	_	
237-87	33832-33842	multiscale	_	
237-88	33843-33850	entropy	_	
237-89	33851-33859	analysis	_	
237-90	33860-33870	Complexity	_	
237-91	33871-33873	of	_	
237-92	33874-33885	spontaneous	_	
237-93	33886-33890	BOLD	_	
237-94	33891-33899	activity	_	
237-95	33900-33902	in	_	
237-96	33903-33910	default	_	
237-97	33911-33915	mode	_	
237-98	33916-33923	network	_	
237-99	33924-33926	is	_	
237-100	33927-33937	correlated	_	
237-101	33938-33942	with	_	
237-102	33943-33952	cognitive	_	
237-103	33953-33961	function	_	
237-104	33962-33964	in	_	
237-105	33965-33971	normal	_	
237-106	33972-33976	male	_	
237-107	33977-33984	elderly	_	
237-108	33984-33985	:	_	
237-109	33986-33987	a	_	
237-110	33988-33998	multiscale	_	
237-111	33999-34006	entropy	_	
237-112	34007-34015	analysis	_	
237-113	34016-34019	The	_	
237-114	34020-34029	nonlinear	_	
237-115	34030-34036	theory	_	
237-116	34037-34039	of	_	
237-117	34040-34053	schizophrenia	_	
237-118	34054-34064	Complexity	_	
237-119	34065-34068	and	_	
237-120	34069-34082	schizophrenia	_	
237-121	34083-34093	Lempel-Ziv	_	
237-122	34094-34104	complexity	_	
237-123	34105-34107	in	_	
237-124	34108-34121	schizophrenia	_	
237-125	34121-34122	:	_	
237-126	34123-34124	a	_	
237-127	34125-34128	MEG	_	
237-128	34129-34134	study	_	
237-129	34135-34145	Complexity	_	
237-130	34146-34154	analysis	_	
237-131	34155-34157	of	_	
237-132	34158-34169	spontaneous	_	
237-133	34170-34175	brain	_	
237-134	34176-34184	activity	_	
237-135	34185-34187	in	_	
237-136	34188-34197	Alzheimer	_	
237-137	34198-34205	disease	_	
237-138	34206-34209	and	_	
237-139	34210-34214	mild	_	
237-140	34215-34224	cognitive	_	
237-141	34225-34235	impairment	_	
237-142	34235-34236	:	_	
237-143	34237-34239	an	_	
237-144	34240-34243	MEG	_	
237-145	34244-34249	study	_	
237-146	34250-34260	Complexity	_	
237-147	34261-34269	analysis	_	
237-148	34270-34272	of	_	
237-149	34273-34284	spontaneous	_	
237-150	34285-34290	brain	_	
237-151	34291-34299	activity	_	
237-152	34299-34300	:	_	
237-153	34301-34308	effects	_	
237-154	34309-34311	of	_	
237-155	34312-34322	depression	_	
237-156	34323-34326	and	_	
237-157	34327-34341	antidepressant	_	
237-158	34342-34351	treatment	_	
237-159	34352-34362	Complexity	_	
237-160	34363-34371	analysis	_	
237-161	34372-34374	of	_	
237-162	34375-34386	spontaneous	_	
237-163	34387-34392	brain	_	
237-164	34393-34401	activity	_	
237-165	34402-34404	in	_	
237-166	34405-34422	attention-deficit	_	
237-167	34422-34423	/	_	
237-168	34423-34436	hyperactivity	_	
237-169	34437-34445	disorder	_	
237-170	34445-34446	:	_	
237-171	34447-34457	diagnostic	_	
237-172	34458-34470	implications	_	
237-173	34471-34482	Voxel-based	_	
237-174	34482-34483	,	_	
237-175	34484-34494	brain-wide	_	
237-176	34495-34506	association	_	
237-177	34507-34512	study	_	
237-178	34513-34515	of	_	
237-179	34516-34524	aberrant	_	
237-180	34525-34535	functional	_	
237-181	34536-34548	connectivity	_	
237-182	34549-34551	in	_	
237-183	34552-34565	schizophrenia	_	
237-184	34566-34576	implicates	_	
237-185	34577-34592	thalamocortical	_	
237-186	34593-34602	circuitry	_	
237-187	34603-34609	DPARSF	_	
237-188	34609-34610	:	_	
237-189	34611-34612	A	_	
237-190	34613-34619	MATLAB	_	
237-191	34620-34627	toolbox	_	
237-192	34628-34631	for	_	
237-193	34632-34633	“	_	
237-194	34633-34641	pipeline	_	
237-195	34641-34642	”	_	
237-196	34643-34647	data	_	
237-197	34648-34656	analysis	_	
237-198	34657-34659	of	_	
237-199	34660-34673	resting-state	_	
237-200	34674-34678	fMRI	_	
237-201	34679-34682	The	_	
237-202	34683-34689	global	_	
237-203	34690-34696	signal	_	
237-204	34697-34700	and	_	
237-205	34701-34709	observed	_	
237-206	34710-34724	anticorrelated	_	
237-207	34725-34732	resting	_	
237-208	34733-34738	state	_	
237-209	34739-34744	brain	_	
237-210	34745-34753	networks	_	
237-211	34754-34755	A	_	
237-212	34756-34769	comprehensive	_	
237-213	34770-34780	assessment	_	
237-214	34781-34783	of	_	
237-215	34784-34792	regional	_	
237-216	34793-34802	variation	_	
237-217	34803-34805	in	_	
237-218	34806-34809	the	_	
237-219	34810-34816	impact	_	
237-220	34817-34819	of	_	
237-221	34820-34824	head	_	
237-222	34825-34839	micromovements	_	
237-223	34840-34842	on	_	
237-224	34843-34853	functional	_	
237-225	34854-34866	connectomics	_	
237-226	34867-34875	Spurious	_	
237-227	34876-34879	but	_	
237-228	34880-34890	systematic	_	
237-229	34891-34903	correlations	_	
237-230	34904-34906	in	_	
237-231	34907-34917	functional	_	
237-232	34918-34930	connectivity	_	
237-233	34931-34934	MRI	_	
237-234	34935-34943	networks	_	
237-235	34944-34949	arise	_	
237-236	34950-34954	from	_	
237-237	34955-34962	subject	_	
237-238	34963-34969	motion	_	
237-239	34970-34979	Automated	_	
237-240	34980-34990	anatomical	_	
237-241	34991-34999	labeling	_	
237-242	35000-35002	of	_	
237-243	35003-35014	activations	_	
237-244	35015-35017	in	_	
237-245	35018-35021	SPM	_	
237-246	35022-35027	using	_	
237-247	35028-35029	a	_	
237-248	35030-35041	macroscopic	_	
237-249	35042-35052	anatomical	_	
237-250	35053-35065	parcellation	_	
237-251	35066-35068	of	_	
237-252	35069-35072	the	_	
237-253	35073-35076	MNI	_	
237-254	35077-35080	MRI	_	
237-255	35081-35095	single-subject	_	
237-256	35096-35101	brain	_	
237-257	35102-35110	Decoding	_	
237-258	35111-35122	wakefulness	_	
237-259	35123-35129	levels	_	
237-260	35130-35134	from	_	
237-261	35135-35142	typical	_	
237-262	35143-35147	fMRI	_	
237-263	35148-35161	resting-state	_	
237-264	35162-35166	data	_	
237-265	35167-35174	reveals	_	
237-266	35175-35183	reliable	_	
237-267	35184-35190	drifts	_	
237-268	35191-35198	between	_	
237-269	35199-35210	wakefulness	_	
237-270	35211-35214	and	_	
237-271	35215-35220	sleep	_	
237-272	35221-35229	Decoding	_	
237-273	35230-35244	subject-driven	_	
237-274	35245-35254	cognitive	_	
237-275	35255-35261	states	_	
237-276	35262-35266	with	_	
237-277	35267-35278	whole-brain	_	
237-278	35279-35291	connectivity	_	
237-279	35292-35300	patterns	_	
237-280	35301-35308	Dynamic	_	
237-281	35309-35319	functional	_	
237-282	35320-35332	connectomics	_	
237-283	35333-35343	signatures	_	
237-284	35344-35347	for	_	
237-285	35348-35364	characterization	_	
237-286	35365-35368	and	_	
237-287	35369-35384	differentiation	_	
237-288	35385-35387	of	_	
237-289	35388-35392	PTSD	_	
237-290	35393-35401	patients	_	
237-291	35402-35411	Assessing	_	
237-292	35412-35418	serial	_	
237-293	35419-35431	irregularity	_	
237-294	35432-35435	and	_	
237-295	35436-35439	its	_	
237-296	35440-35452	implications	_	
237-297	35453-35456	for	_	
237-298	35457-35463	health	_	
237-299	35464-35477	Physiological	_	
237-300	35478-35489	time-series	_	
237-301	35490-35498	analysis	_	
237-302	35498-35499	:	_	
237-303	35500-35504	what	_	
237-304	35505-35509	does	_	
237-305	35510-35520	regularity	_	
237-306	35521-35529	quantify	_	
237-307	35529-35530	?	_	

#Text=Key functional circuitry altered in schizophrenia involves parietal regions associated with sense of self
#Text=The chronnectome: time-varying connectivity networks as the next frontier in fMRI data discovery
#Text=Selective enhancement of associative learning by microstimulation of the anterior caudate
#Text=The roles of the caudate nucleus in human classification learning
#Text=Neural correlates of olfactory learning: critical role of centrifugal neuromodulation
#Text=Long-term potentiation in the amygdala: a mechanism for emotional learning and memory
#Text=New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?
238-1	35531-35534	Key	_	
238-2	35535-35545	functional	_	
238-3	35546-35555	circuitry	_	
238-4	35556-35563	altered	_	
238-5	35564-35566	in	_	
238-6	35567-35580	schizophrenia	_	
238-7	35581-35589	involves	_	
238-8	35590-35598	parietal	_	
238-9	35599-35606	regions	_	
238-10	35607-35617	associated	_	
238-11	35618-35622	with	_	
238-12	35623-35628	sense	_	
238-13	35629-35631	of	_	
238-14	35632-35636	self	_	
238-15	35637-35640	The	_	
238-16	35641-35653	chronnectome	_	
238-17	35653-35654	:	_	
238-18	35655-35667	time-varying	_	
238-19	35668-35680	connectivity	_	
238-20	35681-35689	networks	_	
238-21	35690-35692	as	_	
238-22	35693-35696	the	_	
238-23	35697-35701	next	_	
238-24	35702-35710	frontier	_	
238-25	35711-35713	in	_	
238-26	35714-35718	fMRI	_	
238-27	35719-35723	data	_	
238-28	35724-35733	discovery	_	
238-29	35734-35743	Selective	_	
238-30	35744-35755	enhancement	_	
238-31	35756-35758	of	_	
238-32	35759-35770	associative	_	
238-33	35771-35779	learning	_	
238-34	35780-35782	by	_	
238-35	35783-35799	microstimulation	_	
238-36	35800-35802	of	_	
238-37	35803-35806	the	_	
238-38	35807-35815	anterior	_	
238-39	35816-35823	caudate	_	
238-40	35824-35827	The	_	
238-41	35828-35833	roles	_	
238-42	35834-35836	of	_	
238-43	35837-35840	the	_	
238-44	35841-35848	caudate	_	
238-45	35849-35856	nucleus	_	
238-46	35857-35859	in	_	
238-47	35860-35865	human	_	
238-48	35866-35880	classification	_	
238-49	35881-35889	learning	_	
238-50	35890-35896	Neural	_	
238-51	35897-35907	correlates	_	
238-52	35908-35910	of	_	
238-53	35911-35920	olfactory	_	
238-54	35921-35929	learning	_	
238-55	35929-35930	:	_	
238-56	35931-35939	critical	_	
238-57	35940-35944	role	_	
238-58	35945-35947	of	_	
238-59	35948-35959	centrifugal	_	
238-60	35960-35975	neuromodulation	_	
238-61	35976-35985	Long-term	_	
238-62	35986-35998	potentiation	_	
238-63	35999-36001	in	_	
238-64	36002-36005	the	_	
238-65	36006-36014	amygdala	_	
238-66	36014-36015	:	_	
238-67	36016-36017	a	_	
238-68	36018-36027	mechanism	_	
238-69	36028-36031	for	_	
238-70	36032-36041	emotional	_	
238-71	36042-36050	learning	_	
238-72	36051-36054	and	_	
238-73	36055-36061	memory	_	
238-74	36062-36065	New	_	
238-75	36066-36073	neurons	_	
238-76	36074-36077	and	_	
238-77	36078-36081	new	_	
238-78	36082-36090	memories	_	
238-79	36090-36091	:	_	
238-80	36092-36095	how	_	
238-81	36096-36100	does	_	
238-82	36101-36106	adult	_	
238-83	36107-36118	hippocampal	_	
238-84	36119-36131	neurogenesis	_	
238-85	36132-36138	affect	_	
238-86	36139-36147	learning	_	
238-87	36148-36151	and	_	
238-88	36152-36158	memory	_	
238-89	36158-36159	?	_	

#Text=Visual learning suppressed by cooling the temporal pole
#Text=Dynamic reconfiguration of human brain networks during learning
#Text=Task-based core-periphery organization of human brain dynamics
#Text=Neuropsychological assessment (4th ed.)
239-1	36160-36166	Visual	_	
239-2	36167-36175	learning	_	
239-3	36176-36186	suppressed	_	
239-4	36187-36189	by	_	
239-5	36190-36197	cooling	_	
239-6	36198-36201	the	_	
239-7	36202-36210	temporal	_	
239-8	36211-36215	pole	_	
239-9	36216-36223	Dynamic	_	
239-10	36224-36239	reconfiguration	_	
239-11	36240-36242	of	_	
239-12	36243-36248	human	_	
239-13	36249-36254	brain	_	
239-14	36255-36263	networks	_	
239-15	36264-36270	during	_	
239-16	36271-36279	learning	_	
239-17	36280-36290	Task-based	_	
239-18	36291-36305	core-periphery	_	
239-19	36306-36318	organization	_	
239-20	36319-36321	of	_	
239-21	36322-36327	human	_	
239-22	36328-36333	brain	_	
239-23	36334-36342	dynamics	_	
239-24	36343-36361	Neuropsychological	_	
239-25	36362-36372	assessment	_	
239-26	36373-36374	(	_	
239-27	36374-36377	4th	_	
239-28	36378-36380	ed	_	
239-29	36380-36381	.	_	
239-30	36381-36382	)	_	

#Text=Age-related changes in the structure and function of prefrontal cortex-amygdala circuitry in children and adolescents: a multi-modal imaging approach
#Text=A developmental shift from positive to negative connectivity in human amygdala-prefrontal circuitry
#Text=Age-related changes in amygdala-frontal connectivity during emotional face processing from childhood into young adulthood
#Text=Functional neuroimaging studies of aging and emotion: fronto-amygdalar differences during emotional perception and episodic memory
#Text=Increased functional connectivity between subcortical and cortical resting-state networks in autism spectrum disorder
#Text=Emotion effects on attention, amygdala activation, and functional connectivity in schizophrenia
#Text=Evidence for accelerated decline of functional brain network efficiency in schizophrenia
#Text=Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders
240-1	36383-36394	Age-related	_	
240-2	36395-36402	changes	_	
240-3	36403-36405	in	_	
240-4	36406-36409	the	_	
240-5	36410-36419	structure	_	
240-6	36420-36423	and	_	
240-7	36424-36432	function	_	
240-8	36433-36435	of	_	
240-9	36436-36446	prefrontal	_	
240-10	36447-36462	cortex-amygdala	_	
240-11	36463-36472	circuitry	_	
240-12	36473-36475	in	_	
240-13	36476-36484	children	_	
240-14	36485-36488	and	_	
240-15	36489-36500	adolescents	_	
240-16	36500-36501	:	_	
240-17	36502-36503	a	_	
240-18	36504-36515	multi-modal	_	
240-19	36516-36523	imaging	_	
240-20	36524-36532	approach	_	
240-21	36533-36534	A	_	
240-22	36535-36548	developmental	_	
240-23	36549-36554	shift	_	
240-24	36555-36559	from	_	
240-25	36560-36568	positive	_	
240-26	36569-36571	to	_	
240-27	36572-36580	negative	_	
240-28	36581-36593	connectivity	_	
240-29	36594-36596	in	_	
240-30	36597-36602	human	_	
240-31	36603-36622	amygdala-prefrontal	_	
240-32	36623-36632	circuitry	_	
240-33	36633-36644	Age-related	_	
240-34	36645-36652	changes	_	
240-35	36653-36655	in	_	
240-36	36656-36672	amygdala-frontal	_	
240-37	36673-36685	connectivity	_	
240-38	36686-36692	during	_	
240-39	36693-36702	emotional	_	
240-40	36703-36707	face	_	
240-41	36708-36718	processing	_	
240-42	36719-36723	from	_	
240-43	36724-36733	childhood	_	
240-44	36734-36738	into	_	
240-45	36739-36744	young	_	
240-46	36745-36754	adulthood	_	
240-47	36755-36765	Functional	_	
240-48	36766-36778	neuroimaging	_	
240-49	36779-36786	studies	_	
240-50	36787-36789	of	_	
240-51	36790-36795	aging	_	
240-52	36796-36799	and	_	
240-53	36800-36807	emotion	_	
240-54	36807-36808	:	_	
240-55	36809-36825	fronto-amygdalar	_	
240-56	36826-36837	differences	_	
240-57	36838-36844	during	_	
240-58	36845-36854	emotional	_	
240-59	36855-36865	perception	_	
240-60	36866-36869	and	_	
240-61	36870-36878	episodic	_	
240-62	36879-36885	memory	_	
240-63	36886-36895	Increased	_	
240-64	36896-36906	functional	_	
240-65	36907-36919	connectivity	_	
240-66	36920-36927	between	_	
240-67	36928-36939	subcortical	_	
240-68	36940-36943	and	_	
240-69	36944-36952	cortical	_	
240-70	36953-36966	resting-state	_	
240-71	36967-36975	networks	_	
240-72	36976-36978	in	_	
240-73	36979-36985	autism	_	
240-74	36986-36994	spectrum	_	
240-75	36995-37003	disorder	_	
240-76	37004-37011	Emotion	_	
240-77	37012-37019	effects	_	
240-78	37020-37022	on	_	
240-79	37023-37032	attention	_	
240-80	37032-37033	,	_	
240-81	37034-37042	amygdala	_	
240-82	37043-37053	activation	_	
240-83	37053-37054	,	_	
240-84	37055-37058	and	_	
240-85	37059-37069	functional	_	
240-86	37070-37082	connectivity	_	
240-87	37083-37085	in	_	
240-88	37086-37099	schizophrenia	_	
240-89	37100-37108	Evidence	_	
240-90	37109-37112	for	_	
240-91	37113-37124	accelerated	_	
240-92	37125-37132	decline	_	
240-93	37133-37135	of	_	
240-94	37136-37146	functional	_	
240-95	37147-37152	brain	_	
240-96	37153-37160	network	_	
240-97	37161-37171	efficiency	_	
240-98	37172-37174	in	_	
240-99	37175-37188	schizophrenia	_	
240-100	37189-37200	Accelerated	_	
240-101	37201-37206	brain	_	
240-102	37207-37212	aging	_	
240-103	37213-37215	in	_	
240-104	37216-37229	schizophrenia	_	
240-105	37230-37233	and	_	
240-106	37234-37240	beyond	_	
240-107	37240-37241	:	_	
240-108	37242-37243	a	_	
240-109	37244-37259	neuroanatomical	_	
240-110	37260-37266	marker	_	
240-111	37267-37269	of	_	
240-112	37270-37281	psychiatric	_	
240-113	37282-37291	disorders	_	
